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1 Overview 
Over recent decades, organometallic chemistry has changed the practice in science and industry. Since 
the early 1950s, organometallic chemistry has grown to become an important industrial tool, especially 
in the formation of complex molecules in medicinal, agrochemical or synthetic fragrance chemistry as 
well as in many other fields.1 In case of the agrochemical industry, new technologies such as synthetic 
herbicides, insecticides and fungicides contributed significantly to developments in the area of chemical 
crop protection.2 Population growth as well as greater economic prosperity in emerging markets raised 
the demand for food production while natural resources are limited.3 Therefore, there is a need for new 
innovations and progress in agrochemical industry. Similar to the advance in food production due to 
population growth, the research-based pharmaceutical industry entered a new era in medicines 
development. Scientists have been attempting to find new synthetic methods for the preparation of drugs 
to cure malignant disease like cancer or HIV. The interest in the design and synthesis of small molecule 
drugs for the pharmaceutical industry has increased and is nowadays a significant discipline in modern 
drug discovery and organic chemistry.4 Under the top-selling agents are a lot of small molecules, which 
can be prepared over several steps and with the help of organometallic compounds. Desloratadine (1), 
Etoricoxib (2) as well as Tiagabine (3) represent such small molecules, which are synthesized by 
organometallics.5 Due to this fact, the development of new synthetic routes, using organometallic 
reagents as well as the development of new organometallic reagents is of great importance for the 
chemical industry.  
 
Figure 1: Selected important top-selling drugs (Desloratadine (1), Etoricoxib (2), Tiagabine (3)). 
The nature of the metal and the carbon hybridization is significant for the behavior and the reactivity of 
the organometallic reagent. In general, the ionic character of the carbon-metal bond, depending on the 
difference in electronegativity of the metal and the carbon atom, is responsible for the reactivity of the 
organometallic compound. For instance, a high ionic character accompanied with a lower stability are 
                                                     
1 a) G. W. Parshall, Organometallics 1987, 6, 687; b) Applications of Organometallic compounds (Ed.: I. Omae), 
Wiley-VCH Verlag GmbH & Co KGaA, Weinheim, 1998. 
2 P. A. Urech, Plant Pathol. 1999, 48, 689. 
3 Food and Agriculture Organization of the United Nations (FAO), World Agriculture Towards 2030/2050. The 
2012 Revision. 
4 a) D. P. Rotella, ACS Chem. Neurosci. 2016, 7, 1315; b) H.-J. Federsel, Acc. Chem. Res. 2009, 42, 671. 
5 M. Baumann, I. R. Baxendale, Beilstein J. Org. Chem. 2013, 9, 2265. 
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represented by lithium or sodium organometallics. Such compounds display an exceptional reactivity 
towards a variety of electrophiles but require low temperature for their reactions and possess a low 
functional group tolerance. A more covalent carbon-metal bond and consequently a higher stability and 
functional group compatibility is offered by organomagnesium reagents. In comparison to lithium and 
magnesium reagents, organozinc or boron reagents are less reactive, due to their covalent metal carbon 
bond. Thus, they are compatible with most functional groups applied in organic synthesis.6 With this 
diverse reactivities, various synthetic problems can be solved and therefore organometallic compounds 
play an important role in modern synthetic chemistry. 
2 Preparation of Polyfunctional Zinc and Magnesium Organometallic 
Reagents 
The beginning of organometallic chemistry can be traced back to the year 1760, when de Gassicourt 
reported the first organometallic reagent, the so-called “Cadet’s fuming liquid” containing cacodyl 
oxide [(CH3)2As]2O.7 Since this time, including the pioneering work of Frankland8 and Grignard,9 
various approaches to prepare polyfunctional organometallics especially for magnesium and zinc have 
been developed. The three most commonly used strategies include oxidative insertion, halogen-metal 
exchange and directed metalation. Another approach to organometallic reagents offers transmetalation 
(Scheme 1).  
 
Scheme 1: Preparation of organomagnesium and organozinc reagents via different pathways. 
                                                     
6 Handbook of Functionalized Organometallics Vol. 1 and 2 (Ed.: P. Knochel), Wiley-VCH Verlag GmbH & Co 
KGaA, Weinheim, 2005. 
7 D. Seyferth, Organometallics 2001, 20, 1488. 
8 E. Frankland, Liebigs Ann. Chem. 1849, 71, 171. 
9 V. Grignard, Compt. Rend. Acad. Sci. Paris 1900, 130, 1322. 
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2.1 Oxidative Insertion 
One of the most common methods for the preparation of zinc and magnesium organometallic reagents 
is the oxidative insertion. The method was first described in 1849 by Frankland, who prepared 
diethylzinc by the reaction of granulated zinc with ethyliodide.8 Another milestone in this field was the 
work on organomagnesium reagents from Grignard. He discovered that methyliodide reacted with 
magnesium turnings in diethylether, affording the first organomagnesium compound.9 Since that time 
a remarkable rise of organometallic chemistry began and a wide range of investigations were made. The 
direct insertion of magnesium into the halogen carbon bond takes place in short reaction times but 
sensitive functional groups complicate the preparation of these Grignard reagents. Usually, an activation 
of the metal surface by using 1,2-dibromoethane, iodine or DIBAL-H is required for reducing the 
induction time. However, by adding LiCl, Knochel and co-workers developed an oxidative insertion 
method under mild conditions to prepare organomagnesium reagents with high functional group 
tolerance.6 For example the use of magnesium turnings in the presence of LiCl led to a magnesium 
insertion into 2-chlorobenzonitrile (4) in THF at 25 °C within 45 min. Compared to the previous 
method, the reaction required 5 h and decomposition was observed without the addition of LiCl. After 
transmetallation of magnesium species 5 to zinc, the zinc intermediate underwent a Pd-catalyzed 
Negishi cross-coupling with 4-iodoanisole to furnish the arylated benzonitrile 6 (Scheme 2).10 
 
Scheme 2: Preparation of biaryl 6 using magnesium insertion in the presence of LiCl. 
Furthermore, this method could be extended to a variety of metals such as zinc,11 manganese,12 
aluminum13 or indium.14 The use of commercially available zinc powder for the insertion into highly 
functionalized aromatic and heteroaromatic halides was also shown by Knochel. Thereby, a broad range 
of functional groups like esters, aldehydes and nitriles could be tolerated.11 The role of LiCl during the 
                                                     
10 F. M. Piller, P. Appukkuttan, A. Gavryushin, M. Helm, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 6802. 
11 a) A. Krasovskiy, V. Malakhov, A. Gavryushin, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 6040; b) N. 
Boudet, S. Sase, P. Sinha, C.-Y. Liu, A. Krasovskiy, P. Knochel, J. Am. Chem. Soc. 2007, 129, 12358; c) A. 
Metzger, M. A. Schade, P. Knochel, Org. Lett. 2008, 10, 1107. 
12 Z. Peng, P. Knochel, Org. Lett. 2011, 13, 3198. 
13 a) T. D. Blümke, Y.-H. Chen, Z. Peng, P. Knochel, Nat. Chem. 2010, 2, 313; b) T. D. Blümke, T. Klatt, K. 
Koszinowski, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 9926. 
14 a) Y.-H. Chen, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 7648; b) Y.-H. Chen, M. Sun, P. Knochel, Angew. 
Chem. Int. Ed. 2009, 48, 2236. 
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insertion of zinc into organic halides was investigated by several groups.15 Examples of this oxidative 
insertion are shown in Scheme 3. Furan iodide derivative 7 could be converted into the corresponding 
organozinc compound 8 under mild conditions and subsequently underwent a copper-catalyzed 
allylation with ethyl 2-bromomethyl acrylate to yield 9 in 81% yield.11a Furthermore, the preparation 
and cross-coupling reaction of the zinc reagent 11 with methyl 2-iodobenzoate furnished compound 12 
in 76% yield (Scheme 3).11b 
 
Scheme 3: Preparation of functionalized (hetero)arenes using a zinc insertion in the presence of LiCl. 
2.2 Halogen-Metal Exchange 
Besides the selective insertion of metals into organic halides, a commonly used method for the 
preparation of organometallic reagents is the halogen-metal exchange. In general, the driving force for 
this reaction type is the formation of a more stable organometallic species compared to the exchange 
reagent itself (sp > sp2vinyl > sp2aryl > sp3prim > sp3sec).6,16 Discovered by Gilman17 and Wittig,18 the 
halogen-lithium exchange has proven its synthetic utility over the years for preparing a wide range of 
lithium organometallics.19 Nevertheless, the high reactivity of the carbon-lithium bond has precluded 
the use of this method for preparing polyfunctional lithium reagents at convenient reaction 
temperatures.20 On the other hand, the iodine-magnesium exchange proved to be advantageous for the 
                                                     
15 K. Koszinowski, P. Böhrer, Organometallics 2009, 28, 771; b) J. E. Fleckenstein, K. Koszinowski, 
Organometallics 2011, 30, 5018; c) C. Feng, D. W. Cunningham, Q. T. Easter, S. A. Blum, J. Am. Chem. Soc. 
2016, 138, 11156. 
16 D. Hauk, S. Lang, A. Murso, Org. Process Res. Dev. 2006, 10, 733. 
17 a) H. Gilman, W. Langham, A. L. Jacoby, J. Am. Chem. Soc. 1939, 61, 106; b) R. G. Jones, H. Gilman, Org. 
React. 1951, 6, 339. 
18 G. Wittig, U. Pockels, H. Dröge, Chem. Ber. 1938, 71, 1903. 
19 a) J. Clayden, Organolithiums: Selectivity for Synthesis (Ed.: J. Clayden), Pergamon, Oxford, 2002; b) C. 
Nájera, J. M. Sansano, M. Yus, Tetrahedron 2003, 59, 9255. 
20 Notable exceptions: a) A. Nagaki, H. Kim, H. Usutani, C. Matsuo, J.-i. Yoshida, Org. Biomol. Chem. 2010, 8, 
1212; b) H. Kim, A. Nagaki, J.-i. Yoshida, Nat. Comm. 2011, 2, 264; c) A. Nagaki, K. Imai, S. Ishiuchi, J.-i. 
Yoshida, Angew. Chem. Int. Ed. 2015, 54, 1914; d) H. Kim, H.-J. Lee, D.-P. Kim, Angew. Chem. Int. Ed. 2015, 
54, 1877. 
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preparation of polyfunctional organomagnesium reagents because of the less ionic character of the 
carbon-magnesium bond.21 Whereas the halogen-lithium exchange is one of the fastest reactions in 
organic synthesis,22 iodine-magnesium and especially bromine-magnesium exchanges are considerably 
slow.23 
2.2.1 Halogen-Magnesium Exchange 
The halogen-magnesium exchange reaction was used for generating magnesium carbenoids as shown 
by Köbrich24 and Villieras.25 This exchange reaction has also found to be a convenient method for 
converting iodo- or bromo-heterocycles into the corresponding magnesiated heterocycles.21a General, 
the iodine-magnesium exchange takes place faster than the corresponding bromine-magnesium 
exchange and the more stabilized the resulting magnesium species is, the faster the exchange reaction 
takes place. 
 
Scheme 4: Regioselectivity of the bromine-magnesium exchange. 
An elegant application was shown by Christophersen: whereas 2-bromo-3-iodothiophene (13a) 
produced 3-magnesiated bromothiophene 14a via an iodine-magnesium exchange, 
                                                     
21 a) A. Boudier, L. O. Bromm, M. Lotz, P. Knochel, Angew. Chem. Int. Ed. 2000, 39, 4414; b) P. Knochel, W. 
Dohle, N. Gommermann, F. F. Kneisel, F. Kopp, T. Korn, I. Sapountzis, V. A. Vu, Angew. Chem. Int. Ed. 2003, 
42, 4302; c) N. M. Barl, V. Werner, C. Sämann, P. Knochel, Heterocycles 2014, 88, 827; d) G. Dagousset, C. 
Francois, T. Leon, R. Blanc, E. Sansiaume-Dagousset, P. Knochel, Synthesis 2014, 46, 3133; e) D. Tilly, F. 
Chevallier, F. Mongin, P. C. Gros, Chem. Rev. 2014, 114, 1207; f) R. Li-Yuan Bao, R. Zhao, L. Shi, Chem. 
Commun. 2015, 51, 6884. 
22 W. F. Bailey, J. J. Patricia, T. T. Nurmi, W. Wang, Tetrahedron Lett. 1986, 27, 1861. 
23 a) L. Shi, Y. Chu. P. Knochel, H. Mayr, Angew. Chem. Int. Ed. 2008, 47, 202; b) L. Shi, Y. Chu, P. Knochel, 
H. Mayr, Org. Lett. 2009, 11, 3502; c) L. Shi, Y. Chu, P. Knochel, H. Mayr, J. Org. Chem. 2009, 74, 2760; d) L. 
Shi, Y. Chu, P. Knochel, H. Mayr, Org. Lett. 2012, 14, 2602. 
24 G. Köbrich, P. Buck, Chem. Ber. 1970, 103, 1412. 
25 J. Villieras, B. Kirschleger, R. Tarhouni, M. Rambaud, Bull. Soc. Chim. Fr. 1986, 470. 
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2,3-dibromothiophene (13b) reacted with EtMgCl at 25 °C in THF providing the more stabilized 
Grignard reagent 14b. Quenching reactions with various electrophiles (EX) produced the corresponding 
3- and 2-substituted thiophenes 15a–b in satisfactory yields (Scheme 4).26 The regioselectivity of the 
bromine-magnesium exchange can also be triggered by the presence of a directing group which 
coordinates the exchange reagent and directs the exchange reaction. For example, the dibromoimidazole 
derivative 16 complexed iPrMgBr at the ethoxy group and directed the exchange reaction, producing a 
very stable Grignard reagent 17 which, after trapping with NC-CO2Et provided the bromoimidazole 18 
in 59% yield.27 The presence of electron-withdrawing substituents always accelerated the bromine-
magnesium exchange and gave for the first time access to arylmagnesium reagents bearing a carbethoxy 
group or a nitro group. Thus, ethyl 4-iodobenzoate (19) reacted with iPrMgBr at −40 °C within 1 h, 
providing the functionalized arylmagnesium bromide 20. After addition to PhCHO, the expected 
alcohol 21 was obtained in 90% yield.28a Similarly, various iodonitroarenes underwent a fast iodine-
magnesium exchange reaction with PhMgCl or mesitylmagnesium bromide at −40 °C within a few 
minutes, furnishing novel nitro-substituted arylmagnesium reagents.28 Attempts for preparing such 
nitro-substituted Grignard reagents using magnesium turnings resulted in a complete reaction inhibition 
and only led to reduced products.29 However, the reaction of 2-iodo-1,5-dinitrobenzene (22) with 
PhMgCl at −40 °C for 5 min provided the corresponding Grignard reagent 23. After reaction with 
PhCHO, the alcohol 24 was obtained in 81% yield (Scheme 5).30  
 
Scheme 5: Chemoselective iodine-magnesium exchange reaction. 
                                                     
26 C. Christophersen, M. Begtrup, S. Ebdrup, H. Petersen, P. Vedso, J. Org. Chem. 2003, 68, 9513. 
27 a) M. Abarbri, F. Dehmel, P. Knochel, Tetrahedron Lett. 1999, 40, 7449; b) M. Abarbri, J. Thibonnet, L. 
Berillon, F. Dehmel, M. Rottlaender, P. Knochel, J. Org. Chem. 2000, 65, 4618. 
28 a) L. Boymond, M. Rottländer, G. Cahiez, P. Knochel, Angew. Chem. Int. Ed. 1998, 37, 1701; b) G. Varchi, A. 
Ricci, G. Cahiez, P. Knochel, Tetrahedron 2000, 56, 2727; c) W. Dohle, D. M. Lindsay, P. Knochel, Org. Lett. 
2001, 3, 2871; d) Y. Nakamura, S. Yoshida, T. Hosoya, Chem. Lett. 2017, 46, 858. 
29 a) T. Severin, D. Bätz, H. Krämer, Chem. Ber. 1971, 104, 950; b) G. Bartoli, G. Palmieri, M. Bosco, R. 
Dalpozzo, Tetrahedron Lett. 1989, 30, 2129; c) M. Bosco, R. Dalpozzo, G. Bartoli, G. Palmieri, M. Petrini, J. 
Chem. Soc. 1991, 657. 
30 a) I. Sapountzis, P. Knochel, Angew. Chem. Int. Ed. 2002, 41, 1610; b) I. Sapountzis, H. Dube, R. Lewis, N. 
Gommermann, P. Knochel, J. Org. Chem. 2005, 70, 2445. 
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As a rule, iodo-arenes and iodo-heterocycles were often sufficiently reactive to undergo an iodine-
magnesium exchange with standard exchange reagents (ethyl-, isopropyl- or phenyl-magnesium 
halides). Useful applications have been reported such as the synthesis of alkaloids such as kealiinines 
A–C.31 However, an extension to aryl and heteroaryl bromides was not always possible32 and the use of 
lithium trialkylmagnesiates33 was often required, which reduces the chemoselectivity of the Grignard 
reagent preparation. 
2.2.2 The Study of a Related Exchange Reaction: the I/Zn-Exchange 
The iodine-zinc exchange gave new hints for increasing the rate of the bromine-magnesium exchange: 
the treatment of an aryl iodide (ArI) of type 25 with iPr2Zn in NMP at 25 °C readily leads to the mixed 
zinc reagent ArZniPr 26. However, this zinc reagent does not react with a second equivalent of 25 to 
produce bis-arylzinc 27 despite numerous experiments. It was found that the addition of catalytic 
amounts (10 %) of Li(acac) is tentatively producing the ate-intermediate 28 which is more nucleophilic 
and able to perform an iodine-zinc exchange on ArI 25 to produce the new ate-species 29 and iPrI. This 
ate-species 29 breaks down to Ar2Zn 27 and regenerates Li(acac) which can reenter this catalytic cycle 
(Scheme 6).34 
 
Scheme 6: Proposed mechanism of the iodine-zinc exchange reaction. 
Since a carbon-zinc bond is quite covalent and does not react in the absence of catalysts with most 
electrophilic functional groups, it was possible to prepare a wide range of highly functionalized zinc 
                                                     
31 J. Das, P. B. Koswatta, J. D. Jones, M. Yousufuddin, C. J. Lovely, Org. Lett. 2012, 14, 6210. 
32 a) J. Thibonnet, P. Knochel, Tetrahedron Lett. 2000, 41, 3319; b) O. Ryabtsova, T. Verhelst, M. Baeten, C. M. 
L. Vande Velde, B. U. W. Maes, J. Org. Chem. 2009, 74, 9440. 
33 a) K. Kitagawa, A. Inoue, H. Shinokubo, K. Oshima, Angew. Chem. Int. Ed. 2000, 39, 2481; b) A. Inoue, K. 
Kitagawa, H. Shinokubo, K. Oshima, J. Org. Chem. 2001, 66, 4333; c) A. Inoue, J. Kondo, H. Shinokubo, K. 
Oshima, Chem. - Eur. J. 2002, 8, 1730; d) L. Struk, J. G. Sosnicki, Synthesis 2012, 44, 735. 
34 a) F. F. Kneisel, M. Dochnahl, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 1017; b) L.-Z. Gong, P. Knochel, 
Synlett 2005, 2005, 267. 
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organometallics bearing for example an aldehyde 30 and a methyl ester function 31 via this exchange 
reaction34. In this last synthesis, a very convenient preparation of sBu2Zn was employed, starting from 
commercially available sBuLi.34a Further quenching with appropriate electrophilic reagents produced 
polyfunctional products 34–35 (Scheme 7).34a 
 
Scheme 7: Iodine-zinc exchange reaction catalyzed by Li(acac) in NMP. 
2.2.3 Preparation and Reactions of the turbo-Grignard iPrMgCl·LiCl (36) 
The use of Li(acac) in the iodine-magnesium exchange reaction led to an extension of the iodine- and 
of the bromine-magnesium exchange reaction. Unfortunately Li(acac) could not be used for catalyzing 
a halogen-magnesium exchange, since this lithium salt was decomposed by Grignard reagents. It was 
found that LiCl was perfectly suited as promotor. Thus, the bimetallic reagent iPrMgCl·LiCl (36) gave 
excellent results and considerably accelerated the bromine- and iodine-magnesium exchange.16,35 More 
importantly, this reagent allowed the use of aryl and heteroaryl bromides as cheap and readily available 
substrates. In addition, highly functionalized aryl and heteroaryl iodides could be used as well. For 
example, 4-bromobenzonitrile (37) was converted with iPrMgCl·LiCl (36) to the corresponding 
Grignard reagent 38 at −7 °C within 2 h. Quenching with benzaldehyde led to alcohol 39 in 81% yield 
(Scheme 8).35a 
                                                     
35 a) A. Krasovskiy, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 3333; b) A. Krasovskiy, B. F. Straub, P. Knochel, 
Angew. Chem. Int. Ed. 2006, 45, 159; c) T. Kunz, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 1958; d) J. Nickel, 
M. Fernandez, L. Klier, P. Knochel, Chem. - Eur. J. 2016, 22, 14397. 
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Scheme 8: Selective bromine-magnesium exchange reaction triggered by iPrMgCl·LiCl (36). 
Polybromides such as 40 exclusively underwent a mono-exchange reaction with iPrMgCl·LiCl (36).The 
dibromo-pyridine 40 underwent an exchange at position C(3), since this position leads to the most 
stabilized Grignard reagent 41. After cyanation by using tosyl cyanide, the nitrile 42 was obtained in 
71% yield.36 This mild exchange reaction was compatible with various sensitive functionalities.37 
Functionalized alkenylmagnesium derivatives were also obtained via an iodine- or bromine-magnesium 
exchange. For example, the polyfunctional alkenyl iodide 43 reacted with 36 at −40 °C furnishing 
E-alkenylmagnesium derivative 44. After reaction with propionaldehyde, the alcohol 45 was obtained 
in 82% yield (Scheme 9).38  
 
Scheme 9: Preparation of alkenylmagnesium reagents using iPrMgCl·LiCl (36). 
  
                                                     
36 H. Ren, P. Knochel, Chem. Commun. 2006, 726. 
37 C.-Y. Liu, P. Knochel, Org. Lett. 2005, 7, 2543. 
38 H. Ren, A. Krasovskiy, P. Knochel, Org. Lett. 2004, 6, 4215. 
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iPrMgCl·LiCl (36) was also an efficient reagent for performing a sulfoxide-magnesium exchange 
(Scheme 10).39 The sulfoxide-magnesium exchange was well studied by Satoh40 and Hoffmann.41 
Remarkably, this exchange reaction could be efficiently done with iPrMgCl·LiCl (36) and allows meta- 
and para-difunctionalization of arenes39a and heterocycles.39b,c The metalation of aryl sulfoxide 46 with 
TMPMgCl·LiCl42 followed by a Negishi cross-coupling produced the polyfunctional sulfoxide 47. This 
compound 47 underwent a fast sulfoxide-magnesium exchange at −50 °C within 5 min, producing an 
intermediate Grignard reagent. By addition of aldehyde 48, benzonitrile 49 was furnished in 88% yield 
(Scheme 10).39c 
 
Scheme 10: Preparation of polyfunctional arenes and pyridines using a sulfoxide-magnesium exchange. 
Since the initial report35a the turbo-Grignard (36) has become a very popular exchange reagent and 
numerous applications have been reported in industry as well as in academia. 
                                                     
39 a) F. F. Fleming, S. Gudipati, V. A. Vu, R. J. Mycka, P. Knochel, Org. Lett. 2007, 9, 4507; b) C. B. Rauhut, L. 
Melzig, P. Knochel, Org. Lett. 2008, 10, 3891; c) L. Melzig, C. B. Rauhut, P. Knochel, Synthesis 2009, 1041; d) 
L. Melzig, C. B. Rauhut, N. Naredi-Rainer, P. Knochel, Chem. - Eur. J. 2011, 17, 5362; e) N. M. Barl, E. S. 
Sansiaume-Dagousset, K. Karaghiosoff, P. Knochel, Angew. Chem. Int. Ed. 2013, 52, 10093; f) D. Nath, F. F. 
Fleming, Chem. - Eur. J. 2013, 19, 2023; g) M. Hughes, T. Boultwood, G. Zeppetelli, J. A. Bull, J. Org. Chem. 
2013, 78, 844; h) C. Sämann, E. Coya, P. Knochel, Angew. Chem. Int. Ed. 2014, 53, 1430. 
40 a) T. Satoh, T. Oohara, Y. Ueda, K. Yamakawa, J. Org. Chem. 1989, 54, 3130; b) T. Satoh, K. Horiguchi, 
Tetrahedron Lett. 1995, 36, 8235; c) T. Satoh, K. Takano, H. Ota, H. Someya, K. Matsuda, M. Koyama, 
Tetrahedron 1998, 54, 5557. 
41 a) R. W. Hoffmann, P. G. Nell, Angew. Chem. Int. Ed. 1999, 38, 338; b) R. W. Hoffmann, B. Hölzer, O. Knopff, 
K. Harms, Angew. Chem. Int. Ed. 2000, 39, 3072; c) R. W. Hoffmann, B. Hölzer, O. Knopff, Org. Lett. 2001, 3, 
1945; d) B. Holzer, R. W. Hoffmann, Chem. Commun. 2003, 732; e) R. W. Hoffmann, Chem. Soc. Rev. 2003, 32, 
225. 
42 a) A. Krasovskiy, V. Krasovskaya, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 2958; b) B. Haag, M. Mosrin, 
H. Ila, V. Malakhov, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 9794. 
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Scheme 11: Preparation of polyfunctional Grignard reagents using 36. 
The bromine-magnesium exchange was used to generate arylboronic acids after transmetalation of the 
intermediate Grignard reagent with B(OMe)3.43 Remarkably, an in situ borylation could be readily 
achieved since iPrMgCl·LiCl (36) reacts only slowly with the borate 50. Thus, the treatment of 
iodobenzoate 51 with 36 in the presence of dioxaborinane 50 provided the arylboronic ester 52 in 79% 
yield.44 Bromopyridine N-oxides such as 53 underwent a bromine-magnesium exchange at −40 °C 
forming the Grignard reagent 54. After transmetalation to zinc and palladium-catalyzed cross-coupling, 
the desired functionalized pyridine N-oxide 55 was obtained in 72% yield (Scheme 11).45 The turbo-
Grignard iPrMgCl·LiCl (36) was used to generate complex Grignard intermediates for natural product 
synthesis. For instance, Schmalz showed that the aryl iodide 56 was converted to the corresponding 
Grignard reagent 57 and acylated after transmetalation to a copper species, leading to polyfunctional 
arene 58 in 58% yield (Scheme 12).46 iPrMgCl·LiCl (36) was also used in a synthetic pathway for a 
selective estrogen receptor degrader. The polyfunctional Grignard reagent 59 was prepared from 60 
using 36 in the presence of bis(2-dimethylaminoethyl)ether at −20 °C. After the addition of ketone 61, 
alcohol 62 was obtained as one diastereoisomer (Scheme 12).47  
                                                     
43 T. Leermann, F. R. Leroux, F. Colobert, Org. Lett. 2011, 13, 4479. 
44 E. Demory, V. Blandin, J. Einhorn, P. Y. Chavant, Org. Process Res. Dev. 2011, 15, 710. 
45 X.-F. Duan, Z.-Q. Ma, F. Zhang, Z.-B. Zhang, J. Org. Chem. 2009, 74, 939. 
46 A. O. Termath, S. Ritter, M. König, D. P. Kranz, J. M. Neudörfl, A. Prokop, H. G. Schmalz, Eur. J. Org. Chem. 
2012, 4501. 
47 N.-K. Lim, T. Cravillion, S. Savage, A. McClory, C. Han, H. Zhang, A. Di Pasquale, F. Gosselin, Org. Lett. 
2018, 20, 1114. 
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Scheme 12: Preparation of natural product 58 and drug intermediates 62 using 36. 
Further applications towards the synthesis of tryptamines were reported.48 Reeves showed that Grignard 
reagents, obtained via an iodine-magnesium exchange, reacted with various Bunte salts such as 
BnSSO3Na to produce the corresponding thioethers in excellent yields.49 Therefore, aryl iodide 63 was 
converted with 36 to Grignard reagent 64 which after reaction with BnSSO3Na provided thioether 65 
in 97% yield.49 Bräse showed that the turbo-Grignard reagent 36 allowed an efficient linkage of THP-
protected ethers to the solid phase. Thus, treatment of bromide 66 with iPrMgCl·LiCl (36) produced 
the corresponding Grignard reagent which, after treatment with CS2 followed by the Merrifield resin 
67, gave immobilized dithioester 68 with a high loading efficiency. The use of 36 proved to be 
compatible with carbonyls, nitriles, acetals and other halides present in the bromides of type 66. 
Etherification on the solid phase of 68 with Mitsunobu conditions followed by a fluorinating cleavage 
using a mixture of N-iodosuccinimide (NIS) and Olah’s reagent (HF, Pyr) provided the trifluoromethyl 
derivatives of type 69 in 70–80% yield (Scheme 13).50  
                                                     
48 a) K. C. Nicolaou, A. Krasovskiy, V. É. Trépanier, D. Y. K. Chen, Angew. Chem. 2008, 120, 4285; b) K. C. 
Nicolaou, A. Krasovskiy, U. Majumder, V. É. Trépanier, D. Y. K. Chen, J. Am. Chem. Soc. 2009, 131, 3690. 
49 J. T. Reeves, K. Camara, Z. S. Han, Y. Xu, H. Lee, C. A. Busacca, C. H. Senanayake, Org. Lett. 2014, 16, 1196. 
50 M. Döbele, M. S. Wiehn, S. Bräse, Angew. Chem. Int. Ed. 2011, 50, 11533. 
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Scheme 13: Preparation of fluorinated arenes using the turbo-Grignard reagent 36. 
The multi-functionalization of polyhalogenoarenes such as 70 was performed by using both iPrMgCl 
and iPrMgCl·LiCl (36) as shown by Leroux. In particular, the treatment of 70 with iPrMgCl at −78 °C 
followed by the addition of the dioxaborolane 71 provided the boronic ester 72 in 53% yield. Subsequent 
addition of 36 at −78 °C led to a selective iodine-magnesium exchange furnishing, after the addition of 
71, the dibromo-derivative 73 in ca. 87% yield (Scheme 14).51 
 
Scheme 14: Selective halogen-magnesium exchanges using iPrMgCl·LiCl (36). 
Bromine-magnesium exchanges were performed in continuous flow with microreactors using 
iPrMgCl·LiCl (36).52 Furthermore, conjugated polymers were also prepared using 36.53 For instance, 
the treatment of the dihalogenofluorene derivative 74 with iPrMgCl·LiCl (36) at −20 °C in THF 
selectively provided the Grignard reagent 75, which underwent a polymerization at 0 °C. In the presence 
                                                     
51 V. Diemer, F. R. Leroux, F. Colobert, Eur. J. Org. Chem. 2011, 327. 
52 a) H. Wakami, J.-i. Yoshida, Org. Process Res. Dev. 2005, 9, 787; b) T. Tricotet, D. F. O’Shea, Chem. - Eur. 
J. 2010, 16, 6678; c) T. Brodmann, P. Koos, A. Metzger, P. Knochel, S. V. Ley, Org. Process Res. Dev. 2012, 
16, 1102; d) Q. Deng, R. Shen, Z. Zhao, M. Yan, L. Zhang, Chem. Eng. J. 2015, 262, 1168; e) S. Korwar, S. Amir, 
P. N. Tosso, B. K. Desai, C. J. Kong, S. Fadnis, N. S. Telang, S. Ahmad, T. D. Roper, B. F. Gupton, Eur. J. Org. 
Chem. 2017, 6495. 
53 a) S. Wu, L. Huang, H. Tian, Y. Geng, F. Wang, Macromolecules 2011, 44, 7558; b) Y. Nanashima, A. 
Yokoyama, T. Yokozawa, Macromolecules 2012, 45, 2609; c) Y. Takeoka, K. Umezawa, T. Oshima, M. Yoshida, 
M. Yoshizawa-Fujita, M. Rikukawa, Polym. Chem. 2014, 5, 4132; d) F. Pammer, U. Passlack, ACS Macro Lett. 
2014, 3, 170; e) Z.-K. Yang, N.-X. Xu, R. Takita, A. Muranaka, C. Wang, M. Uchiyama, Nature Comm. 2018, 9, 
1587. 
A. INTRODUCTION    16 
of catalytic amounts of Ni(dppp)Cl2, leading to poly(9,9-dioctylfluorene) (76) with a Mn as high as 
8.6·104 and a polydispersity index of 1.49. Without LiCl, the polymerization afforded a lower molecular 
weight product (Scheme 15).54  
 
Scheme 15: LiCl-promoted polymerization using turbo-Grignard reagent 36. 
2.2.4 Preparation of Improved Turbo-Grignard Reagents 
Although in the original patent55 the use of other anion donor ligands for improving the rate of the 
halogen-magnesium exchange such as alkoxides and amides was mentioned, efforts to improve the 
exchange power of iPrMgCl·LiCl (36) were first made by preparing dialkylmagnesium complexed with 
two equivalents of LiCl.35b The presence of lithium chloride was essential for achieving high exchange 
rates. Accordingly, the treatment of two equivalents of iPrMgCl·LiCl (36) with 10 vol% of 1,4-dioxane 
displaced the Schlenk-equilibrium towards formation of 77. The reaction of the electron-rich aryl 
bromide 4-bromoanisole with 36 at 25 °C for 24 h produced the corresponding Grignard reagent with 
only 31% conversion, whereas the reagent 77 led to the di(4-methoxyphenyl)magnesium complexed 
with LiCl with 100% conversion after 10 h at 25 °C. This behavior was quite general and could also be 
applied to the bromoaniline derivative 78, which was converted to the diarylmagnesium reagent 79 in 
ca. 96% conversion (compared to 16% conversion using 36). Addition of benzaldehyde provided the 
alcohol 80 in 95% yield (Scheme 16).35b 
                                                     
54 a) L. Huang, S. Wu, Y. Qu, Y. Geng, F. Wang, Macromolecules 2008, 41, 8944; b) E. L. Lanni, A. J. McNeil, 
J. Am. Chem. Soc. 2009, 131, 16573; c) M. C. Stefan, A. E. Javier, I. Osaka, R. D. McCullough, Macromolecules 
2009, 42, 30. 
55 a) J. Farkas, S. J. Stoudt, E. M. Hanawalt, A. D. Pajerski, H. G. Richey, Organometallics 2004, 23, 423; b) P. 
Knochel, A. Krasovskiy, EP1582523A1 2005. 
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Scheme 16: Preparation of magnesium reagents using iPr2Mg·2LiCl (77). 
Similarly, sBu2Mg·2LiCl (81) prepared from sBuLi and sBuMgCl in THF reacted with 1,4-
diiodobenzene (82) in the presence of Me(OCH2CH2)OMe, leading to the bis-magnesium reagent 83. 
Copper-catalyzed allylation with allyl bromide gave 1,4-diallylbenzene (84) in 85% yield. Brückner 
showed that in presence of various additives, especially LiOCH2CH2NMe2, iPr2Mg underwent a 
complete bromine-magnesium exchange on (o-bromophenyl)ethanol within 6 h at 25 °C in ether.56 This 
fast bromine-magnesium exchange was used for the enantioselective synthesis of (R)-orphenadrine 
(85). The reaction of iPr2Mg in ether with the chiral lithium alcoholate of binol-derivative 86, the 
subsequent solvent removal and switch to toluene furnished the chiral alcohol 87 in 51% yield and 
52% ee after the addition of the dibromide 88. After an O-alkylation and methylation (R)-orphenadrine 
(85) was obtained (Scheme 17).56 
 
Scheme 17: Desymmetrization of benzhydryl alcohol 85 via an enantioselective bromine-magnesium exchange. 
                                                     
56 D. Sälinger, R. Brückner, Chem. - Eur. J. 2009, 15, 6688. 
A. INTRODUCTION    18 
2.3 Directed Metalation 
Another approach towards organometallic species is the directed metalation using metal bases. Since 
the pioneering work of Snieckus,57 Quéguiner,58 and Schlosser,59 lithium bases like lithium 
dialkylamides (R2NLi) have been used extensively for the metalation of diverse unsaturated substrates 
at low temperatures. Despite the frequent use of lithium reagents for metalations in chemical literature, 
the high reactivity of lithium bases has hampered their use for functionalized substrates. Hauser 
(R2NMgX or (R2N)2Mg) and Eaton (TMP2Mg), which developed magnesium amides as metalating 
agents, provided bases with higher tolerance towards sensitive functional groups.6,60 Mulzer 
demonstrated the use of these sterically hindered TMP-bases in organic synthesis and applied them in 
natural product synthesis. However, due to their low solubility as well as their low kinetic basicity, a 
large excess of magnesium bases and electrophiles was required to achieve high conversion.61 
These limitations have lowered their general use until Knochel and co-workers developed a highly 
reactive LiCl-solubilized 2,2,6,6-tetramethylpiperidine (TMP) metal amide base, TMPMgCl·LiCl (89), 
and improved the synthesis of metalated aromatics and heteroaromatics. The first LiCl-solubilized 
metal amide base was prepared in 2006 by reacting iPrMgCl·LiCl (36) with TMP-H (90) in THF 
(Scheme 18). The resulting base exhibited an excellent solubility in common organic solvents as well 
as improved kinetic basicity.42 
 
Scheme 18: Preparation of TMPMgCl·LiCl (89) by using iPrMgCl·LiCl (36) and TMP-H (90). 
In the following years a number of new TMP-bases were established.42b The most important of these 
sterical hindered TMP-bases are TMPMgCl·LiCl (89),42a TMP2Mg·2MgCl2·2LiCl (91),62 
TMPZnCl·LiCl (92)63 and TMP2Zn·2MgCl2·2LiCl (93)64 (Figure 2). Since the development of the 
described LiCl solubilized TMP-bases, the scope of the metalation of unsaturated substrates was 
                                                     
57 a) P. Beak, V. Snieckus, Acc. Chem. Res. 1982, 15, 306; b) V. Snieckus, Chem. Rev. 1990, 90, 879; c) L. Green, 
B. Chauder, V. Snieckus, J. Heterocyclic Chem. 1999, 36, 1453; d) M. C. Whisler, S. MacNeil, V. Snieckus, P. 
Beak, Angew. Chem. Int. Ed. 2004, 43, 2206; e) K. R. Campos, Chem. Soc. Rev. 2007, 36, 1069. 
58 a) A. Turck, N. Plé, F. Mongin, G. Quéguiner, Tetrahedron 2001, 57, 4489; b) F. Mongin, G. Quéguiner, 
Tetrahedron 2001, 57, 4059. 
59 a) M. Schlosser, Angew. Chem. Int. Ed. 2005, 44, 376; b) M. Schlosser, F. Mongin, Chem. Soc. Rev. 2007, 36, 
1161. 
60 a) C. R. Hauser, H. G. Walker, J. Am. Chem. Soc. 1947, 69, 295; b) P. E. Eaton, C. H. Lee, Y. Xiong, J. Am. 
Chem. Soc 1989, 111, 8016; c) P. E. Eaton, K. A. Lukin, J. Am. Chem. Soc. 1993, 115, 11370. 
61 W. Schlecker, A. Huth, E. Ottow, J. Mulzer, J. Org. Chem. 1995, 60, 8414. 
62 G. C. Clososki, C. J. Rohbogner, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7681. 
63 M. Mosrin, P. Knochel, Org. Lett. 2009, 11, 1837. 
64 S. H. Wunderlich, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7685. 
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considerably expanded. TMP-bases offered the possibility to the chemo- and regioselectively 
functionalization of a wide range of aromatic systems, as well as highly functionalized heterocycles and 
non-aromatic, unsaturated systems. The high kinetic basicity of the TMP-bases, their high functional-
group tolerance, and the practical metalation conditions were especially remarkable.42b 
 
Figure 2: TMP-derived, mixed metal/lithium amide bases. 
Due to the high functional group tolerance of TMPMgCl·LiCl (89), a huge variety of polyfunctional 
aromatics and heteroaromatics could be converted into the corresponding magnesium species, which 
could be further reacted with electrophiles.42 For example, the magnesiation with TMPMgCl·LiCl (89) 
allowed the metalation of the highly functionalized benzene derivative 94 by using an OBoc as a 
directing group. Using this method, the magnesium derivative 95 was smoothly converted into 96 in 
93% yield.65 Also, substrates bearing electrophilic groups such as nonaflates were magnesiated with 89 
providing the Grignard reagent 98. Addition of an aromatic aldehyde led to the expected product 99 in 
94% yield (Scheme 19).66  
 
Scheme 19: Metalation of polyfunctional aromatics using TMPMgCl·LiCl (89). 
Furthermore, electronpoor and -rich heteroaromatics could be metalated using TMPMgCl·LiCl (89). 
Thus, protected uracils 100 reacted with TMPMgCl·LiCl (89) at −40 °C in 4 h and provided the C(5) 
metalated heterocycle 101 in a regioselective manner. Transmetalation with ZnCl2, followed by a Pd-
catalyzed Negishi cross-coupling with 4-iodobenzonitrile led to the arylated methyl protected uracil 
                                                     
65 W. Lin, O. Baron, P. Knochel, Org. Lett. 2006, 24, 5673. 
66 G. Monon, P. Knochel, Synthesis 2010, 304. 
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102 in 78% yield (Scheme 20).67 Interestingly, N-heterocycles such as 103 bearing an N,N,N’,N’-
tetramethyldiaminophosphorodiamidate group as directing group were metalated at 0 °C within 1 h. By 
using 89, the desired product 105 was afforded in 77% yield after the reaction with NC-CO2Et (Scheme 
20).68 
 
Scheme 20: Metalation of heteroaromatics using TMPMgCl·LiCl (89). 
Aromatic substrates bearing electron-donating or weakly-accepting substituents were difficult to 
magnesiate at low temperature. The higher reactivity of TMP2Mg·2MgCl2·2LiCl (91) enabled the 
magnesiation of moderately activated aromatics and heteroraromatics and solved this problem. For 
instance, TMP2Mg·2MgCl2·2LiCl (91) allowed the magnesiation of dimethyl-1,3-benzodioxan-4-one 
(106) at −40 °C in 10 min. After transmetalation with ZnCl2 and Pd-catalyzed cross-coupling with (E)-
1-hexenyl iodide, the 6-substituted benzodioxane was obtained in 77% yield. Subsequent hydrogenation 
and deprotection produced the natural product 108 in 89% yield, which was found in the essential oil 
of Pelargonium sidoides DC (Scheme 21).62 
 
Scheme 21: Magnesiation of dimethyl-1,3-benzodioxan-4-one (108) by using TMP2Mg·2MgCl2·2LiCl (91). 
Several sensitive aromatics and heterocyclic substrates such as electron-poor N-heterocycles could be 
metalated with TMPZnCl·LiCl (92). Consequently, 92 displays a higher tolerance towards functional 
                                                     
67 L. Klier, E. Aranzamendi, D. Ziegler, J. Nickel, K. Karaghiosoff, T. Carell, P. Knochel, Org. Lett. 2016, 18, 
1068. 
68 C. J. Rohbogner, S. Wirth, P. Knochel, Org. Lett. 2010, 12, 1984. 
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groups such as nitro, aldehyde or methyl ketone groups and the high thermal stability of these zinc 
organometallics (up to 120 °C) enabled the direct metalation under a wide range of conditions. 42b,63 For 
example, the sensitive pyridazine heterocycle 109, which previously could only be metalated at low 
temperatures in moderate yields,58a was zincated at 25 °C within 30 min. A copper-mediated acylation 
led to the ketone 111 in 96% yield (Scheme 22).63 
 
Scheme 22: Zincation of sensitive pyrazine 109 by using TMPZnCl·LiCl (92). 
Furthermore, TMPZnCl·LiCl (92) allowed the regioselective zincation of chromones of type 112 at 
25 °C in 15 min. Quenching with various electrophiles led to C(3) functionalized products of type 114 
in 75–93% yield. The C(2)-selective zincation was achieved by using the more powerful zinc base 
TMP2Zn·2MgCl2·2LiCl (93), providing the bis-heterocyclic zinc reagent 115. Subsequent reaction of 
the organometallic species with electrophiles afforded the desired products of type 116 in 75–83% yield 
(Scheme 23).69 
 
Scheme 23: Regioselective zincation of chromone 112 by using TMPZnCl·LiCl (92) and TMP2Zn·2MgCl2·2LiCl 
(93). 
The zinc base 93 was also used for the metalation of sensitive heterocycles such as oxadiazole 117, 
which was prone to undergo fragmentation during metalation process.64,70 Also, sensitive functional 
groups could be tolerated by using 93. Thus, 2-nitrobenzofuran was zincated at −25 °C within 1.5 h, 
leading to benzofuran 122 in 80% yield after copper catalyzed allylation (Scheme 24).64 
                                                     
69 L. Klier, T. Bresser, T. A. Nigst, K. Karaghiosoff, P. Knochel, J. Am. Chem. Soc. 2012, 134, 13584. 
70 a) A. Turck, N. Plé, L. Mojovic, G. Quéguiner, J. Heterocycl. Chem. 1990, 27, 1377; b) L. Mojovic, A. Turck, 
N. Plé, M. Dorsy, B. Ndzi, G. Quéguiner, Tetrahedron 1996, 52, 10417. 
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Scheme 24: Zincation of sensitive heterocycles by using TMP2Zn·2MgCl2·2LiCl (93). 
2.4 Transmetalation 
The transmetalation of organometallic compounds offers another approach for the preparation of 
organozinc or organomagnesium compounds by addition of a metal salt. Driving force for the 
transmetalation reaction is the formation of a more covalent carbon-metal bond and along with it the 
formation of a more stable reagent. For example, the sensitive functionalized arene 126 was prepared 
by a magnesium insertion in the presence of ZnCl2. Thereby, the unstable magnesium reagent 124 was 
directly transmetalated using ZnCl2 to form the comparatively stable zinc reagent 125. After a Negishi 
cross-coupling, the arylated product 126 was obtained in 87% yield.71 
 
Scheme 25: Preparation of the functionalized arene 126 reagent via in situ generated zinc reagents. 
All these different methods allow the synthesis of functionalized organomagnesium or organozinc 
reagents, which have found widespread uses in organic synthesis. 
 
  
                                                     
71 F. M. Piller, A. Metzger, M. A. Schade, B. A. Haag, A. Gavryushin, P. Knochel, Chem. - Eur. J. 2009, 15, 
7192. 
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3 Objectives 
Based on previous results on directed metalation, the aim of the first project was the development of a 
method for the regioselective metalation and functionalization of 2-pyridones by using TMP-bases. 
These scaffolds are of great interest due to the number of biologically active molecules bearing such a 
moiety and their appeareance in pharmaceutical agents. Starting from protected 2-pyridones, the 
metalation should lead to the corresponding zincated 2-pyridone by using a zinc amide. These 
heterocyclic zinc species can react with various electrophiles furnishing highly functionalized 2-
pyridones. It should be envisioned that these synthetic sequences are general and therefore can be 
applied in metalation and functionalization of protected 2,7-naphthyridones. After deprotection, the 
functionalized 2,7-naphthyridones should be converted into the corresponding naphthyridines and 
subsequent Negishi cross-couplings should lead to highly functionalized naphthyridines.72 
 
Scheme 26: a) Functionalization of the 2-pyridone and 2,7-naphthyridone scaffold using TMP2Zn·2MgCl2·2LiCl. 
b) Co-catalyzed Negishi cross-couplings of chlorinated 2,7-naphthyridines. 
Additionally, pyrones can be used in a broad range of synthetic applications, in particular as dienes in 
Diels-Alder reactions as well as precursors for the preparation of more complex heterocyclic systems 
in natural products. For that reason, a regio- and chemoselective metalation and functionalization of 2- 
and 4-pyrone derivatives should be investigated. Starting from commercially available 2- and 4-
pyrones, successive metalations using TMP-bases should lead to the corresponding magnesiated or 
zincated 2-pyrones. These resulting organometallic reagents can react with various electrophiles, 
                                                     
72 This project was developed in cooperation with Robert Greiner see: R. Greiner, Dissertation 2018, LMU 
München. 
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providing highly functionalized 2-pyrones. Furthermore, the metalation should be extended to 
functionalized pyrones such as methyl coumalate. 
 
Scheme 27: Functionalization of the 2- and 4-pyrone scaffold using TMP-bases. 
Finally, new magnesium reagents in non-polar solvents should be developed using 
magnesiumalkoxides and alkyllithium reagents for the preparation. Grignard reagents are commonly 
prepared in ethereal solvents and their preparation in toluene or hydrocarbons is almost unknown. 
Therefore, it was anticipated that these weakly-coordinated magnesium reagents should display an 
unusual reactivity. Furthermore, it was proposed that these organomagnesium reagents allow very fast 
bromine-magnesium exchanges and, for the first time, a chlorine-magnesium exchange on various aryl 
chlorides, leading to functionalized (hetero)aryl- and di(hetero)arylmagnesium derivatives in toluene.  
 
Scheme 28: a) Preparation of new magnesium exchange reagents in toluene. b) Halogen-magnesium exchange in 
toluene. 
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1 Directed Zincation or Magnesiation of the 2-Pyridone and 2,7-
Naphthyridone Scaffold using TMP-Bases 
1.1 Introduction 
The selective functionalization of 2-pyridone (127) and 2,7-naphthyridone (128) is an important 
synthetic goal due to the pharmaceutical relevance of many substituted 2-pyridones and 2,7-
naphthyridones.73 These heterocycles are known to display antibiotic, antifungal, anticancer, and 
antiviral activity.74 Typical pharmaceutically and biologically active derivatives are milrinone (129),75 
ciclopirox (130),76 pirfenidone (131),77 and lophocladine A (132) (Figure 3).78 
 
Figure 3: Structures of 2-pyridone (127) and 2,7-naphthyridone (128) and their pharmaceutically and biologically 
active derivatives. 
 
                                                     
73 a) T. Ukita, Y. Nakamura, A. Kubo, Y. Yamamoto, Y. Moritani, K. Saruta, T. Higashijima, J. Kotera, K. 
Fujishige, M. Takagi, K. Kikkawa, K. Omori, Bioorg. Med. Chem. 2003, 13, 2341; b) H. J. Jessen, K. Gademann, 
Nat. Prod. Rep. 2010, 27, 1168; c) G. Yu, P. N. Praveen Ra, M. A. Chowdhury, K. R. A. Abdellatif, Y. Dong, D. 
Das, C. A. Velázquez, M. R. Suresh, E. E. Knaus, Bioorg. Med. Chem. 2010, 20, 2168; d) W. S. Hamama, M. 
Waly, I. El-Hawary, H. H. Zoorob, Synth. Commun. 2014, 44, 1730. 
74 a) N. C. Desai, K. M. Rajpara, V. V. Joshi, Bioorg. Med. Chem. 2013, 23, 2714; b) Z. Lv, Y. Zhabg, M. Zhang, 
H. Chen, Z. Sun, D. Geng, C. Niu, K. Li, Eur. J. Med. Chem. 2013, 67, 447; c) H. Jia, Y. Song, J. Yu, P. Zhan, 
D. Rai, X. Liang, C. Ma, X. Liu, Eur. J. Med. Chem. 2017, 136, 144; d) S. Singh, J.-I. Goo, H. Noh, S. J. Lee, M. 
W. Kim, H. Park, H. B. Jalani, K. Lee, C. Kim, W.-K. Kim, C. Ju, Y. Choi, Bioorg. Med. Chem. 2017, 25, 1394. 
75 a) K. T. Santhosh, O. Elkhateeb, N. Nolette, O. Outbih, A. J. Halayko, S. Dakshinamurti, Br. J. Pharmacol. 
2010, 163, 1223; b) M. Ravinder, B. Mahendar, S. Mattapally, K. V. Hamsini, T. N. Reddy, C. Rohit, K. Srinivas, 
S. K. Banerjee, Bioorg. Med. Chem. 2012, 22, 6010. 
76 D. Monti, L. Saccomani, P. Chetoni, S. Burgalassi, S. Tampucii, F. Mailland, Br. J. Dermatol. 2011, 165, 99. 
77 a) K. Takakura, K. Mizukami, H. Mitori, T. Noto, Y. Tomura, Eur. J. Pharma. 2014, 737, 106; b) E. S. Kim, 
G. M. Keating, Drugs 2015, 75, 219. 
78 a) K. Kumpan, A. Nathubhai, C. Zhang, P. J. Wood, M. D. Lloyd, A. S. Thompson, T. Haikarainen, L. Lehtiö, 
M. D. Threadgill, Bioorg. Med. Chem. 2015, 23, 3013; b) S. Theeramunkong, O. Vajragupta, M. Chawannuch, 
Med. Chem. Res. 2016, 25, 2959. 
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Functionalizations of these 2-pyridones via lithiation have been reported.58b,79 Alternatively, a 
regioselective direct C-H activation allows the functionalization of 2-pyridone (127) either at position 
C(3) or C(6).80 Recently, it was found that a broad array of functionalized aromatic and heteroaromatic 
compounds could be metalated with various TMP-derived Mg- and Zn-bases.42b,81 Preliminary 
metalation studies have shown that TMPLi82 and TMPMgCl∙LiCl (89)42a,83 led to the decomposition of 
protected 2-pyridones or 2,7-naphthyridones even at low temperatures or produced a complex mixture 
of products. Therefore, the use of more selective metalating agents was investigated. TMPZnCl·LiCl 
(92)63,84 and TMP2Zn·2MgCl2·2LiCl (93)64,69,85 have been proven to be especially efficient for 
performing zincations of sensitive (hetero)arenes, as these metalations produce organozinc derivatives 
which tolerate a range of functional groups. Herein, the functionalization of MEM-protected 2-
pyridones like 133 and 134 as well as the MEM-protected 2,7-naphthyridone (135) using 
TMP2Zn·2MgCl2·2LiCl (93)64 followed by reactions with various electrophiles (EX) is reported. 
  
                                                     
79 a) P. Meghani, J. A. Joule, J. Chem. Soc., Perkin Trans. 1 1988, 1; b) F. Effenberger, W. Daub, Chem. Ber. 
1991, 124, 2119. 
80 a) Y. Nakao, H. Idei, K. S. Kanyiva, T. Hiyama, J. Am. Chem. Soc. 2009, 131, 15996; b) A. Nakatani, K. Hirano, 
T. Satoh, M. Miura, Chem. - Eur. J. 2013, 19, 7691; c) A. Modak, S. Rana, D. Maiti, J. Org. Chem. 2015, 80, 
296. 
81 a) D. Haas, D. Sustac-Roman, S. Schwarz, P. Knochel, Org. Lett. 2016, 18, 6380; b) J. Nafe, P. Knochel, 
Synthesis 2016, 48, 103; c) L. Klier, D. S. Ziegler, R. Rahimoff, M. Mosrin, P. Knochel, Org. Process Res. Dev. 
2017, 21, 660; d) A. Castello-Mico, J. Nafe, K. Higashida, K. Karaghiosoff, M. Gingras, P. Knochel, Org. Lett. 
2017, 19, 360. 
82 a) C. L. Kissel, B. Rickborn, J. Org. Chem. 1972, 37, 2060; b) R. A. Olofson, C. M. Dougherty, J. Am. Chem. 
Soc. 1973, 95, 581; c) M. Uzelac, A. R. Kennedy, E. Hevia, R. E. Mulvey, Angew. Chem. Int. Ed. 2016, 55, 13147. 
83 a) R. E. Mulvey, Organometallics 2006, 25, 1060; b) R. E. Mulvey, F. Mongin, M. Uchiyama, Y. Kondo, 
Angew. Chem. Int. Ed. 2007, 46, 3802; c) M. Mosrin, P. Knochel, Org. Lett. 2008, 10, 2497; d) P. Garcia-Alvarez, 
D. V. Graham, E. Hevia, A. R. Kennedy, J. Klett, R. E. Mulvey, C. T. O’Hara, S. Weatherstone, Angew. Chem. 
Int. Ed. 2008, 47, 8079. 
84 a) M. Mosrin, T. Bresser, P. Knochel, Org. Lett. 2009, 11, 3406; b) T. Bresser, P. Knochel, Angew. Chem. Int. 
Ed. 2011, 50, 1914; c) S. Duez, A. K. Steib, S. M. Manolikakes, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 
7686; d) A. Unsinn, M. J. Ford, P. Knochel, Org. Lett. 2013, 15, 1128; e) D. Haas, M. Mosrin, P. Knochel, Org. 
Lett. 2013, 15, 6162; f) J. Shen, B. Wong, C. Gu, H. Zhang, Org. Lett. 2015, 17, 4678. 
85 a) M. Mosrin, P. Knochel, Chem. - Eur. J. 2009, 15, 1468; b) J. M. Hammann, D. Haas, P. Knochel, Angew. 
Chem. Int. Ed. 2015, 54, 4478; c) M. Tichý, S. Smoleń, E. Tloušt’ová, R. Pohl, T. Oždian, K. Hejtmánková, B. 
Lišková, S. Gurská, P. Džubák, M. Hajdúch, M. Hocek, J. Med. Chem. 2017, 60, 2411. 
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1.2 Functionalization of MEM-Protected 2-Pyridones 
Treatment of the MEM-protected 2-pyridone derivative 133 with the zinc amide 93 (1.20 equiv, −10 °C, 
72 h) led to the quantitative formation of the corresponding zincated 2-pyridone 136. The zinc reagent 
136 was quenched by various electrophiles furnishing 2-pyridones of type 137 (Table 1). Thus, 
quenching of 136 with iodine provided the 6-iodo-2-pyridone 137a in 93% yield (entry 1). Additionally, 
Negishi cross-coupling86 of 136 proceeded with various aryl iodides containing electron-withdrawing 
or -donating substituents in the presence of 4% Pd(dba)2 and 8% of tris(o-furyl)phosphine87 affording 
a variety of arylated pyridone derivatives (137b–f) in 66–88% yield (entries 2–6). This zincation was 
extended to the MEM-protected 3-cyano-2-pyridone 134, which was metalated with 93 (1.20 equiv, 
−10 °C, 72 h) to give the C(6)-zincated heterocycle 138. After iodolysis, the desired product 139a was 
isolated in 80% yield (entry 7). Pd-catalyzed cross-coupling of 138 with 4-iodoanisole provided the 
arylated 3-cyano-2-pyridone 139b in 68% yield (entry 8). Moreover, 2-iodothiophene underwent a 
Negishi cross-coupling86 with the zinc species 138, to afford the 3-cyano-2-pyridone 139c in 80% yield 
(entry 9). 
 
Table 1: Zincation of MEM-protected 2-pyridone 133 or 134 and reaction with electrophiles. 
 
Entry Substrate Electrophile (EX) Product/Yield[a] 
 
 
I2 
 
1 133  137a, 93% 
 
 
 
 
2 133  137b, 92%[b] 
    
                                                     
86 a) E.-i. Negishi, L. F. Valente, M. Kobayashi, J. Am. Chem. Soc. 1980, 102, 3298; b) E.-i. Negishi, Acc. Chem. 
Res. 1982, 15, 340. 
87 a) V. Farina, S. R. Baker, D. A. Benigni, C. Jr. Sapino, Tetrahedron Lett. 1988, 29, 5739; b) V. Farina, S. R. 
Baker, D. A. Benigni, S. I. Hauck, C. Jr. Sapino, J. Org. Chem. 1990, 55, 5833. 
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3 133  137c, 66%[b] 
 
  
 
4 133  137d, 70%[b] 
 
  
 
5 133  137e, 80%[b] 
 
 
 
 
6 133  137f, 88%[b] 
 
 
I2 
 
7 134  139a, 80% 
 
 
 
 
8 134  139b, 68%[b] 
 
 
 
 
9 134  139c, 80%[b] 
[a] Yield of isolated, analytically pure product. [b] Obtained by Negishi cross-coupling86 using 4% Pd(dba)2 
and 8% P(o-furyl)3.87 
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1.3 Functionalization of MEM-Protected 2,7-Naphthyridone Derivative 
The scope of this zincation using the zinc-base 93 on a MEM-protected 2,7-naphthyridone derivative 
135 was explored. The MEM-protecting group was essential to achieve a regioselective zincation of 
2,7-naphthyridone 135 in position 3 with the zinc base (93, 1.20 equiv, −10 °C, 72 h). The resulting 
zinc reagent 140 was readily functionalized by reaction with various electrophiles to furnish 3-
substituted 2,7-naphthyridones of type 141 (Table 2). After iodolysis, compound 141a was isolated in 
92% yield (entry 1). The X-ray structure of compound 141a confirmed exclusive iodination at position 
3.88 Furthermore, the zinc reagent 140 underwent smooth Pd-catalyzed Negishi cross-coupling 
reactions86 with aryl iodides to afford the 3-arylated 2,7-naphthyridones 141b–f in 46–86% yield 
(entries 2–6). The cross-coupling with 4-iodoaniline proceeded smoothly using an inverse addition with 
4% Pd(OAc)2 and 8% of Buchwald’s SPhos89 via syringe pump, to afford the desired product 141g in 
76% yield (entry 7).90 Furthermore, the zinc intermediate 140 reacted with 5-bromo-
benzo[d][1,3]dioxole in the presence of 4% PEPPSI-iPr91 to afford the corresponding product 141h in 
80% yield (entry 8). Transmetalation of 140 with CuCN·2LiCl92 (1.10 equiv, −10 °C, 10 min) and 
subsequent reaction with 2-thiophenecarbonyl chloride provided the 2,7-naphthyridone 141i in 52% 
yield (entry 9). 
  
                                                     
88 CCDC-1565047 (141a) contains the supplementary crystallographic data for this compound. The data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
89 R. Martin, R.; S. L. Buchwald, Acc. Chem. Res. 2008, 41, 1461. 
90 a) G. Manolikakes, M. A. Schade, C. Munoz Hernandez, H. Mayr, P. Knochel, Org. Lett. 2008, 10, 2765; b) G. 
Manolikakes, M. A. Schade, C. Munoz Hernandez, H. Mayr, P. Knochel, Org. Lett. 2008, 73, 8422. 
91 a) N. Hadei, E. A. B. Kantchev, C.J. O’Brie, J. Christopher, M. G. Organ, Org. Lett. 2005, 7, 3805; b) C. 
Valente, M. E. Belowich, N. Hadei, M. G. Organ, Chem. - Eur. J. 2010, 23, 4343. 
92 P. Knochel, M. C. P. Yeh, S. C. Berk, J. Talbert, J. Org. Chem. 1988, 53, 2390. 
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Table 2: Zincation of MEM-protected 2,7-naphthyridone 135 and subsequent reaction with electrophiles.  
 
Entry Substrate Electrophile (EX) Product/Yield[a] 
 
 
I2 
 
1 135  141a, 92% 
 
 
 
 
2 135  141b, 81%[b] 
 
 
 
 
3 135  141c, 84%[b] 
 
 
 
 
4 135  141d, 86%[b] 
 
 
 
 
5 135  141e, 74%[b] 
 
 
 
 
6 135  141f, 46%[b] 
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7 135  141g, 76%[c] 
 
  
 
8 135  141h, 80%[d] 
 
  
 
9 135  141i, 52%[e] 
[a] Yield of isolated, analytically pure product. [b] Obtained by Negishi cross-coupling86 using 4% Pd(dba)2 
and 8% P(o-furyl)3.87 [c] Obtained by Negishi cross-coupling86 using 4% Pd(OAc)2 and 8% SPhos. 
[d] Obtained by Negishi cross-coupling86 using 4% PEPPSI-iPr.91 [e] Obtained after transmetalation with 
CuCN·2LiCl (1.10 equiv).92 
1.4 I/Mg-Exchange of Iodinated 2-Pyridone and Iodinated 2,7-Naphthyridone 
In order to extend the electrophile range, 6-magnesiated pyridone 142 and magnesiated naphthyridone 
143 were prepared by treating the corresponding iodo-heterocycles 137a and 141a with iPrMgCl·LiCl 
(36)35a,b at −40 °C or 0 °C (Table 3). The magnesium intermediate 142 reacted readily with aldehydes, 
such as benzaldehyde or furfural, providing the corresponding alcohols 144a–b in 80–84% yield 
(entries 1–2). After magnesiation of 137a and transmetalation with CuCN·2LiCl92 (1.20 equiv, −40 °C, 
30 min), a copper-mediated allylation with ethyl 2-(bromomethyl)acrylate93 or 3-bromocyclohex-1-ene 
led to 6-allylated 2-pyridones 144c–d in 65–76% yield (entries 3–4). Copper-mediated acylation with 
cyclopropanecarbonyl chloride or tert-butyl acetyl chloride gave 2-pyridone ketones 144e–f in 72–76% 
yield (entries 5–6). Quenching the magnesiated 2,7-naphthyridone 143 with p-toluenesulfonyl cyanide 
or S-phenyl benzenethiosulfonate afforded the desired products 145a–b in 60–72% yield (entries 7–8). 
                                                     
93 J. Villieras, M. Rambaud, Org. Synth. 1988, 66, 220. 
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Table 3: Iodine-magnesium exchange of iodinated 2-pyridone 137a and 2,7-naphthyridone 141a and reaction 
with various electrophiles. 
 
Entry Substrate Electrophile (EX) Product/Yield[a] 
 
 
 
 
1 137a  144a, 80% 
 
 
 
 
2 137a  144b, 84% 
 
 
 
 
3 137a  144c, 65%[b] 
 
 
 
 
4 137a  144d, 76%[b] 
 
 
 
 
5 137a  144e, 76%[b] 
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6 137a  144f, 72%[b] 
 
   
7 141a  145a, 60% 
 
 
PhSSO2Ph 
 
8 141a  145b, 72% 
[a] Yield of isolated, analytically pure product. [b] Obtained after transmetalation with CuCN·2LiCl92 
(1.20 equiv).  
1.5 Second Metalation of 6-Substituted 2-Pyridones 
A second metalation of the 6-substituted 2-pyridones 137a and 137b occured at position C(3) using 
TMPMgCl∙LiCl (89).42a Thus, treatment of the 6-iodinated 2-pyridone 137a with the magnesium amide 
89 (1.20 equiv, −40 °C, 2 h) led to the quantitative formation of 3-magnesiated pyridone 146 (Scheme 
29). The magnesium reagent 146 reacted with iodine, benzaldehyde or p-toluenesulfonyl cyanide, to 
provide the 3,6-disubstituted 2-pyridones 148a–c in 40–80% yield. Furthermore, the 6-arylated 2-
pyridone 137b was metalated in position C(3) with 89 (1.20 equiv, −40 °C, 2 h) and this magnesiated 
species 147 was then iodinated to provide iodo-derivative 149 in 70% yield. 
 
Scheme 29: 3,6-Disubstituted pyridones of type 148 and 149 obtained by regioselective magnesiation of 2-
pyridone derivatives of type 137 using TMPMgCl∙LiCl (89)42a and quenching with electrophiles. 
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1.6 Further Functionalization of the 2,7-Naphthyridone Scaffold 
As an application of this method, the functionalized MEM-protected 2,7-naphthyridone 141d was 
converted into a bioactive deprotected 2,7-naphthyridone, which acts as an inhibitor of tankyrase 
(150).78a The MEM-group was selectively removed by treatment with HCl at 65 °C, which furnished 
the unprotected 2,7-naphthyridone 150 in 84% yield (Scheme 30). Further functionalization at C(1) of 
the 2,7-naphthyridone scaffold 150 was achieved by chlorination with POCl3 leading to the 
naphthyridine 151 in 82% yield (Scheme 30). 
 
Scheme 30: Preparation of a functionalized halonaphthyridine from naphthyridone 141d. 
Finally, treatment of the 1-chloro-3-(4-chlorophenyl)-2,7-naphthyridine (151) with arylzinc chlorides 
152a–c94 in the presence of 10% CoCl294,95 in THF (0 °C up to 25 °C, 48 h) gave the cross-coupling 
products 153a–c in 67–83% yield (Scheme 31). 
 
Scheme 31: Cobalt-catalyzed Negishi cross-couplings86 of chlorinated 2,7-naphthyridine 151. 
  
                                                     
94 D. Haas, J. M. Hammann, F. H. Lutter, P. Knochel, Angew. Chem. Int. Ed. 2016, 55, 3809. 
95 G. Cahiez, A. Moyeux, Chem. Rev. 2010, 110, 1435. 
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2 Directed Zincation or Magnesiation of 2- and 4-Pyrones and their 
Derivatives 
2.1 Introduction 
 
Figure 4: Structures of 2- and 4-pyrone (154 and 155) and their derivatives. 
Pyrones are important scaffolds that are highly biologically active, widely distributed in biological 
processes of bacteria, microbial, plants and animals and are therefore interesting heterocycles in modern 
drug discovery (Figure 4).96 Furthermore, the resulting functionalized pyrones can be used in a broad 
range of synthetic applications, in particular as dienes in Diels-Alder reactions97 as well as precursors 
for the preparation of more complex heterocyclic systems in natural products.98 Therefore, a number of 
methods have been developed to derivatize this core structure by transition-metal-catalyzed cross-
couplings.99 Despite the synthetic utility of pyrones, the preparation of substituted derivatives of this 
class of heterocycles can be accomplished only with difficulties, often requiring multi-step syntheses.100 
                                                     
96 a) F. A. Macias, A. M. Simonet, P.C. Pacheco, A. F. Barrero, E. Cabrera, D. J. Jiménez-González, Agric. Food 
Chem. 2000, 48, 3003; b) G. P. McGlacken, I. J. S. Fairlamb, Nat. Prod. Rep. 2005, 22, 369; c) H. Gao, R. 
Popescu, B. Kopp, Z. Wang, Z. Nat. Prod. Rep. 2011, 28, 953; d) A. Ligresti, R. Villano, M. Allará, I. Ujváry, V. 
Di Marzo, Pharmacol. Res. 2012, 66, 163; e) Z. S. Bhat, M. A. Rather, M. Maqbool, H.UL Lah, S. K. Yousuf, Z. 
Ahmad, Biomed. Pharmacother. 2017, 91, 265. 
97 a) C.-G. Cho, Y.-W. Kim, Y.-K. Lim, J.-S. Park, H. Lee, S. Koo, J. Org. Chem. 2002, 67, 290; b) P. Zhao, C. 
M. Beaudry, Angew. Chem. Int. Ed. 2014, 126, 10668; c) P. Gan, M. W. Smith, N. R. Braffman, S. A. Snyder, 
Angew. Chem. Int. Ed. 2016, 55, 3625. 
98 a) M. Luparia, M. T. Oliveira, D. Audisio, F. Frébault, R. Goddard, N. Maulide, Angew. Chem. Int. Ed., 2011, 
50, 12631; b) C.-X. Zhuo, A. Fürstner, Angew. Chem. Int. Ed. 2016, 55, 6051; c) J. Preindl, S. Schulthoff, C. 
Wirtz, J. Lingnau, A. Fürstner, Angew. Chem. Int. Ed. 2017, 56, 7525. 
99 a) F. Frébault, M. T. Oliveira, E. Wöstefeld, N. Maulide, J. Org. Chem. 2010, 75, 7962; b) M.-T. Nolan, L. M. 
Pardo, A. M. Prendergast, G. P. McGlacken, J. Org. Chem. 2015, 80, 10904. 
100 a) M. Grigalunas, O. Wiest, P. Helquist, Org. Lett. 2016, 18, 5724; b) D. Dobler, O. Reiser, J. Org. Chem. 
2016, 81, 10357. 
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Herein, the functionalization of 2- and 4-pyrones (154 and 155) and methyl coumalate (156) as well as 
the 3,5-dibrominated 2-pyrone 157 using TMPMgCl·LiCl42a,81b,101 (89), TMPZnCl·LiCl63,81d,84,102 (92) 
and TMP2Zn·2LiCl·2MgCl264,67,85 (93) followed by reactions with various electrophiles (EX) is 
reported. 
2.2 Functionalization of 2-Pyrone 
2-Pyrone (154) was treated with TMPMgCl·LiCl42a (89, 1.20 equiv) for 15 min at –40 °C in THF, which 
resulted in the coordination of the TMP-base to the oxygen atom O(1), inducing a magnesiation in 
position C(6). This method led to a magnesium species of type 158, which, after quenching with 
aldehydes, gave the alcohols 159a103 and 159b in 60–72% yield (Table 4, entries 1–2). Reaction of the 
magnesium intermediate 158 with S-methyl methanethiosulfonate led to the thiolated 2-pyrone 159c in 
95% yield (entry 3). After transmetalation of the magnesium species to zinc using ZnCl2, a Negishi 
cross-coupling86 was performed with aryl iodides containing electron-withdrawing or -donating 
substituents in the presence of 4% Pd(dba)2 and 8% tris (o-furyl)phosphine87 affording arylated 2-
pyrones 159d–f in 75–95% yield (entries 4–6). Reaction of this zinc species in a Pd-catalyzed cross-
coupling with (E)-2-bromobut-2-ene provided 159g in 95% yield (entry 7). After transmetalation to the 
corresponding copper-species using CuCN·2LiCl92 (1.20 equiv, −40 °C, 30 min) and subsequent 
reaction with 3-bromocyclohex-1-ene led to the allylated product 159h in 50% yield (entry 8). 
Moreover, acylation reactions of the copper intermediates using various acid chlorides afforded 6-acyl-
2-pyrones 159i–j in 44–60% yield (entries 9–10). 
  
                                                     
101 a) M. Balkenhohl, C. Francois, D. Sustac-Roman, P. Quinio, P. Knochel, Org. Lett. 2017, 19, 536; b) M. 
Balkenhohl, R. Greiner, I. S. Makarov, B. Heinz, K. Karaghiosoff, H. Zipse, P. Knochel, Chem. - Eur. J. 2017, 
23, 13046. 
102 M. Balkenhohl, B. Salgues, T. Hirai, K. Karaghiosoff, P. Knochel, Org Lett. 2018, 20, 3114. 
103 CCDC-1847973 (159a) contains the supplementary crystallographic data for this compound. The data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
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Table 4: Magnesiation of 2-pyrone (154) leading to the metalated species 158 followed by reactions with several 
electrophiles. 
 
Entry Substrate Electrophile (EX) Product/Yield[a] 
 
 
 
 
1 154  159a, 72% 
 
  
 
2 154  159b, 60% 
 
 
MeSSO2Me 
 
3 154  159c, 95% 
 
 
 
 
4 154  159d, 75%[b] 
 
 
 
 
5 154  159e, 90%[b] 
 
  
 
6 154  159f, 95%[b] 
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7 154  159g, 95%[c] 
 
 
 
 
8 154  159h, 50%[d] 
 
  
 
9 154  159i, 44%[d] 
 
  
 
10 154  159j, 60%[d] 
[a] Yield of isolated, analytically pure product. [b] Obtained by Negishi cross-coupling86 using 4% Pd(dba)2 
and 8% P(o-furyl)3.87 [c] Obtained by Negishi cross-coupling86 using 4% PEPPSI-iPr.91 [d] Obtained after 
transmetalation with CuCN·2LiCl92 (1.20 equiv).  
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2.3 Functionalization of 2-Pyrone Derivatives 
2-Pyrones bearing an ester functionality in the C(5) position also underwent metalation using 
TMPZnCl·LiCl63 (92, 1.20 equiv, −78 °C, 10 min), allowing a facile functionalization of the C(6) 
position. Pd-catalyzed Negishi cross-couplings86 with aryl iodides led to cross-coupling products 160a–
b in 45–58% yield (Table 5, entries 1–2). Transmetalation of 161 with CuCN·2LiCl92 (1.20 equiv, 
−40 °C, 30 min) and subsequent reaction with allyl bromide provided methyl coumalate 160c in 70% 
yield (entry 3). The corresponding reaction with acyl chlorides afforded the expected ketones 160d–f 
in 40–64% yield (entries 4–6). 
Table 5: Zincation of methyl coumalate (156) leading to the metalated species 161 followed by reactions with 
several electrophiles. 
 
Entry Substrate Electrophile (EX) Product/Yield[a] 
 
 
 
 
1 156  160a, 45%[b] 
 
 
 
 
2 156  160b, 58%[b] 
 
 
 
 
3 156  160c, 70%[c] 
 
 
 
 
4 156  160d, 40%[c] 
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5 156  160e, 55%[c] 
 
   
6 156  160f, 64%[c] 
[a] Yield of isolated, analytically pure product. [b] Obtained by Negishi cross-coupling86 using 4% Pd(dba)2 
and 8% P(o-furyl)3.87 [c] Obtained after transmetalation with CuCN·2LiCl92 (1.20 equiv).  
The scope of this zincation using the zinc-base 92 on 3,5-dibrominated 2-pyrone 15797 achieving a 
regioselective zincation of 3,5-dibromo-2H-pyran-2-one (157) at position C(6) with the zinc base (92, 
1.20 equiv, −10 °C, 1.5 h) was explored. The resulting zinc reagent 162 was readily functionalized by 
reaction with various electrophiles to furnish 6-substituted 3,5-dibromo-2H-pyran-2-one of type 163 
(Table 6). Similarly, iodolysis, Pd-catalyzed Negishi cross-coupling86 and Cu-mediated allylation or 
acylation, provided the C(6)-substituted pyrones 163a–e in 53–64% yield (entries 1–5).104 
Table 6: Zincation of 3,5-dibromo-2H-pyran-2-one (157) leading to the metalated species 162 followed by 
reactions with several electrophiles. 
 
Entry Substrate Electrophile (EX) Product/Yield[a] 
 
 
I2 
 
1 157  163a, 64% 
    
                                                     
104 CCDC-1851127 (163a) contains the supplementary crystallographic data for this compound. The data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
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2 157  163b, 60%[b] 
 
 
 
 
3 157  163c, 60%[c] 
 
 
 
 
4 157  163d, 55%[c] 
 
 
 
 
5 157  163e, 53%[c] 
[a] Yield of isolated, analytically pure product. [b] Obtained by Negishi cross-coupling86 using 4% Pd(dba)2 
and 8% P(o-furyl)3.87 [c] Obtained after transmetalation with CuCN·2LiCl92 (1.20 equiv). 
2.4 Further Functionalization of Substituted 2-Pyrone 
A second metalation of the 6-substituted 2-pyrone 159c and 159e occured at position C(3) or C(5) using 
TMPMgCl∙LiCl42a (89). Thus, the 6-thiolated 2-pyrone 159c was metalated in position C(5) with 89 
(1.20 equiv, −40 °C, 1.5 h) and this magnesiated species 164 was then iodinated to provide iodo-
derivative 165 in 43% yield (Scheme 32). 
 
Scheme 32: Further functionalization of the 6-substituted 2-pyrone 159c. 
Furthermore, treatment of the 6-arylated 2-pyrone 159e with 89 (1.20 equiv, –40 °C, 1.5 h) led to the 
quantitative formation of 3-magnesiated pyrone 166 (Table 7). The magnesium reagent 166 reacted 
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with iodine and benzaldehyde, to provide the 3,6-disubstituted 2-pyrones 167a–b in 45–95% yield 
(entries 1–2). 
Table 7: A second metalation of the 6-substituted 2-pyrone 159e. 
 
Entry Substrate Electrophile (EX) Product/Yield[a] 
 
 
I2 
 
1 159c  167a, 95%[b] 
 
 
 
 
2 159e  167b, 45% 
[a] Yield of isolated, analytically pure product. [b] Obtained by Negishi cross-coupling86 using 4% Pd(dba)2 and 
8% P(o-furyl)3.87 
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2.5 Functionalization of 4-Pyrone Scaffold 
In order to extend the substrate scope, a 2-zincated 4-pyrone (168) was prepared by treating 4-pyrone 
(155) with TMP2Zn·2LiCl·2MgCl264 (93) at –35 °C for 2 h (Table 8). The zinc intermediate 168 reacted 
readily with aryl iodides in the presence of 4% Pd(dba)2 and 8% P(o-furyl)3,87 providing the 
corresponding arylated products 169a–b in 50–86% yield (Table 8, entries 1–3). Copper-mediated 
acylation with thiophene-2-carbonyl chloride or cyclopropanecarbonyl chloride gave 4-pyrone ketones 
169c–169d in 50–71% yield (entries 3–4). 
Table 8: Zincation of 4-pyrone (155) leading to the metalated species 168 followed by reactions with several 
electrophiles. 
 
Entry Substrate Electrophile (EX) Product/Yield[a] 
 
 
 
 
1 155  169a, 50%[b] 
 
  
 
2 155  169b, 86%[b] 
 
  
 
3 155  169c, 71%[c] 
 
  
 
4 155  169d, 50%[c] 
[a] Yield of isolated, analytically pure product. [b] Obtained by Negishi cross-coupling86 using 4% Pd(dba)2 
and 8% P(o-furyl)3.87 [c] Obtained after transmetalation with CuCN·2LiCl92 (1.20 equiv).  
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3 Generation of Aryl and Heteroaryl Magnesium Reagents in Toluene by 
Br/Mg- or Cl/Mg-Exchange 
3.1 Introduction 
Organomagnesium halides are key intermediates in organic synthesis.6 They are usually prepared by a 
direct insertion of magnesium turnings,105 Rieke magnesium,106 or magnesium powder, and lithium 
chloride10 to organic halides. The heterogenous nature of this reaction complicates scale-up and 
industrial use.83 A deprotomagnesiation of arenes or heteroarenes can also be accomplished using 
soluble hindered magnesium amides.42b,83b,107 Alternatively, various organomagnesium halides can be 
prepared via a halogen-magnesium exchange by treating aryl or heteroaryl iodides or bromides with an 
alkylmagnesium halide108 or better with iPrMgCl·LiCl (36).23,35 Furthermore, synthetically useful 
reagents for halogen-metal exchange are lithium organomagnesiates (R3MgLi). However, in this case, 
lithium triorgano magnesiates are produced.21e All these preparation methods provide Grignard reagents 
in ethereal solvents such as diethyl ether or THF and only a few methods have been reported describing 
the preparation of magnesium organometallics in non-polar solvents.109 The synthesis of Grignard 
reagents in hydrocarbons or toluene is of great interest, since these weakly-coordinated Grignard 
reagents may display an original and unusual reactivity. Also, Grignard reagents in hydrocarbons or 
toluene are industrial friendly reagents, as such solvents improve aqueous extraction during work-
ups.110 Herein, new halogen-magnesium exchange reagents sBuMgOR·LiOR (170a) and 
sBu2Mg·2LiOR (170b) (R = 2-ethylhexyl), that allow very fast bromine-magnesium exchanges and, 
for the first time, a chlorine-magnesium exchange on various electron-rich aryl chlorides are reported. 
3.2 Optimization of Reaction Conditions 
First, a convenient synthesis of 170a and 170b was developed. Thus, the magnesium alkoxide was 
prepared by treating nBu2Mg (0.70 M in hexane, 1.00 equiv) with 2-ethylhexanol (171, 2.00 equiv) at 
                                                     
105 Grignard Reagents, New Developments (Ed.: H. G. Jr. Richey.), Wiley-VCH Verlag GmbH & Co KGaA, 
Weinheim, 2000. 
106 a) R. D. Rieke, T.-J. Li, T. P. Burns, S. T. Uhm, J. Org. Chem. 1981, 46, 4324; b) R. D. Rieke, Science 1989, 
246, 1260; c) Active Metals (Ed.: A. Fuerstner), Wiley-VCH Verlag GmbH & Co KGaA, Weinheim, 1995; d) J. 
Lee, R. Velarde-Ortitz, A. Guijarro, J. R. Wurst, R. D. Rieke, J. Org. Chem. 2000, 65, 5428. 
107 M. Balkenhohl, P. Knochel, SynOpen 2018, 2, 78. 
108 D. R. Rieke, M. S. Sell, In Handbook of Grignard reagents (Eds.: G. S. Silvermann, P. E. Rakita) 1996. 
109 a) C. G. Screttas, M. Micha-Screttas, J. Organomet. Chem. 1985, 290, 1; b) C. G. Screttas, B. R. Steele, J. Org. 
Chem. 1989, 54, 1013; c) T. Iida, T. Wada, K. Tomimoto, T. Mase, Tetrahedron Lett. 2001, 42, 4841; d) L. 
Chtcheglova, S. Carlotii, A. Deffieux, N. Poirier, M. Barbier, FR-2840901, 2003; e) E. S. Baillie, T. D. Bluemke, 
A. R. Clegg, Kennedy, J. Klett, L. Russo, M. de Tullio, E. Hevia, Chem. Commun. 2014, 50, 12859. 
110 a) Solvent Recovery Handbook (Ed.: I. M. Smallwood), Blackwell Science Ltd., Oxford, 2002; b) L. Delhaye, 
A. Ceccato, P. Jacobs, C. Köttgen, A. Merschaert, Org. Process Res. Dev. 2007, 11, 160. 
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25 °C for 24 h.111,112 The addition of one or two equivalents of sBuLi (1.21 M in cyclohexane) to the 
colorless gel (172) at 25 °C for 2 h provided slightly yellow solutions of 170a and 170b. Removal of 
the solvent in vacuo produced a foam which readily dissolves in toluene, affording a 1.00–1.50 M 
solution of 170a and a 0.60–0.85 M slightly yellow solution of 170b (Scheme 33).113 
 
Scheme 33: Preparation of the new exchange reagents 170a and 170b. 
Both 170a–b are very powerful exchange reagents, which for the first time, allow the synthesis of 
arylmagnesium reagents in toluene.114 In preliminary experiments, the bromine-magnesium exchange 
on 4-bromoanisole (173a) was examined (Table 9). 
In THF, iPrMgCl·LiCl (36)35a,b required 27 h at 25 °C to complete the exchange reaction and produced 
the desired arylmagnesium halide 174a (Y = Cl). However, less than 1% of 174a was formed with this 
exchange reagent after 15 min reaction time (entry 1).115 The currently most powerful available 
exchange reagent sBu2Mg·2LiCl (81)35b led to 13% of 174a (Y = 4-anisyl) after 15 min (entry 2). A full 
conversion with this reagent required 8 h reaction time. Switching to toluene showed, that both of these 
reagents were unreactive. 
  
                                                     
111 H. Thoms, M. Epple, H. Viebrock, A. Reller, J. Mater. Chem. 1995, 5, 589. 
112 Alternatively, a magnesium alkoxide solution (0.94 M in heptane) is commercially available from Albemarle, 
Frankfurt: U. Wietelmann, U. Emmel, J. Roeder, M. Steinbild, K. Papstein, K. (Albemarle), WO-2010146122, 
2010. 
113 Further detailed screening tables can be found in the EXPERIMENTAL PART. 
114 The reactions were also performed in other apolar solvents such as hexane and cyclohexane or in cyclopentyl 
methyl ether (CPME). 
115 Yield of 174a determined by GC-analysis of water quenched reaction aliquots with undecane as internal 
standard. 
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Table 9: Bromine-magnesium exchange for 4-bromoanisole (173a) using various magnesium-exchange reagents 
at 25 °C. 
 
Entry Mg-exchange reagent Equiv Solvent Yield(%)[a] 
1 iPrMgCl·LiCl (36) 1.20 THF 1 [0][b] 
2 sBu2Mg·2LiCl (81) 0.60 THF 13 [0][b] 
3 sBuMgOR·LiOR (170a) 1.20 toluene 85 
4 sBuMgOR·LiOR (170a) 1.20 toluene 99[c] 
5 sBuMgOR·LiOR (170a) 1.20 THF 14[c] 
[a] Yield of 174a determined by GC-analysis of water quenched reaction aliquots with undecane as internal 
standard. [b] Yield obtained in toluene. [c] Yield obtained in the presence of TMEDA (1.20 equiv). 
However, the addition of the new reagent sBuMgOR·LiOR (170a) to 173a in toluene provided 174a 
(Y = OR·LiOR) in 85% yield within 15 min reaction time (entry 3). The addition of TMEDA 
(1.20 equiv) further improved the reaction conversion to 99% (entry 4).116 The addition of TMEDA to 
iPrMgCl·LiCl (36)35a,b or sBu2Mg·2LiCl (81) 35b had no effect. Interestingly, the rate of the bromine-
magnesium exchange using 174a in THF instead of toluene was considerably decreased and only a 
conversion of 14% was observed (entry 5). This showed, that there is a real advantage for carrying out 
the bromine-magnesium exchange in non-polar solvents such as toluene. 
3.3 Aryl Magnesium Reagents in Toluene by Br/Mg-Exchange 
Quenching of 174a (Y = OR·LiOR·TMEDA) with iodine furnished the aryl iodide 175a in 70% yield 
(25 °C, 30 min; Table 10, entry 1). Usually, arylmagnesium reagents do not add well to ketones.21b,117,118 
However, trapping 174a in toluene with ketones furnished the tertiary alcohols 175b–c in 80–86% yield 
(25 °C, 2 h; entries 2–3). Related aryl bromides such as 3-bromoanisole (173b) or 1-bromo-3,5-
dimethoxybenzene (173c) underwent a complete bromine-magnesium exchange by treatment with 170a 
                                                     
116 F. M. Perna, A. Salomone, M. Dammacco, S. Florio, V. Capriati, Chem. - Eur. J. 2011, 17, 8216. 
117 a) M. Hatano, S. Suzuki, K. Ishihara, J. Am. Chem. Soc. 2006, 128, 9998; b) M. Hatano, O. Ito, S. Suzuki, K. 
Ishihara, J. Org. Chem. 2010, 75, 5008.  
118 Notable exceptions: a) C. Vidal, J. García-Álvarez, A. Hernán-Gómez, A. R. Kennedy, E. Hevia, Angew. Chem. 
Int. Ed. 2014, 53, 5969; b) L. Cicco, S. Sblendorio, R. Mansueto, F. M. Perna, A. Salmone, S. Florio, V. Capriati, 
Chem. Sci. 2016, 7, 1192. 
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(25 °C, 15 min). These Grignard reagents were added to PhCHO or were acylated with a Weinreb 
amide,119 furnishing the desired products 175d and 175e in 89–95% yield (25 °C, 1 h; entries 4–5).  
Table 10: Bromine-magnesium exchange for aryl bromides of type 173 leading, via intermediate 
organomagnesiums of type 174, to functionalized arenes of type 175. 
 
Entry Arylbromide Electrophile (EX) Product/Yield[b] 
 
 
I2 
 
1 173a  175a, 70% 
 
  
 
2 173a  175b, 80% 
 
 
  
3 173a  175c, 86% 
 
  
 
4 173b  175d, 95%  
 
  
 
5 173c  175e, 89% 
 
 
MeSO2SMe 
 
6 173d  175f, 84%[c] 
    
                                                     
119 S. M. Weinreb, S. Nahm, Tetrahedron Lett. 1981, 22, 3815. 
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7 173e  175g, 65%[d] 
 
  
 
8 173f  175h, 80%[e] 
 
   
9 173g  175i, 86% 
 
 
  
10 173h  175j, 75% 
 
   
11 173i  175k, 72% 
[a] TMEDA has been omitted for the sake of clarity. [b] Yield of analytically pure isolated product. [c] The 
reaction time was 1 h. [d] The reaction time was 4 h. [e] The reaction time was 2 h. 
Also, bromoanilines 173d–f which are very reluctant to undergo a bromine-magnesium exchange with 
previously known exchange reagents,23,35b were converted into the corresponding arylmagnesium 
alkoxides within 1–4 h at 25 °C in toluene. Their trapping with MeSO2SMe, morpholino(phenyl) 
methanone120 or dicyclopropyl ketone produced the polyfunctional aniline derivatives 175f–h in 65–
84% yield (25 °C, 1–2 h; entries 6–8). Similar electron-rich aryl bromides such as 173g and 173h were 
converted to the Grignard reagents and were quenched with cyclohexanone or N-benzylideneamine, 
leading to 175i and 175j in 75–86% yield (25 °C, 2 h; entries 9–10). Finally, electron-poor aryl bromide 
173i underwent the bromine-magnesium exchange at 25 °C within 15 min and gave after quenching 
with a ketone the product 175k in 72% yield (25 °C, 2 h; entry 11). These results demonstrated, that 
arylmagnesium alkoxides of type 174 complexed with LiOR and TMEDA are superior nucleophiles, 
since they react smoothly with various ketones. The structure of the magnesium reagents 174 were 
tentatively proposed to be A (Table 10). 
                                                     
120 a) R. Peters, P. Waldmeier, A. Joncour, Org. Process Res. Dev. 2005, 9, 508; b) Y. Chen, M. Ellwart, G. 
Toupalas, Y. Ebe, P. Knochel, Angew. Chem. Int. Ed. 2017, 56, 4612. 
B. RESULTS AND DISCUSSION    51 
3.4 Aryl Magnesium Reagents in Toluene by Br/Mg-Exchange and Subsequent Copper-
Catalyzed Reactions 
Furthermore, the Grignard reagents 174 (Y = OR·LiOR·TMEDA) underwent a range of copper-
catalyzed reactions such as acylations with various acyl chlorides in toluene leading to ketones 175l–o 
in 60–95% yield (10% CuI, 0 °C, 1 h; Table 11, entries 1–4). Also, allylations of arylmagnesium 
alkoxides were realized at 25 °C with allylic bromides, providing products 175p–r in 89–92% yield 
(entries 5–7). The opening of epoxides and aziridines with arylmagnesium reagents is also a challenging 
reaction that often required Lewis acids or harsh reaction conditions.121 It was found that epoxides like 
propylene oxide, or aziridines such as 2-methyl-1-tosylaziridine, 2-benzyl-1-tosylaziridine or 2-
isobutyl-1-tosylaziridine were opened under mild conditions (25 °C, 4–10 h), leading to the expected 
products 175s–175v in 73–95% yield (entries 8–11). 
Table 11: Bromine-magnesium exchange for aryl bromides of type 173 leading, via intermediate 
organomagnesiums of type 174, to functionalized arenes of type 175 in the presence of 10% CuI. 
 
Entry Arylbromide Electrophile (EX) Product/Yield[b] 
 
 
  
1 173a  175l, 95% 
    
 
   
2 173a  175m, 60% 
 
   
3 173j  175n, 70% 
                                                     
121 a) M. J. Eis, J. E. Wrobel, B. Ganem J. Am. Chem. Soc. 1984, 106, 3693; b) A. Alexakis, I. Marek, P. Mangeney, 
J. F. Normant, Tetrahedron Lett. 1989, 2387; c) D. Tanner, Angew. Chem. Int. Ed. Engl. 1994, 33, 599; d) 
Aziridines and Epoxides in Organic Synthesis (Ed: A. Yudin), Wiley-VCH Verlag GmbH & Co KGaA, 
Weinheim, 2006; e) S. Stankovic, M. D’hooghe, S. Catak, H. Eum, M. Waroquier, V. Van Speybroeck, N. De 
Kimpe, H.-J. Ha, J. Chem. Soc. Rev. 2012, 41, 643; f) K. L. Jensen, E. A. Standley, T. F. Jamison, J. Am. Chem. 
Soc 2014, 136, 11145. 
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4 173k  175o, 64% 
 
 
 
 
5 173l  175p, 92% 
 
 
 
 
6 173m  175q, 90% 
 
  
 
7 173n  175r, 89% 
 
   
8 173a  175s, 92% 
 
   
9 173a  175t, 73% 
 
   
10 173o  175u, 95% 
 
   
11 173o  175v, 92% 
[a] TMEDA has been omitted for the sake of clarity. [b] Yield of analytically pure isolated product. 
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3.5 Aryl Magnesium Reagents in Toluene by Br/Mg-Exchange and Subsequent Palladium-
Catalyzed Cross-Couplings 
The arylmagnesium alkoxides of type 174 (Y = OR·LiOR·TMEDA) also participate in Pd-catalyzed 
cross-couplings (Scheme 34). 
 
Scheme 34: Cross-couplings of organomagnesium intermediate 174a: [a] TMEDA has been omitted for the sake 
of clarity. [b] Yield of analytically pure isolated product. 
Thus, p-anisylmagnesium derivative (174a; Y = OR·LiOR·TMEDA) underwent a Kumada cross-
coupling122 with 1-chloro-4-(trifluoromethyl)benzene in the presence of 2% Pd(OAc)2 and 3% SPhos89 
(25 °C, 2 h), producing the biphenyl 175w in 70% yield. Transmetalation with Zn(OPiv)2123 in toluene 
led to a milky suspension which reacted with 4-bromobenzonitrile (25 °C, 15 h) via a Negishi cross-
coupling using 4% of PEPPSI-iPr,91,86,124 furnishing the desired product 175x in 72% yield (Scheme 
34). 
3.6 Heteroaryl Magnesium Reagents in Toluene by Br/Mg-Exchange 
This method was extended to the preparation of some heterocyclic magnesium alkoxides. Thus, the 
treatment of 5-bromobenzofuran (176a) with sBuMgOR·LiOR (170a, 1.20 equiv) for 15 min at 25 °C 
led to the corresponding heteroarylmagnesium alkoxide 177a in ca. 90% yield. Quenching with benzoyl 
chloride in the presence of 10% CuI provided the benzofuran derivative 178a in 70% yield (Table 12, 
entry 1). Similarly, 3-bromobenzothiophene 176b was converted to the corresponding 
organomagnesium alkoxide 177b. Quenching with morpholino(phenyl) methanone120 gave 
benzothiophene 178b in 65% yield (−10 °C, 15 min; entry 2). Also, N-methyl-5-bromoindole (176c) 
and the 3-bromoazaindole 176d were converted into the corresponding organomagnesium alkoxides 
177c and 177d. After quenching with benzofuran-2-carbaldehyde, the desired products 178c–d were 
obtained in 62–70% yield (entries 3–4). The pyridine derivatives 176e and 176f were converted into 
                                                     
122 a) R. Martin, S. L. Buchwald, J. Am. Chem. Soc. 2007, 129, 3844; b) G. Manolikakes, P. Knochel, Angew. 
Chem. Int. Ed. 2009, 48, 205; c) X. Hua, J. Masson-Makdissi, R. J. Sullivan, S. G. Newman, Org. Lett. 2016, 18, 
5312. 
123 Y.-H. Chen, M. Ellwart, V. Malakhov, P. Knochel, Synthesis 2017, 49, 3215. 
124 a) D. Haas, J. M. Hammann, R. Greiner, P. Knochel, ACS Catal. 2016, 6, 1540; b) D.-Y. Wang, K. Morimoto, 
Z.-K. Yang, C. Wang, M. Uchiyama, Chem. Asian J. 2017, 12, 2554. 
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the Grignard reagents 177e and 177f and were quenched with aldehydes, leading to the alcohols 178e 
and 178f in 68–72% yield (−30 °C, 1 h; entries 5–6). Interestingly, the treatment of 2,3,4,5-
tetrachlorothiophene125 (176g) with 170a (2.40 equiv) led to a double chlorine-magnesium exchange, 
providing a bis-magnesium species, which after a copper-catalyzed allylation with allyl bromide, gave 
2,5-bis-allylthiophene 178g in 60% yield (entry 7). 
Table 12: Bromine-magnesium exchange for heteroaryl bromides and chlorides of type 176 leading, via 
intermediate organomagnesiums of type 177, to functionalized heteroarenes of type 178. 
 
Entry Heteroarylhalides Electrophile (EX) Product/Yield[b] 
 
 
  
1 176a  178a, 70%[c] 
 
   
2 176b  178b, 65%[d] 
 
  
 
3 176c  178c, 62% 
 
 
 
 
4 176d  178d, 70%[e] 
                                                     
125 Previously, it was found that 176 is the only substrate, which undergoes a fast mono-chlorine-magnesium 
exchange using iPrMgCl·LiCl (36): M. Abarbri, J. Thibonnet, L. Bérillon, F. Dehmel, M. Rottländer, P. Knochel, 
J. Org. Chem. 2000, 65, 4618. 
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5 176e  178e, 72%[f] 
 
  
 
6 176f  178f, 68%[f] 
 
 
 
 
 
7 176g  178g, 60%[g] 
[a] TMEDA has been omitted for the sake of clarity. [b] Yield of analytically pure isolated product. [c] 10% 
CuI was added. [d] The reaction temperature was −10 °C. [e] The reaction time was 3 h. [f] The reaction time 
was 1 h at −30 °C [g] The reaction time was 4 h. 
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3.7 Aryl Magnesium Reagents in Toluene by Cl/Mg-Exchange 
This excellent propensity of magnesium exchange reagent 170a for undergoing chlorine-magnesium 
exchanges was used to explore the scope of such an almost unknown chlorine-magnesium exchange.125 
2-Chloro-1,4-dimethoxybenzene (179a) was used as substrate and was submitted to various Grignard 
exchange reagents (Table 13). It was found that iPrMgCl·LiCl (36)35a,b or sBu2Mg·2LiCl (81)35b did not 
react with 179a, even in the presence of TMEDA or PMDTA. Also, sBuMgOR·LiOR (170a, R = 2-
ethylhexyl) gave no exchange under various conditions (entries 1–3). After extensive experimentations, 
it was found, that sBu2Mg·2LiOR (170b, 0.60 equiv) led to 48% of a chlorine-magnesium exchange 
affording a bis-magnesium reagent of type 180 after 1 h reaction time at 25 °C (entry 4). The addition 
of TMEDA (0.60 equiv) improved the conversion to 59% and the addition of PMDTA (0.60 equiv) 
instead of TMEDA further increased the conversion to 75% yield (entries 5 and 6). 
Table 13: Chlorine-magnesium exchange on aryl chloride 179a using various magnesium-exchange reagents. 
 
Entry Mg-exchange reagent Equiv Additive Yield (%)[a] 
1 iPrMgCl·LiCl (36) 1.20 PMDTA 0 [0][b] 
2 sBu2Mg·2LiCl (81) 0.60 PMDTA 0 [0][b] 
3 sBuMgOR·LiOR (170a) 1.20 PMDTA 0 [0][b] 
4 sBu2Mg·2LiOR (170b) 0.60 - 48 
5 sBu2Mg·2LiOR (170b) 0.60 TMEDA 59 
6 sBu2Mg·2LiOR(170b) 0.60 PMDTA 73 [20][c] 
[a] Yield of 180a determined by GC-analysis of water quenched reaction aliquots. [b] Yield obtained in toluene. 
[c] Yield obtained in THF. 
The addition of benzaldehyde (1.50 equiv) led to the alcohol 181a in 61% yield (25 °C, 1 h; Table 14, 
entry 1). This chlorine-magnesium exchange was extended to a range of aryl chlorides bearing a 
methoxy group126 in ortho-position. For all these substrates the chlorine-magnesium exchange was 
completed within 1 h at 25 °C and produced a diarylmagnesium species 180 of tentative structure B. 
Quenching with various electrophiles (1.50 equiv) furnished the expected products 181b–f in 50–75% 
                                                     
126 This o-methoxy group facilitates the coordination of the magnesium exchange reagent (170b) and therefore 
accelerates the chlorine-magnesium exchange. Compare with: D. W. Slocum, E. A. Maulden, P. E. Whitley, T. 
K. Reinscheld, C. S. Jackson, J. B. Maddox, Eur. J. Org. Chem. 2017, 6882. 
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yield (entries 2–6). In case of a stronger directing group such as MOM, the exchange reaction proceeded 
within 15 min at 25 °C and furnished after reaction with an aldehyde 181g in 79% yield (entry 7). 
Table 14: Chlorine-magnesium exchange for aryl chlorides of type 179 leading via intermediate 
organomagnesiums of type 180 to functionalized arenes of type 181. 
 
Entry Arylchlorides Electrophile (EX) Product/Yield[b] 
 
 
 
 
1 179a  181a, 61% 
 
 
 
 
2 179b  181b, 70% 
 
 
 
 
3 179c  181c, 50% 
 
 
 
 
4 179d  181d, 70% 
 
 
MeSO2SMe 
 
5 179e  181e, 62% 
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6 179e  181f, 75%[c] 
 
  
 
7 179f  181g, 79% 
[a] PMDTA has been omitted for the sake of clarity. [b] Yield of analytically pure isolated product. [c] 10% 
CuI was added. 
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4 Summary 
This work dealt with two different subjects: the first two topics were focused on the chemo- and 
regioselective functionalization of N- and O-containing heterocycles via directed metalation. The third 
topic dealt with the generation of new Grignard-reagents in non-polar solvents. First, 2-pyridones and 
2,7-naphthyridones were metalated with TMP2Zn·2MgCl2·2LiCl under mild conditions (−10 °C, 72 h). 
The zincated intermediate could subsequently be quenched with various electrophiles affording 
functionalized 2-pyridones and 2,7-naphthyridones that are interesting synthetic scaffolds for the 
pharmaceutical industry. In addition, 2- and 4-pyrone and their derivatives such as methyl coumalate 
and 3,5-dibromo-2H-pyran-2-one were metalated and functionalized by using TMP-bases. 
Furthermore, the new exchange reagent sBuMgOR·LiOR (R = 2-ethylhexyl) was developed, which 
underwent extremely fast bromine-magnesium exchanges in toluene (30-110 times faster than previous 
exchange reagents), leading to new aryl and heteroaryl magnesium reagents with exceptional high 
reactivity. The new reagents ArMgOR·LiOR (R = 2-ethylhexyl) reacted with a wide range of 
electrophiles. Finally, the preparation of sBu2Mg·2LiOR (R = 2-ethylhexyl), which was the first reagent 
triggering a chlorine-magnesium exchange on electron-rich aryl chlorides, was reported. This method 
allowed the preparation of diarylmagnesium reagents (Ar2Mg·2LiOR) in toluene. 
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4.1 Directed Zincation or Magnesiation of the 2-Pyridone and 2,7-Naphthyridone Scaffold using 
TMP-Bases 
 
Scheme 35: a) Metalation of MEM-protected 2-pyridones and 2,7-naphthyridone using TMP2Zn·2MgCl2·2LiCl. 
b) Iodine-magnesium exchange of iodinated 2-pyridones and 2,7-naphthyridones. 
A new and general method for the regioselective metalation of MEM-protected 2-pyridones as well as 
MEM-protected 2,7-naphthyridone using TMP2Zn·2MgCl2·2LiCl leading to a variety of new 
functionalized 2-pyridones and 2,7-naphthyridones was developed. Furthermore, an iodine-magnesium 
exchange of iodinated 2-pyridones and 2,7-naphthyridones using iPrMgCl·LiCl afforded magnesiated 
intermediates which reacted with a broad range of electrophiles. A second metalation of the 2-pyridone 
scaffold was achieved by using TMPMgCl·LiCl. Additionally, cobalt(II) chloride catalyzed cross-
couplings of 1-chloro-2,7-naphthyridine with arylzinc halides led to the desired naphthyridines in 
satisfying yields. 
 
Scheme 36: Preparation of a functionalized halonaphthyridine from naphthyridone and cobalt-catalyzed Negishi 
cross-couplings of chlorinated 2,7-naphthyridine. 
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4.2 Directed Zincation or Magnesiation of 2- and 4-Pyrones and their Derivatives 
 
Scheme 37: Magnesiation of 2-pyrone leading to the metalated species followed by reactions with several 
electrophiles. 
The regioselective metalation of 2-pyrone, methyl coumalate as well as the 3,5-dibrominated 2-pyrone 
using the reactive metal amides TMPMgCl·LiCl or TMPZnCl·LiCl was described. Electrophilic 
trapping led to a broad range of highly functionalized pyrones. After functionalization at the C(6)-
position with various electrophiles, a selective magnesiation at the 3- or 5-position of the 2-pyrone 
heterocycle was achieved. As an extension of this project, the functionalization of the 4-pyrone scaffold 
in position 2 using TMP2Zn 2LiCl 2MgCl2 was reported. 
4.3 Generation of Aryl and Heteroaryl Magnesium Reagents in Toluene by Br/Mg- or Cl/Mg-
Exchange 
A method for preparing well soluble aryl and heteroaryl magnesium alkoxides complexed with one or 
two equivalents of lithium alkoxide (LiOR; R = 2-ethylhexyl) in toluene using the new exchange 
reagents sBuMgOR·LiOR and sBu2Mg·2LiOR was developed. These exchange reactions are ca. 30 
times faster than the previous exchange reagent sBu2Mg·2LiCl and ca. 110 times faster than 
iPrMgCl·LiCl (turbo-Grignard). Furthermore, the resulting Grignard reagent of type ArMgOR·LiOR 
or HetArMgOR·LiOR displayed an excellent reactivity in toluene adding well to ketones and opening 
epoxides and aziridines under mild conditions. Furthermore, sBu2Mg·2LiOR was able to trigger a 
chlorine-magnesium exchange leading to diarylmagnesium species (Ar2Mg·2LiOR). 
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Scheme 38: a) Bromine-magnesium exchange of (hetero)aryl bromides leading via intermediate 
organomagnesiums to functionalized (hetero)arenes. b) Chlorine-magnesium exchange of aryl chlorides leading, 
via intermediate organomagnesiums, to functionalized arenes. 
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1 General Considerations 
1.1 Solvents 
Solvents were dried according to standard procedures by distillation over drying agents as stated below 
and stored under argon. Otherwise they were obtained from commercial sources and used without 
further purification.  
THF was continuously refluxed and freshly distilled from sodium benzophenone ketyl under nitrogen 
and then stored over molecular sieves. 
PhMe was continuously refluxed and freshly distilled from sodium under nitrogen and stored over 
molecular sieves. 
TMEDA and PMDTA were freshly distilled from calcium hydride under nitrogen. 
Solvents for column chromatography were distilled prior to use. 
1.2 Reagents 
All reagents were obtained from commercial sources and used without further purification unless 
otherwise stated. Liquid aldehydes and acyl chlorides were distilled prior to use. 
TMPH was distilled prior to use and stored under argon. 
nBuLi, sBuLi, tBuLi solutions in hexane were purchased from Albemarle and the concentration was 
determined by titration against 1,10-phenanthroline in THF with iPrOH.127 
nBu2Mg solution in hexane was purchased from Albemarle and the concentration was determind by 
iodometric titration.128 
Magnesium-2-ethylhexanolate was purchased from Albemarle and the concentration was determined 
by acidimetric titration. 
iPrMgCl·LiCl (36) solution in THF was obtained from Albemarle and the concentration was determind 
by iodometric titration.128 
                                                     
127 H.-S. Lin, A. Paquette, Synth. Commun. 1994, 24, 2503. 
128 A. Krasovskiy, P. Knochel, Synthesis 2006, 890. 
C. EXPERIMENTAL PART    66 
 
 
 
CuCN∙2LiCl92 solution (1.00 M in THF) was prepared by drying CuCN (8.96 g, 100 mmol, 1.00 equiv) 
and LiCl (8.48 g, 200 mmol, 2.00 equiv) in a Schlenk-flask under vacuum for 5 h at 150 °C. After 
cooling to 25 °C, dry THF (100 mL) was added and stirred until the salts were dissolved. 
ZnCl2 solution (1.00 M in THF) was prepared by drying ZnCl2 (27.3 g, 200 mmol) in a Schlenk-flask 
under vacuum for 5 h at 150 °C. After cooling to 25 °C, dry THF (200 mL) was added and stirred until 
the salts were dissolved. 
Preparation of the reagent TMPMgCl·LiCl42a (89) 
A dry and argon-flushed 500 mL Schlenk-flask, equipped with a magnetic stirring bar and a rubber 
septum, was charged with iPrMgCl·LiCl (36, 1.31 M in THF, 229 mL, 300 mmol, 1.00 equiv). Then, 
TMP-H (52.0 mL, 306 mmol, 1.02 equiv) was added and the mixture was stirred until gas evolution 
ceased (48 h). The freshly prepared TMPMgCl·LiCl (89) solution was titrated prior to use at 0 °C with 
benzoic acid using 4-(phenylazo)diphenylamine as indicator. 
Preparation of the reagent TMPZnCl·LiCl84a (92) 
A dry and argon-flushed 500 mL Schlenk-flask, equipped with a magnetic stirring bar and a rubber 
septum, was charged with freshly distilled TMP-H (10.2 mL, 60 mmol, 1.00 equiv) dissolved in THF 
(60.0 mL). This solution was cooled to –40 °C and nBuLi (2.40 M in hexane, 25.0 mL, 60 mmol, 
1.00 equiv) was added dropwise. After the addition was complete, the reaction mixture was allowed to 
warm slowly to –10 °C for 1 h. ZnCl2 (1.00 M in THF, 66.0 mL, 66 mmol, 1.10 equiv) was added 
dropwise and the resulting solution was stirred for 30 min at –10 °C and then for 30 min at 25 °C. The 
solvents were then removed under vacuum affording a yellowish solid. Freshly distilled THF was then 
slowly added under vigorous stirring until the salts were completely dissolved. The freshly prepared 
TMPZnCl·LiCl (92) solution was titrated prior to use at 0 °C with benzoic acid using 4-
(phenylazo)diphenylamine as indicator. 
Preparation of the reagent TMP2Zn·2MgCl2·2LiCl64 (93) 
A flame-dried and argon-flushed 500 mL Schlenk-flask, equipped with a magnetic stirring bar and 
rubber septum, was charged with a solution of TMPMgCl·LiCl (89, 1.20 M, 50.0 mL, 60 mmol, 
1.00 equiv) and cooled to 0 °C. Then, ZnCl2 (1.00 M in THF, 30.0 mL, 30 mmol, 0.50 equiv) was added 
over a period of 15 min. After stirring this mixture for 12 h at 25 °C, TMP2Zn·2MgCl2·2LiCl (93) was 
titrated prior to use at 0 °C with benzoic acid using 4-(phenylazo)diphenylamine as indicator. 
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1.3 Chromatography 
Flash column chromatography was performed using silica gel 60 (0.040–0.063 mm, 230–400 mesh 
ASTM) from Merck. 
Thin layer chromatography was performed using aluminum plates covered with SiO2 (Merck 60, 
F-254). The chromatograms were examined under UV light at 254 nm and/or by staining of the TLC 
plate with one of the solutions given below followed by heating with a heat gun: 
- KMnO4 stain: KMnO4 (3.0 g), K2CO3 (20 g), 5% NaOH solution (5.00 mL), water (300 mL).  
- Neat iodine absorbed on silica gel. 
1.4 Analytical Data 
NMR spectra were recorded on VARIAN Mercury 200, BRUKER AXR 300, VARIAN VXR 400 S 
and BRUKER AMX 600 instruments in CDCl3. Chemical shifts are reported as δ-values in parts per 
million (ppm) relative to the residual solvent peak CDCl3 (δH: 7.26; δC: 77.16), (CD3)2CO (δH: 2.05; 
δC: 29.80), (CD3)2SO (δH: 2.50; δC: 39.52) or C6D6 (δH: 7.16; δC: 128.06). Abbreviations for signal 
coupling are as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. If not otherwise 
noted, the coupling constants given are H-H-coupling constants for proton signals and C-F-coupling 
constants for carbon signals. 
High resolution Mass spectroscopy (HR-MS) electron impact ionization (EI) and low resolution (MS) 
spectra were recorded on a FINNIGAN MAT 95Q instrument. EI was conducted with an electron energy 
of 70 eV. Electrospray ionization (ESI) spectra were recorded on a FINNIGAN LTQ FTICR instrument.  
Gas chromatography (GC) was performed on machines of the types Hewlett-Packard 6890 or 5890 
Series II (Hewlett Packard, 5% phenylmethylpolysiloxane; length: 10 m, diameter: 0.25 mm; film 
thickness: 0.25 μm). The detection was accomplished using a flame ionization detector.  
Infrared spectra (IR) were recorded from 4500 cm−1 to 650 cm−1 on a PERKIN ELMER Spectrum BX-
59343 instrument. For detection a SMITHS DETECTION DuraSamplIR II Diamond ATR sensor was 
used. Samples were measured neat. The absorption bands are reported in wavenumbers (cm−1). 
Melting points (M.p.) were determined on a BÜCHI B-540 apparatus and are uncorrected. 
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2 Directed Zincation or Magnesiation of the 2-Pyridone and 2,7-
Naphthyridone Scaffold using TMP-Bases 
2.1 Synthesis of Starting Material 
Pyridine-2(1H)-one (127) was purchased from TCI. 3-Cyano-2(1H)-pyridinone was purchased from 
Sigma-Aldrich. 2,7-Naphthyridin-1(2H)-one (128) was prepared using known procedures.129 
1-((2-Methoxyethoxy)methyl)pyridin-2(1H)-one (133) 
 
According to a literature procedure,130 in a dry and argon-flushed Schlenk-flask, equipped with a 
magnetic stirring bar and a septum, pyridine-2(1H)-one (127, 4.00 g, 42 mmol, 1.00 equiv) was 
dissolved in THF (80 mL). NaH (1.21 g, 50 mmol, 1.20 equiv) was slowly added at 0 °C. The resulting 
mixture was stirred for 1 h, treated with MEMCl (7.20 mL, 63 mmol, 1.50 equiv) and stirred for 2 h at 
0 °C. The solution was warmed to 25 °C, treated with water (50 mL) and the aq. layer was extracted 
with EtOAc (3 × 50 mL) and CH2Cl2 (3 × 50 mL). The combined organic phases were washed with sat. 
aq. NaCl solution and dried over anhydrous Na2SO4. After filtration, the solvent was evaporated in 
vacuo. The crude product was purified by column chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) 
to give the title compound 133 as a violet liquid (5.40 g, 30 mmol, 70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.40 (ddd, J = 6.9, 2.1, 0.6 Hz, 1H), 7.31 (ddd, J = 8.7, 6.5, 
2.1 Hz, 1H), 6.53 (dt, J = 9.2, 0.9 Hz, 1H), 6.18 (td, J = 6.7, 1.3 Hz, 1H), 5.39 (s, 2H), 3.76–3.69 (m, 
2H), 3.54–3.49 (m, 2H), 3.34 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 163.1, 140.2, 136.4, 121.4, 106.4, 77.2, 71.6, 69.0, 59.1. 
MS (EI, 70 eV): m/z (%) = 125 (52), 124 (11), 108 (30), 95 (100), 80 (47), 78 (33), 67 (15), 59 (10). 
HRMS (EI): m/z calc. for [C9H14NO3]: 184.0968; found: 184.0964 (M+ + H). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3474, 2926, 2884, 2822, 1656, 1586, 1538, 1466, 1080, 868, 846, 
766, 732. 
                                                     
129 A. Zhang, C. Ding, C. Cheng, Q. Yao, J. Comb. Chem. 2007, 9, 916. 
130 N. H. Nguyen, C. Len, A.-S. Castanet, J. Mortier, Beilstein J. Org. Chem. 2011,7, 1228. 
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1-((2-Methoxyethoxy)methyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile (134) 
 
According to a literature procedure,130 in a dry and argon-flushed Schlenk-flask, equipped with a 
magnetic stirring bar and a septum, 3-cyano-2(1H)-pyridinone (4.00 g, 33 mmol, 1.00 equiv) was 
dissolved in THF (80 mL). NaH (0.96 g, 40 mmol, 1.20 equiv) was slowly added at 0 °C. The resulting 
mixture was stirred for 1 h, treated with MEMCl (5.69 mL, 50.0 mmol, 1.50 equiv) and stirred for 2 h 
at 0 °C. The solution was warmed to 25 °C, treated with water (50 mL) and the aq. layer was extracted 
with EtOAc (3 × 50 mL) and CH2Cl2 (3 × 50 mL). The combined organic phases were washed with sat. 
aq. NaCl solution and dried over anhydrous Na2SO4. After filtration, the solvent was evaporated in 
vacuo. The crude product was purified by column chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) 
to give the title compound 134 as a light-brown powder (5.15 g, 25 mmol, 74%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.83 (dd, J = 7.1, 2.1 Hz, 1H), 7.73 (dd, J = 6.9, 2.1 Hz, 1H), 
6.32 (t, J = 7.0 Hz, 1H), 5.44 (s, 2H), 3.80–3.75 (m, 2H), 3.55–3.51 (m, 2H), 3.35 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 160.0, 147.8, 141.5, 115.4, 106.3, 105.7, 78.2, 71.5, 70.0, 
59.2. 
MS (EI, 70 eV): m/z (%) = 208 (13), 151 (10), 150 (33), 133 (35), 121 (35), 120 (23), 105 (45), 103 
(26), 92 (13), 89 (41), 78 (19), 59 (100), 58 (33), 45 (39). 
HRMS (EI): m/z calc. for [C10H12N2O3]: 208.0848; found: 208.0843 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3524, 2930, 2886, 2822, 2228, 1654, 1598, 1546, 1468, 1258, 
1098, 1084, 860, 766. 
2-((2-Methoxyethoxy)methyl)-2,7-naphthyridin-1(2H)-one (135) 
 
According to a literature procedure,131 in a dry and argon-flushed Schlenk-flask, equipped with a 
magnetic stirring bar and a septum, 2,7-naphthyridone (128, 260 mg, 1.8 mmol, 1.00 equiv) was 
dissolved in CH2Cl2 (50 mL). Diisopropylethylamin (0.51 mL, 3.7 mmol, 2.05 equiv) and MEMCl 
                                                     
131 Smith, A. B.; Freeze, B. S., LaMarche, M. J.; Hirose, T.; Brouard, I.; Xian, M.; Sundermann, K.F.; Shaw, S. J.; 
Burlingame, M. A.; Horwitz, S. B.; Myles, D. C. Org. Lett. 2005, 7, 315. 
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(0.40 mL, 3.5 mmol, 1.95 equiv) were added at room temperature and the mixture was stirred for 12 h. 
The reaction mixture was poured into sat. aq. NaHCO3 solution (100 mL) and the aq. phase was 
extracted with CH2Cl2 (3 × 50 mL). The combined organic phases were washed with sat. aq. NaCl 
solution and dried over anhydrous MgSO4. After filtration, the solvent was evaporated in vacuo. The 
crude product was purified by column chromatography (EtOAc/MeOH = 9.5:0.5) to give the title 
compound 135 as a light-brown powder (142 mg, 0.61 mmol, 34%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 9.55 (s, 1H), 8.69 (d, J = 5.4 Hz, 1H), 7.40 (d, J = 7.4 Hz, 1H), 
7.32 (dd, J = 5.5, 0.8 Hz, 1H), 6.45 (dd, J = 7.4, 0.6 Hz, 1H), 5.45 (s, 2H), 3.76–3.71 (m, 2H), 3.52–3.48 
(m, 2H), 3.32 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 162.0, 151.4, 151.1, 142.8, 135.5, 121.1, 119.2, 104.6, 76.9, 
71.6, 69.0, 59.1. 
MS (EI, 70 eV): m/z (%) = 234 (7), 176 (61), 175 (28), 160 (22), 159 (84), 147 (36), 146 (100), 
129 (11), 128 (53), 84 (20), 77 (12), 59 (77), 57 (12), 46 (12), 45 (19). 
HRMS (EI): m/z calc. for [C12H14N2O3]: 234.1004; found: 234.1011 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 3070, 3045, 2926, 2885, 1667, 1625, 1082, 1050, 844, 757. 
M.p. (°C): 85 °C. 
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2.2 Typical Procedures (TP) 
Typical procedure for the zincation of 2-pyridone 133 and 3-cyano-2-pyridone 134 using 
TMP2Zn·2MgCl2·2LiCl (93) (TP1): 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 2-pyridone 
133 or 3-cyano-2-pyridone 134 (1.00 equiv) were dissolved in dry THF (0.50 M solution). After the 
solution was cooled to −10 °C, TMP2Zn·2MgCl2·2LiCl (93, 1.20 equiv) was added and the mixture was 
stirred at the same temperature. The completion of the metalation was achieved after 72 h, stated by 
TLC-analysis of reaction aliquots quenched with a solution of I2 in dry THF. Subsequent reactions with 
electrophiles were carried out under the indicated conditions. After complete conversion, the mixture 
was quenched with sat. aq. NH4Cl solution (10 mL) and extracted with Et2O (3 × 20 mL) if not noted 
differently. The combined organic extracts were dried over anhydrous Na2SO4, filtered and concentrated 
in vacuo. The crude product was purified by flash-column chromatography. 
Typical procedure for the zincation of 2,7-naphthyridone 135 using TMP2Zn·2MgCl2·2LiCl (93) 
(TP2): 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 2,7-
naphthyridone 135 (1.00 equiv) was dissolved in dry THF (0.50 M solution). After the solution was 
cooled to −10 °C, TMP2Zn·2MgCl2·2LiCl (93, 1.20 equiv) was added and the mixture was stirred at the 
same temperature. The completion of the metalation was achieved after 72 h, stated by TLC-analysis of 
reaction aliquots quenched with a solution of I2 in dry THF. Subsequent reactions with electrophiles 
were carried out under the indicated conditions. After complete conversion, the mixture was quenched 
with sat. aq. NH4Cl solution (10 mL) and extracted with Et2O (3 × 20 mL) if not noted differently. The 
combined organic extracts were dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The 
crude product was purified by flash-column chromatography. 
Typical procedure for the I/Mg-exchange of 6-iodo-2-pyridone (137a) using iPrMgCl·LiCl (36) 
(TP3): 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 2-pyridone 
137a (1.00 equiv) was dissolved in dry THF (0.50 M solution) and was cooled to −40 °C. iPrMgCl·LiCl 
(36, 1.20 equiv) was added dropwise and the mixture was stirred at the same temperature for 30 min. 
The completion of the exchange reaction was checked by TLC-analysis of reaction aliquots quenched 
with sat. aq. NH4Cl solution. Subsequent reactions with electrophiles were carried out under the 
indicated conditions. After complete conversion, the mixture was quenched with sat. aq. NH4Cl solution 
(10 mL) and extracted with Et2O (3 × 20 mL) if not noted differently. The combined organic extracts 
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were dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The crude product was purified 
by flash-column chromatography. 
Typical procedure for the I/Mg-exchange of 3-iodo-2,7-naphthyridone (141a) using 
iPrMgCl·LiCl (36) (TP4): 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 2,7-
naphthyridon 141a (1.00 equiv) was dissolved in dry THF (0.50 M solution) and was cooled to 0 °C. A 
solution of iPrMgCl·LiCl (36, 1.20 equiv) was added dropwise and the mixture was stirred at the same 
temperature. The completion of the exchange reaction was checked by TLC-analysis of reaction aliquots 
quenched with sat. aq. NH4Cl solution. Subsequent reactions with electrophiles were carried out under 
the indicated conditions. After complete conversion, the mixture was quenched with sat. aq. NH4Cl 
solution (10 mL) and extracted with Et2O (3 × 20 mL) if not noted differently. The combined organic 
extracts were dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The crude product was 
purified by flash-column chromatography. 
Preparation of Zinc reagents (152a–c):94 
LiCl (1.10 equiv) was dried under high vacuum and allowed to cool to room temperature, then Mg 
turnings (1.20 equiv), ZnCl2 solution (1.00 M THF, 1.10 equiv) and THF (1.00 M, solution relating to 
the aryl bromide) were added. The reaction mixture was cooled to 0 °C and the corresponding aryl 
bromide (1.00 equiv) was added dropwise. The reaction was stirred until iodolysis of a reaction aliquot 
indicated full consumption of the starting material. 
Typical Procedure (TP5) for the Cobalt-Catalyzed Cross-Couplings of Organozionc Reagents:94 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with dry CoCl2 (10 mol %) and dry THF (1 mL). 1-Chloro-3-(4-chlorophenyl)-2,7-naphthyridine (151, 
0.30 mmol, 1.00 equiv) was added at room temperature. Then, a solution of the appropriate zinc reagent 
(152a–c, 0.45 mmol, 1.50 equiv) was added dropwise over 15 min via syringe at 0 °C. The reaction was 
stirred and monitored by GC-MS-analysis (Undecane was used as an internal standard). Upon 
consumption of the starting material, sat. aq. NH4Cl solution (2 mL) and EtOAc (2 mL) were added, the 
phases were separated and the aq. phase was extracted with EtOAc (3 × 50 mL). The combined organic 
layers were dried over Na2SO4. The solvents were evaporated and the residue was subjected to column 
chromatography on silica yielding the respective title compounds.  
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2.3 Directed Zincation of the 2-Pyridone and 2,7-Naphthyridone Scaffold with 
TMP2Zn·2MgCl2·2LiCl (93) 
2.3.1 Reaction of Zincated 2-Pyridone with Electrophiles 
6-Iodo-1-((2-methoxyethoxy)methyl)pyridin-2(1H)-one (137a) 
 
According to TP1, 2-pyridone 133 (92 mg, 0.50 mmol, 1.00 equiv) was completely metalated within 
72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.36 M in THF, 1.67 mL, 0.60 mmol, 1.20 equiv). Iodine 
(152 mg, 0.60 mmol, 1.20 equiv) dissolved in dry THF (1 mL) was then added dropwise at −10 °C. The 
reaction was stirred for 30 min. The reaction mixture was quenched with sat. aq. Na2S2O3 solution 
(5 mL), extracted with EtOAc (3 × 20 mL) and dried over anhydrous Na2SO4. After filtration, the solvent 
was evaporated in vacuo. The crude product was purified by column chromatography 
(CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title compound 137a as a lightly brown solid (145 mg, 
0.47 mmol, 93%). 
Scale-up: 
According to TP1, 2-pyridone 133 (549 mg, 3.00 mmol, 1.00 equiv) was completely metalated within 
72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.36 M in THF, 10.0 mL, 3.60 mmol, 1.20 equiv). Iodine 
(914 mg, 3.60 mmol, 1.20 equiv) dissolved in dry THF (3 mL) was then added dropwise at −10 °C. The 
reaction was stirred for 30 min. The reaction mixture was quenched with sat. aq. Na2S2O3 solution 
(20 mL), extracted with EtOAc (3 × 100 mL) and dried over anhydrous Na2SO4. After filtration, the 
solvent was evaporated in vacuo. The crude product was purified by column chromatography 
(CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title compound 137a as a lightly brown solid (832 mg, 
2.60 mmol, 89%). 
1H-NMR (400 MHz, CDCl3): 6.93 (dd, J = 9.1, 7.0 Hz, 1H), 6.80 (dd, J = 7.0, 1.2 Hz, 1H), 6.48 (dd, 
J = 9.2, 1.2 Hz, 1H), 5.71 (s, 2H), 3.79–3.76 (m, 2H), 3.56–3.53 (m, 2H), 3.37 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 162.9, 140.0, 136.3, 121.3, 106.2, 76.7, 71.5, 68.9, 59.0. 
MS (EI, 70 eV): m/z (%) = 309 (1), 251 (24), 250 (13), 234 (22), 222 (59), 221 (100), 94 (12), 79 (17), 
59 (22). 
HRMS (EI): m/z calc. for [C9H13INO3]: 309.9935 found: 309.9933 (M+ + H). 
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IR (Diamond-ATR, neat): ?̃? / cm-1 = 2906, 2886, 1644, 1574, 1500, 1450, 1350, 1130, 1084, 904, 850, 
786. 
M.p. (°C): 96–98. 
1-((2-Methoxyethoxy)methyl)-6-phenylpyridin-2(1H)-one (137b) 
 
According to TP1, 2-pyridone 133 (92 mg, 0.50 mmol, 1.00 equiv) was completely metalated within 
72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.36 M in THF, 1.67 mL, 0.60 mmol, 1.20 equiv) at −10 °C. 
Pd(dba)2 (12 mg, 4 mol%), P(2-furyl)3 (9.0 mg, 8 mol%) and iodobenzene (122 mg, 0.60 mmol, 
1.20 equiv) were added at −10 °C and the resulting mixture was stirred for 12 h at 25 °C. The crude 
product was purified by column chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title 
compound 137b as a brown liquid (118 mg, 0.47 mmol, 92%). 
1H-NMR (400 MHz, CDCl3): 7.53–7.47 (m, 2H), 7.46–7.40 (m, 3H), 7.33 (dd, J = 9.2, 6.8 Hz, 1H), 
6.57 (dd, J = 9.2, 1.3 Hz, 1H), 6.06 (dd, J = 6.8, 1.3 Hz, 1H), 5.28 (s, 2H), 3.81–3.75 (m, 2H), 3.55–3.48 
(m, 2H), 3.34 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 164.0, 150.6, 139.7, 135.0, 129.4, 129.3, 128.4, 119.9, 108.3, 
74.3, 71.9, 69.0, 59.0. 
MS (EI, 70 eV): m/z (%) = 259 (1), 201 (29), 200 (12), 184 (62), 183 (13), 172 (63), 171 (100), 
156 (13), 154 (27), 143 (28), 131 (11), 128 (11), 127 (12), 115 (12), 77 (13), 59 (61). 
HRMS (EI): m/z calc. for [C15H17NO3]: 259.1208; found: 259.1195 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 3448, 2928, 2888, 1654, 1582, 1538, 1468, 1080, 868, 846, 768. 
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1-((2-Methoxyethoxy)methyl)-6-(4-methoxyphenyl)pyridin-2(1H)-one (137c) 
 
According to TP1, 2-pyridone 133 (92 mg, 0.50 mmol, 1.00 equiv) was completely metalated within 
72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.36 M in THF, 1.67 mL, 0.60 mmol, 1.20 equiv) at −10 °C. 
Pd(dba)2 (12 mg, 4 mol%), P(2-furyl)3 (9.0 mg, 8 mol%) and 1-iodo-4-methoxybenzene (140 mg, 
0.60 mmol, 1.20 equiv) were added at −10 °C and the resulting mixture was stirred for 12 h at 25 °C. 
The crude product was purified by column chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give 
the title compound 137c as a brown liquid (95 mg, 0.33 mmol, 66%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.32–7.26 (m, 2H), 7.06 (dd, J = 2.4, 1.7 Hz, 1H), 7.01 (dt, 
J = 7.5, 1.2 Hz, 1H), 6.94 (ddd, J = 8.3, 2.6, 0.9 Hz, 1H), 6.53 (dd, J = 9.2, 1.3 Hz, 1H), 6.04 (dd, J = 6.8, 
1.3 Hz, 1H), 5.25 (s, 2H), 3.80 (s, 3H), 3.79–3.76 (m, 2H), 3.50–3.46 (m, 2H), 3.28 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 164.1, 160.4, 150.6, 139.6, 130.7, 127.3, 119.4, 113.7, 108.3, 
74.3, 71.8, 68.9, 58.9, 55.4. 
MS (EI, 70 eV): m/z (%) = 214 (39), 202 (25), 201 (100), 173 (11), 158 (19). 
HRMS (EI): m/z calc. for [C16H19NO4]: 289.1314; found: 289.1296 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 2960, 2930, 1654, 1578, 1548, 1486, 1450, 1294, 1230, 1088, 
1080, 1036, 840, 802, 792, 710. 
1-((2-Methoxyethoxy)methyl)-6-(3-methoxyphenyl)pyridin-2(1H)-one (137d) 
 
According to TP1, 2-pyridone 133 (92 mg, 0.50 mmol, 1.00 equiv) was completely metalated within 
72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.36 M in THF, 1.67 mL, 0.60 mmol, 1.20 equiv) at −10 °C. 
Pd(dba)2 (12 mg, 4 mol%), P(2-furyl)3 (9.0 mg, 8 mol%) and 1-iodo-3-methoxybenzene (140 mg, 
0.60 mmol, 1.20 equiv) were added at −10 °C and the resulting mixture was stirred for 12 h at 25 °C. 
The crude product was purified by column chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give 
the title compound 137d as a brown liquid (101 mg, 0.35 mmol, 70%). 
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1H-NMR (600 MHz, CDCl3): δ / ppm = 7.30–7.22 (m, 2H), 7.03 (dd, J = 2.4, 1.7 Hz, 1H), 6.98 (dt, 
J = 7.5, 1.2 Hz, 1H), 6.91 (ddd, J = 8.3, 2.6, 0.9 , 1H), 6.50 (dd, J = 9.2, 1.4 Hz, 1H), 6.02 (dd, J = 6.8, 
1.4 Hz, 1H), 5.22 (s, 2H), 3.79–3.72 (m, 5H), 3.48–3.42 (m, 2H), 3.26 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 163.9, 159.2, 150.4, 139.6, 136.0, 129.4, 121.4, 119.7, 115.5, 
114.6, 108.0, 74.3, 71.8, 69.0, 58.8, 55.3. 
MS (EI, 70 eV): m/z (%) = 289 (1), 231 (36), 215 (10), 214 (69), 202 (57), 201 (100), 200 (33), 
171 (11), 59 (38). 
HRMS (EI): m/z calc. for [C16H19NO4]: 289.1314; found: 289.1296 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 2932, 2838, 1654, 1608, 1506, 1456, 1292, 1248, 1080, 1028, 
836, 800. 
Methyl 4-(1-((2-methoxyethoxy)methyl)-6-oxo-1,6-dihydropyridin-2-yl)benzoate (137e) 
 
According to TP1, 2-pyridone 133 (92 mg, 0.50 mmol, 1.00 equiv) was completely metalated within 
72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.36 M in THF, 1.67 mL, 0.60 mmol, 1.20 equiv) at −10 °C. 
Pd(dba)2 (12 mg, 4 mol%), P(2-furyl)3 (9.0 mg, 8 mol%) and methyl 4-iodobenzoate (157 mg, 
0.60 mmol, 1.20 equiv) were added at −10 °C and the resulting mixture was stirred for 12 h at 25 °C. 
The crude product was purified by column chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give 
the title compound 137e as a brown liquid (127 mg, 0.40 mmol, 80%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.12–8.04 (m, 2H), 7.58 (dd, J = 8.7, 0.8 Hz, 2H), 7.33 (ddd, 
J = 9.2, 6.8, 0.8 Hz, 1H), 6.58 (dd, J = 9.2, 1.3 Hz, 1H), 6.05 (dd, J = 6.8, 1.3 Hz, 1H), 5.23 (s, 2H), 3.93 
(s, 3H), 3.79–3.73 (m, 2H), 3.51–3.46 (m, 2H), 3.32 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 166.5, 163.8, 149.4, 139.5, 139.1, 131.0, 129.6, 129.4, 120.5, 
108.4, 74.3, 71.8, 69.0, 59.0, 52.4. 
MS (EI, 70 eV): m/z (%) = 286 (10), 259 (23), 242 (40), 241 (13), 230 (69), 229 (100), 198 (23), 154 
(11), 89 (12), 59 (45). 
HRMS (EI): m/z calc. for [C17H19NO5]: 317.1263; found: 317.1277 (M+). 
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IR (Diamond-ATR, neat): ?̃? / cm-1 = 2928, 2886, 1722, 1660, 1586, 1548, 1436, 1276, 1102, 1084, 
1022, 802, 772, 704. 
6-(4-Chlorophenyl)-1-((2-methoxyethoxy)methyl)pyridin-2(1H)-one (137f) 
 
According to TP1, 2-pyridone 133 (92 mg, 0.50 mmol, 1.00 equiv) was completely metalated within 
72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.36 M in THF, 1.67 mL, 0.60 mmol, 1.20 equiv) at −10 °C. 
Pd(dba)2 (12 mg, 4 mol%), P(2-furyl)3 (9.0 mg, 8 mol%) and 1-iodo-4-chlorobenzene (143 mg, 
0.60 mmol, 1.20 equiv) were added at −10 °C and the resulting mixture was stirred for 12 h at 25 °C. 
The crude product was purified by column chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give 
the title compound 137f as a brown liquid (129 mg, 0.44 mmol, 88%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.50–7.44 (m, 2H), 7.44–7.39 (m, 2H), 7.32 (dd, J = 9.2, 
6.8 Hz, 1H), 6.58 (dd, J = 9.2, 1.3 Hz, 1H), 6.04 (dd, J = 6.8, 1.3 Hz, 1H), 5.25 (s, 2H), 3.83–3.76 (m, 
2H), 3.54–3.48 (m, 2H), 3.34 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 163.9, 149.4, 139.6, 135.8, 133.3, 130.8, 128.7, 120.3, 108.4, 
74.3, 71.9, 69.0, 59.0. 
MS (EI, 70 eV): m/z (%) = 293 (1), 237 (15), 236 (11), 235 (51), 234 (16), 220 (18), 219 (64), 217 (13), 
208 (27), 207 (57), 206 (97), 205 (77), 205 (100), 190 (17), 188 (20), 183 (33), 177 (21), 154 (12), 89 
(26), 59 (99). 
HRMS (EI): m/z calc. for [C15H16ClNO3]: 293.0819; found: 293.0809 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 2926, 2880, 1658, 1596, 1548, 1488, 1088, 1016, 836, 798. 
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2.3.2 Reaction of Zincated 3-Cyano-2-pyridone with Electrophiles 
6-Iodo-1-((2-methoxyethoxy)methyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile (139a) 
 
According to TP1, 3-cyano-2-pyridone 134 (104 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.36 M in THF, 1.67 mL, 0.60 mmol, 1.20 equiv) at 
−10 °C. Iodine (152 mg, 0.60 mmol, 1.20 equiv) dissolved in dry THF (1 mL) was then added dropwise 
at −10 °C. The reaction was stirred for 30 min. The reaction mixture was quenched with sat. aq. Na2S2O3 
solution (5 mL), extracted with EtOAc (3 × 20 mL) and dried over anhydrous Na2SO4. After filtration, 
the solvent was evaporated in vacuo. The crude product was purified by column chromatography 
(CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title compound 139a as a lightly brown solid (116 mg, 
0.40 mmol, 80%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.03 (d, J = 7.2 Hz, 1H), 6.48 (d, J = 7.3 Hz, 1H), 5.66 (s, 2H), 
3.83–3.80 (m, 2H), 3.55–3.52 (m, 2H), 3.34 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 159.1, 147.3, 121.2, 116.5, 112.3, 102.5, 77.7, 71.7, 70.2, 
59.2. 
MS (EI, 70 eV): m/z (%) = 334 (5), 276 (34), 259 (37), 247 (60), 246 (45), 132 (10), 104 (17), 89 (77), 
64 (16), 59 (100), 58 (12), 45 (25). 
HRMS (EI): m/z calc. for [C10H11IN2O3]: 333.9814; found: 333.9810 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3090, 2926, 2882, 2228, 1652, 1594, 1548, 1450, 1270, 1240, 
1154, 1098, 870, 778, 758. 
M.p. (°C): 108–110. 
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1-((2-Methoxyethoxy)methyl)-6-(4-methoxyphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile 
(139b) 
 
According to TP1, 3-cyano-2-pyridone 134 (104 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.36 M in THF, 1.67 mL, 0.60 mmol, 1.20 equiv) at 
−10 °C. Pd(dba)2 (12 mg, 4 mol%), P(2-furyl)3 (9.0 mg, 8 mol%) and 1-iodo-4-methoxybenzene 
(140 mg, 0.60 mmol, 1.20 equiv) were added at −10 °C and the resulting mixture was stirred for 12 h at 
25 °C. The crude product was purified by column chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) 
to give the title compound 139b as a lightly brown liquid (106 mg, 0.34 mmol, 68%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.79 (d, J = 7.4, 1H), 7.53–7.46 (m, 2H), 7.02–6.96 (m, 2H), 
6.18 (d, J = 7.4, 1H), 5.31 (s, 2H), 3.94–3.89 (m, 2H), 3.87 (s, 3H), 3.59–3.51 (m, 2H), 3.36 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 161.5, 161.4, 156.8, 146.8, 130.6, 125.9, 115.9, 114.3, 107.9, 
103.7, 75.7, 71.9, 70.0, 59.1, 55.6. 
MS (EI, 70 eV): m/z (%) = 314 (3), 256 (15), 239 (20), 227 (27), 226 (100), 89 (28), 61 (13), 59 (47), 
45 (11), 43 (60). 
HRMS (EI): m/z calc. for [C17H18N2O4]: 314.1267; found: 314.1255 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3524, 2930, 2886, 2822, 2228, 1654, 1598, 1546, 1468, 1258, 
1098, 1084, 860, 766. 
1-((2-Methoxyethoxy)methyl)-2-oxo-6-(thiophen-2-yl)-1,2-dihydropyridine-3-carbonitrile (139c) 
 
According to TP1, 3-cyano-2-pyridone 134 (104 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.36 M in THF, 1.67 mL, 0.60 mmol, 1.20 equiv) at 
−10 °C. Pd(dba)2 (12 mg, 4 mol%), P(2-furyl)3 (9.0 mg, 8 mol%) and 2-iodothiophene (126 mg, 
0.60 mmol, 1.20 equiv) were added at −10 °C and the resulting mixture was stirred for 12 h at 25 °C. 
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The crude product was purified by column chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give 
the title compound 139c as a yellow liquid (116 mg, 0.40 mmol, 80%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.84–7.71 (m, 2H), 7.54 (dt, J = 5.1, 1.0 Hz, 1H), 7.16 (ddd, 
J = 5.1, 3.7, 0.8 Hz, 1H), 6.45–6.35 (m, 1H), 5.48 (s, 2H), 4.02–3.91 (m, 2H), 3.64–3.54 (m, 2H), 3.37 
(s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 161.4, 149.4, 146.4, 133.6, 131.9, 129.9, 128.6, 115.7, 108.7, 
104.0, 75.4, 71.8, 70.0, 59.1. 
MS (EI, 70 eV): m/z (%) = 290 (3), 232 (19), 215 (15), 203 (21), 202 (100), 89 (20), 59 (30). 
HRMS (EI): m/z calc. for [C14H14N2O3S]: 290.0725; found: 290.0720 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3096, 2926, 2880, 2226, 1656, 1544, 1450, 1328, 1078, 846, 778, 
714. 
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2.3.3 Reaction of Zincated 2,7-Naphthyridone with Electrophiles 
3-Iodo-2-((2-methoxyethoxy)methyl)-2,7-naphthyridin-1(2H)-one (141a) 
 
According to TP2, 2,7-naphthyridone 135 (60 mg, 0.26 mmol, 1.00 equiv) was completely metalated 
within 72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.27 M in THF, 1.15 mL, 0.31 mmol, 1.20 equiv). Iodine 
(132 mg, 0.52 mmol, 1.20 equiv) dissolved in dry THF (2 mL) was then added dropwise at −10 °C. The 
resulting mixture was allowed to warm up to room temperature and was further stirred for 30 min. The 
reaction mixture was quenched with sat. aq. Na2S2O3 solution (5 mL), extracted with EtOAc 
(3 × 20 mL) and dried over anhydrous MgSO4. After filtration, the solvent was evaporated in vacuo. 
The crude product was purified by column chromatography (EtOAc/MeOH = 9.5:0.5) to give the title 
compound 141a as a brown crystalline solid (86 mg, 0.24 mmol, 92%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 9.52 (s, 1H), 8.73 (d, J = 5.4 Hz, 1H), 7.18 (d, J = 6.4 Hz, 1H), 
7.15 (s, 1H), 5.79 (s, 2H), 3.82–3.77 (m, 2H), 3.57–3.53 (m, 2H), 3.35 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 161.7, 152.1, 152.0, 142.8, 120.2, 118.5, 117.5, 99.7, 80.7, 
71.7, 69.1, 59.2. 
MS (EI, 70 eV): m/z (%) = 360 (3), 302 (14), 285 (16), 272 (39), 232 (13), 159 (11), 158 (17), 24 (145), 
89 (88), 59 (100). 
HRMS (EI): m/z calc. for [C12H13IN2O3]: 359.9971; found: 359.9983 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 3080, 2953, 2921, 1662, 1597, 1197, 1088, 1036, 871, 789. 
M.p. (°C): 120. 
2-((2-Methoxyethoxy)methyl)-3-(4-methoxyphenyl)-2,7-naphthyridin-1(2H)-one (141b) 
 
According to TP2, 2,7-naphthyridone 135 (60 mg, 0.26 mmol, 1.00 equiv) was completely metalated 
within 72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.27 M in THF, 1.15 mL, 0.31 mmol, 1.20 equiv). A 
solution of Pd(dba)2 (6.00 mg, 4 mol%), P(2-furyl)3 (5.00 mg, 8 mol%) and 1-iodo-4-methoxybenzene 
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(72 mg, 0.31 mmol, 1.20 equiv) in dry THF (1 mL) was added at −10 °C. The resulting mixture was 
allowed to warm up to room temperature and was further stirred for 12 h. The crude product was purified 
by column chromatography (ihex/EtOAc = 2:8) to give the title compound 141b as a yellowish solid 
(72 mg, 0.21 mmol, 81%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 9.56 (s, 1H), 8.68 (d, J = 5.1 Hz, 1H), 7.48 (d, J = 8.5 Hz, 2H), 
7.29 (d, J = 5.1 Hz, 1H), 6.96 (d, J = 8.4 Hz, 2H), 6.33 (s, 1H), 5.32 (s, 2H), 3.85 (s, 3H), 3.81–3.74 (m, 
2H), 3.55–3.47 (m, 2H), 3.32 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 163.2, 160.7, 151.2, 150.6, 149.9, 142.5, 130.7, 127.0, 120.0, 
119.1, 113.9, 106.1, 74.3, 71.9, 69.1, 59.0, 55.5. 
MS (EI, 70 eV): m/z (%) = 340 (10), 265 (55), 253 (38), 252 (100), 89 (12), 59 (43). 
HRMS (EI): m/z calc. for [C19H20N2O4]: 340.1423; found: 340.1416 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 3077, 2913, 2854, 1660, 1606, 1510, 1299, 1091, 947, 786.  
M.p. (°C): 84–86. 
2-((2-Methoxyethoxy)methyl)-3-(p-tolyl)-2,7-naphthyridin-1(2H)-one (141c) 
 
According to TP2, 2,7-naphthyridone 135 (117 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.20 M in THF, 3.00 mL, 0.60 mmol, 1.20 equiv). A 
solution of Pd(dba)2 (12 mg, 4 mol%), P(2-furyl)3 (9.0 mg, 8 mol%) and 1-iodo-4-methylbenzene 
(131 mg, 0.60 mmol, 1.20 equiv) in dry THF (1 mL) was added at −10 °C. The resulting mixture was 
allowed to warm up to room temperature and was further stirred for 12 h. The crude product was purified 
by column chromatography (EtOAc/MeOH = 9.5:0.5) to give the title compound 141c as a yellow solid 
(135 mg, 0.42 mmol, 84%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 9.55 (s, 1H), 8.66 (d, J = 5.4 Hz, 1H), 7.40 (d, J = 7.9 Hz, 2H), 
7.27–7.21 (m, 3H), 6.30 (s, 1H), 5.29 (s, 2H), 3.75–3.71 (m, 2H), 3.50–3.45 (m, 2H), 3.29 (s, 3H), 2.38 
(s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 163.1, 151.5, 151.1, 149.7, 142.1, 139.7, 131.8, 129.1, 129.1, 
120.0, 118.9, 106.0, 74.1, 71.8, 68.9, 58.9, 21.4. 
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MS (EI, 70 eV): m/z (%) = 324 (4), 266 (13), 249 (59), 236 (100), 89 (10), 59 (39). 
HRMS (EI): m/z calc. for [C19H20N2O3]: 324.1474; found: 324.1473 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 3077, 2912, 2867, 1662, 1618, 1544, 1093, 1008, 882, 813. 
M.p. (°C): 56–58. 
3-(4-Chlorophenyl)-2-((2-methoxyethoxy)methyl)-2,7-naphthyridin-1(2H)-one (141d) 
 
According to TP2, 2,7-naphthyridone 135 (117 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.20 M in THF, 3.00 mL, 0.60 mmol, 1.20 equiv). A 
solution of Pd(dba)2 (12 mg, 4 mol%), P(2-furyl)3 (9.0 mg, 8 mol%) and 1-chloro-4-iodobenzene 
(143 mg, 0.60 mmol, 1.20 equiv) in dry THF (1 mL) was added at −10 °C. The resulting mixture was 
allowed to warm up to room temperature and was further stirred for 12 h. The crude product was purified 
by column chromatography (EtOAc/MeOH = 9.5:0.5) to give the title compound 141d as a yellow 
crystalline solid (148 mg, 0.43 mmol, 86%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 9.58 (s, 1H), 8.71 (d, J = 5.5 Hz, 1H), 7.54–7.48 (m, 2H), 7.46–
7.42 (m, 2H), 7.31 (dd, J = 5.5, 0.8 Hz, 1H), 6.33 (s, 1H), 5.29 (s, 2H), 3.80–3.74 (m, 2H), 3.53–3.47 
(m, 2H), 3.32 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 163.0, 151.4, 151.1, 148.6, 142.2, 136.1, 133.1, 130.7, 128.8, 
120.2, 119.1, 106.4, 74.2, 71.9, 69.1, 59.0. 
MS (EI, 70 eV): m/z (%) = 344 (4), 286 (22), 269 (35), 256 (87), 234 (35), 89 (39), 59 (100). 
HRMS (EI): m/z calc. for [C18H17ClN2O3]: 344.0928; found: 344.0924 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 3078, 2917, 2871, 1657, 1618, 1092, 1008, 946, 881, 820. 
M.p. (°C): 102. 
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4-(2-((2-Methoxyethoxy)methyl)-1-oxo-1,2-dihydro-2,7-naphthyridin-3-yl)benzonitrile (141e) 
 
According to TP2, 2,7-naphthyridone 135 (117 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.20 M in THF, 3.00 mL, 0.60 mmol, 1.20 equiv). A 
solution of Pd(dba)2 (12 mg, 4 mol%), P(2-furyl)3 (9.0 mg, 8 mol%) and 4-iodobenzonitrile (137 mg, 
0.60 mmol, 1.20 equiv) in dry THF (1 mL) was added at −10 °C. The resulting mixture was allowed to 
warm up to room temperature and was further stirred for 12 h. The crude product was purified by column 
chromatography (EtOAc/MeOH = 9.5:0.5) to give the title compound 141e as a yellow crystalline solid 
(124 mg, 0.37 mmol, 74%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 9.61 (s, 1H), 8.76 (s, 1H), 7.77 (d, J = 8.6 Hz, 2H), 7.72 (d, 
J = 8.6 Hz, 2H), 7.35 (d, J = 5.2 Hz, 1H), 6.35 (s, 1H), 5.28 (s, 2H), 3.79–3.76 (m, 2H), 3.51–3.48 (m, 
2H), 3.32 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 162.7, 151.3, 151.2, 147.8, 142.0, 138.9, 132.3, 130.2, 120.3, 
119.3, 118.1, 113.8, 106.7, 74.2, 71.8, 69.1, 59.1. 
MS (EI, 70 eV): m/z (%) = 335 (2), 277 (20), 260 (39), 247 (61), 230 (13), 89 (55), 59 (100). 
HRMS (EI): m/z calc. for [C19H17N3O3]: 335.1270; found: 335.1261 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3080, 3046, 2926, 2361, 2231, 1650, 1622, 1103, 1082, 850, 792. 
M.p. (°C): 106–108. 
2-((2-Methoxyethoxy)methyl)-3-(4-(trifluoromethyl)phenyl)-2,7-naphthyridin-1(2H)-one (141f) 
 
According to TP2, 2,7-naphthyridone 135 (117 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.20 M in THF, 3.00 mL, 0.60 mmol, 1.20 equiv). A 
solution of Pd(dba)2 (12 mg, 4 mol%), P(2-furyl)3 (9.0 mg, 8 mol%) and 4-iodobenzotrifluoride 
(163 mg, 0.60 mmol, 1.20 equiv) in dry THF (1 mL) was added at −10 °C. The resulting mixture was 
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allowed to warm up to room temperature and was further stirred for 12 h. The crude product was purified 
by column chromatography (EtOAc/MeOH = 9.5:0.5) to give the title compound 141f as a yellow solid 
(88 mg, 0.23 mmol, 46%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 9.60 (s, 1H), 8.74 (d, J = 5.5 Hz, 1H), 7.77–7.69 (m, 4H), 7.34 
(d, J = 5.9 Hz, 1H), 6.36 (s, 1H), 5.30 (s, 2H), 3.82–3.75 (m, 2H), 3.54–3.47 (m, 2H), 3.31 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 162.8, 151.3, 151.0, 148.4, 142.2, 138.1(d, J = 1.1 Hz), 
132.1(q, J = 32.9 Hz), 129.9, 125.6 (q, J = 3.7 Hz), 122.5 (q, J = 272.8 Hz), 120.3, 119.3, 106.6, 74.2, 
71.9, 69.1, 59.0. 
MS (EI, 70 eV): m/z (%) = 378 (2), 320 (21), 303 (50), 290 (81), 89 (43), 59 (100). 
HRMS (EI): m/z calc. for [C19H17F3N2O3]: 378.1191; found: 378.1187 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3080, 2926, 2891, 2824, 2361, 2340, 1660, 1611, 1126, 1107, 
1065, 1007, 848. 
M.p. (°C): 97–99. 
3-(4-Aminophenyl)-2-((2-methoxyethoxy)methyl)-2,7-naphthyridin-1 (2H)-one (141g) 
 
According to TP2, 2,7-naphthyridone 135 (117 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.20 M in THF, 3.00 mL, 0.60 mmol, 1.20 equiv). Using 
a syringe-pump, the zinc-species was then added dropwise to a solution of Pd(OAc)2 (5.0 mg, 4 mol%), 
S-Phos (16 mg, 8 mol%) and 4-iodoaniline (131 mg, 0.60 mmol, 1.20 equiv) in dry THF (1 mL) over 
1 h at room temperature.90 The resulting mixture was further stirred for 12 h. The crude product was 
purified by column chromatography (EtOAc/MeOH = 9.5:0.5) to give the title compound 141g as a 
yellow solid (124 mg, 0.38 mmol, 76%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 9.51 (s, 1H), 8.62 (s, 1H), 7.32–7.27 (m, 2H), 7.24–7.21 (m, 
1H), 6.71–6.65 (m, 2H), 6.27 (s, 1H), 5.31 (s, 2H), 4.10–3.98 (m, 2H), 3.74 (dt, J = 4.6, 2.4 Hz, 2H), 
3.48 (dt, J = 4.6, 2.7 Hz, 2H), 3.29 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 163.3, 151.4, 150.9, 150.2, 148.0, 142.2, 130.4, 124.2, 119.7, 
118.8, 114.3, 105.7, 74.4, 71.8, 68.8, 58.9. 
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MS (EI, 70 eV): m/z (%) = 325 (31), 250 (52), 237 (100), 59 (39). 
HRMS (EI): m/z calc. for [C18H19N3O3]: 325.1426; found: 325.1422 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 3326, 3193, 2926, 1665, 1602, 1511, 1294, 1088, 1044, 832. 
M.p. (°C): 109. 
3-(Benzo[d][1,3]dioxol-5-yl)-2-((2-methoxyethoxy)methyl)-2,7-naphthyridin-1(2H)-one (141h) 
 
According to TP2, 2,7-naphthyridone 135 (117 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.35 M in THF, 1.71 mL, 0.60 mmol, 1.20 equiv). A 
solution of PEPPSI-iPr (14 mg, 4 mol%) and 5-bromobenzo[d][1,3]dioxole (121 mg, 0.60 mmol, 
1.20 equiv) in dry THF (1 mL) was added at −10 °C. The resulting mixture was allowed to warm up to 
room temperature and was further stirred for 12 h at 60 °C. The crude product was purified by column 
chromatography (EtOAc / MeOH = 9.5:0.5) to give the title compound 141h as a colorless solid 
(141 mg, 0.40 mmol, 80%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 9.07 (s, 1H), 8.26 (d, J = 5.5 Hz, 1H), 6.99 (d, J = 5.5, 1H), 
6.68 (s, 1H), 6.63 (dd, J = 8.0, 1.7 Hz, 1H), 6.46 (d, J = 8.2 Hz, 1H), 5.98 (s, 1H), 5.65–5.61 (m, 2H), 
4.91 (s, 2H), 3.36–3.30 (m, 2H), 3.10–3.04 (m, 2H), 2.86 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 162.8, 151.0, 150.0, 149.2, 148.7, 147.8, 143.5, 128.1, 123.5, 
120.4, 119.7, 109.9, 108.5, 106.0, 101.8, 74.5, 71.9, 69.3, 59.1. 
MS (EI, 70 eV): m/z (%) = 354 (14), 279 (20), 278 (12), 267 (34), 266 (100), 249 (23), 89 (10), 59 (41). 
HRMS (EI): m/z calc. for [C19H18N2O5]: 354.1216; found: 354.1215 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 3071, 2932, 2820, 1657, 1615, 1482, 1234, 1086, 1036, 821. 
M.p. (°C): 107. 
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2-((2-Methoxyethoxy)methyl)-3-(thiophene-2-carbonyl)-2,7-naphthyridin-1(2H)-one (141i) 
 
According to TP2, 2,7-naphthyridone 135 (117 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 72 h, using TMP2Zn·2MgCl2·2LiCl (93, 0.20 M in THF, 3.00 mL, 0.60 mmol, 1.20 equiv). A 
solution of CuCN·2LiCl (1.00 M in THF, 0.55 mL, 0.55 mmol, 0.55 equiv) was added and the reaction 
mixture was stirred for 10 min at −10 °C before thiophene-2-carbonyl chloride (95 mg, 0.07 mL 
0.65 mmol, 1.20 equiv) was added. The resulting mixture was allowed to warm up to room temperature 
and was further stirred for 12 h. The reaction mixture was quenched with a 10:1 mixture of sat. aq. 
NH4Cl solution and NH3 (10 mL), extracted with EtOAc (3 × 20 mL) and dried over anhydrous MgSO4. 
After filtration, the solvent was evaporated in vacuo. The crude product was purified by column 
chromatography (EtOAc / ihex = gradient 2:8–10:0, then EtOAc/MeOH = 9.5:0.5) to give the title 
compound 141i as an orange crystalline solid (88 mg, 0.26 mmol, 52%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 9.60 (s, 1H), 8.78 (d, J = 5.4 Hz, 1H), 7.82 (dd, J = 4.9, 1.1 Hz, 
1H), 7.75 (dd, J = 3.8, 1.1 Hz, 1H), 7.36 (dd, J = 5.4, 0.7 Hz, 1H), 7.19 (dd, J = 4.9, 3.9 Hz, 1H), 6.71 
(s, 1H), 5.76 (s, 2H), 3.53–3.49 (m, 2H), 3.22–3.17 (m, 2H), 3.10 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 181.5, 161.7, 152.1, 151.8, 142.4, 142.1, 140.5, 136.6, 136.2, 
128.5, 121.0, 119.7, 108.1, 72.3, 71.1, 68.4, 58.9. 
MS (EI, 70 eV): m/z (%) = 344 (2), 268 (100), 256 (36), 228 (17), 111 (35), 97 (18), 89 (25), 59 (84), 
43 (16). 
HRMS (EI): m/z calc. for [C17H16N2O4S]: 344.0831; found: 344.0830 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 3077, 2922, 2855, 1643, 1616, 1407, 1100, 855, 755, 724. 
M.p. (°C): 79–81. 
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2.4 Further Functionalization of the 2-Pyridone and 2,7-Naphthyridone Scaffold 
2.4.1 Reactions of Magnesiated 2-Pyridone with Electrophiles 
6-(Hydroxy(phenyl)methyl)-1-((2-methoxyethoxy)methyl)pyridin-2(1H)-one (144a) 
 
According to TP3, the iodine-magnesium exchange of 2-pyridone 137a (155 mg, 0.50 mmol, 
1.00 equiv) was completed within 30 min using a solution of iPrMgCl·LiCl (36, 1.00 M in THF, 
0.60 mL, 0.60 mmol, 1.20 equiv) at −40 °C. Benzaldehyde (0.06 mL, 0.60 mmol, 1.20 equiv) was 
added. The resulting mixture was further stirred for 1.5 h at 0 °C. The crude product was purified by 
column chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title compound 144a as a 
yellow liquid (92 mg, 0.32 mmol, 80%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.42–7.33 (m, 5H), 7.32–7.28 (m, 1H), 6.48 (dd, J = 9.2, 
1.3 Hz, 1H), 6.20 (d, J = 6.9 Hz, 1H), 6.10 (s, 1H), 5.88 (d, J = 10.8 Hz, 1H), 5.42 (d, J = 10.8 Hz, 1H), 
3.77 (t, J = 4.5 Hz, 2H), 3.59–3.45 (m, 2H), 3.35 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 164.1, 151.4, 140.4, 139.9, 128.7, 128.3, 126.8, 119.7, 107.5, 
71.7, 71.3, 71.2, 68.2, 58.9. 
MS (EI, 70 eV): m/z (%) = 231 (28), 214 (22), 213 (19), 212 (23), 202 (14), 201 (100), 200 (52), 196 
(13), 185 (32), 184 (99), 183 (31), 182 (17), 165 (32), 154 (10), 124 (17), 105 (10), 91 (11), 77 (12). 
HRMS (EI): m/z calc. for [C16H19NO4]: 289.1314; found: 289.1320 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 3316, 2926, 2882, 1652, 1550, 1452, 1084, 1046, 800, 700. 
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6-(Furan-2-yl(hydroxy)methyl)-1-((2-methoxyethoxy)methyl)pyridin-2(1H)-one (144b) 
 
According to TP3, the iodine-magnesium exchange of 2-pyridone 137a (155 mg, 0.50 mmol) was 
completed within 30 min using a solution of iPrMgCl·LiCl (36, 1.00 M in THF, 0.60 mL, 0.60 mmol, 
1.20 equiv) at −40 °C. Furfural (0.05 mL, 0.60 mmol, 1.20 equiv) was added. The resulting mixture was 
further stirred for 1.5 h at 0 °C. The crude product was purified by column chromatography 
(CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title compound 144b as a yellow liquid (118 mg, 
0.42 mmol, 84%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.38 (dd, J = 1.2 Hz, 1H), 7.29 (dd, J = 9.2, 6.9 Hz, 1H), 6.49 
(dd, J = 9.2, 1.3 Hz, 1H), 6.37–6.34 (m, 2H), 6.30 (dd, J = 6.9, 1.3 Hz, 1H), 6.08 (d, J = 4.7 Hz, 1H), 
5.95 (d, J = 10.9 Hz, 1H), 5.33 (d, J = 10.9 Hz, 1H), 4.48 (d, J = 4.9 Hz, 1H), 3.73 (dd, J = 4.9, 4.1 Hz, 
2H), 3.56–3.50 (m, 1H), 3.47–3.42 (m, 1H), 3.31 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 163.9, 153.0, 149.2, 142.8, 140.1, 120.2, 110.7, 108.3, 106.9, 
71.7, 71.3, 68.1, 65.9, 58.9. 
MS (EI, 70 eV): m/z (%) = 279 (1), 203 (16), 202 (12), 192 (11), 191 (100), 190 (32), 182 (19), 175 
(32), 163 (25), 162 (34), 146 (69), 145 (31), 144 (22), 134 (11), 124 (20), 122 (23), 118 (13), 117 (38), 
97 (12), 95 (15), 94 (15), 91 (10). 81 (66), 59 (48).  
HRMS (EI): m/z calc. for [C14H17NO5]: 279.1107; found: 279.1098 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3254, 2926, 2882, 1654, 1576, 1552, 1232, 1138, 1094, 1080, 
1044, 812, 742. 
Ethyl 2-((1-((2-methoxyethoxy)methyl)-6-oxo-1,6-dihydropyridin-2-yl)methyl)acrylate (144c) 
 
According to TP3, the iodine-magnesium exchange of 2-pyridone 137a (155 mg, 0.50 mmol, 
1.00 equiv) was completed within 30 min using a solution of iPrMgCl·LiCl (36, 1.00 M in THF, 
0.60 mL, 0.60 mmol, 1.20 equiv) at −40 °C. A solution of CuCN·2LiCl (1.00 M in THF, 0.60 mmol, 
C. EXPERIMENTAL PART    90 
 
 
 
0.60 mL, 1.20 equiv) was added and the reaction mixture was stirred for 30 min at −40 °C. Ethyl 2-
(bromomethyl)acrylate (0.09 mL, 0.60 mmol, 1.20 equiv) was added. The resulting mixture was 
allowed to warm up to room temperature and was further stirred for 12 h. The crude product was purified 
by column chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title compound 144c as a 
yellow liquid (96 mg, 0.33 mmol, 65%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.22 (dd, J = 9.2, 6.9 Hz, 1H), 6.44 (d, J = 9.2 Hz, 1H), 6.32 
(s, 1H), 5.96 (d, J = 6.8 Hz, 1H), 5.57 (d, J = 1.0 Hz, 2H), 5.46 (td, J = 1.6, 0.8 Hz, 1H), 4.24–4.17 (m, 
2H), 3.78 (s, 2H), 3.76–3.72 (m, 2H), 3.53–3.48 (m, 2H), 3.34 (s, 3H), 1.27 (td, J = 7.1, 0.8 Hz, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 166.1, 164.4, 147.3, 139.8, 137.3, 127.3, 119.0, 107.3, 72.3, 
71.6, 68.7, 61.3, 59.0, 34.5, 14.3. 
MS (EI, 70 eV): m/z (%) = 220 (18), 218 (12), 207 (70), 190 (28), 174 (11), 162 (100), 161 (83), 148 
(88), 147 (16), 146 (90), 135 (10), 134 (40), 133 (56), 132 (12), 118 (15), 117 (12), 106 (12), 104 (14), 
59 (26).  
HRMS (EI): m/z calc. for [C15H21NO5]: 295.1420; found: 295.1409 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 2982, 2928, 1714, 1662, 1586, 1550, 1240, 1136, 1096, 1050, 
1024, 802. 
6-(Cyclohex-2-en-1-yl)-1-((2-methoxyethoxy)methyl)pyridin-2(1H)-one (144d) 
 
According to TP3, the iodine-magnesium exchange of 2-pyridone 137a (155 mg, 0.50 mmol, 
1.00 equiv) was completed within 30 min using a solution of iPrMgCl·LiCl (36, 1.00 M in THF, 
0.60 mL, 0.60 mmol, 1.20 equiv) at −40 °C. A solution of CuCN·2LiCl (1.00 M in THF, 0.60 mmol, 
0.60 mL, 1.20 equiv) was added and the reaction mixture was stirred for 30 min at −40 °C. 3-
Bromocyclohexene (0.04 mL, 0.60 mmol, 1.20 equiv) was added. The resulting mixture was allowed to 
warm up to room temperature and was further stirred for 12 h. The crude product was purified by column 
chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title compound 144d as a brown liquid 
(100 mg, 0.38 mmol, 76%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.23–7.16 (m, 1H), 6.39–6.32 (m, 1H), 6.02 (dd, J = 7.0, 
1.3 Hz, 1H), 5.92–5.83 (m, 2H), 5.51 (dq, J = 10.1, 2.1 Hz, 1H), 5.35 (d, J = 10.6 Hz, 1H), 3.73 (qdd, 
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J = 11.3, 5.2, 3.7 Hz, 3H), 3.46 (ddd, J = 6.3, 3.5, 2.3 Hz, 2H), 3.30 (s, 3H), 1.99 (m, J = 13.4, 8.6, 5.9, 
3.1 Hz, 3H), 1.70–1.43 (m, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 164.4, 154.0, 139.8, 129.6, 127.0, 118.0, 106.2, 71.6, 71.5, 
68.6, 58.9, 36.5, 29.9, 24.6, 19.8. 
MS (EI, 70 eV): m/z (%) = 263 (1), 205 (23), 188 (48), 187 (35), 186 (39), 176 (31), 175 (87), 174 (37), 
172 (18), 160 (33), 159 (31), 158 (26), 147 (12), 146 (100), 134 (26), 133 (21), 130 (15), 122 (10), 117 
(11), 109 (24), 59 (32).  
HRMS (EI): m/z calc. for [C15H21NO3]: 263.1521; found: 263.1516 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 2928, 2876, 1658, 1586, 1548, 1450, 1134, 1096, 1084, 1050, 
800, 774. 
6-(Cyclopropanecarbonyl)-1-((2-methoxyethoxy)methyl)pyridin-2(1H)-one (144e) 
 
According to TP3, the iodine-magnesium exchange of 2-pyridone 137a (155 mg, 0.50 mmol, 
1.00 equiv) was completed within 30 min using a solution of iPrMgCl·LiCl (36, 1.00 M in THF, 
0.60 mL, 0.60 mmol, 1.20 equiv) at −40 °C. A solution of CuCN·2LiCl (1.00 M in THF, 0.60 mmol, 
0.60 mL, 1.20 equiv) was added and the reaction mixture was stirred for 30 min at −40 °C. 
Cyclopropanecarbonyl chloride (0.06 mL, 0.60 mmol, 1.20 equiv) was added. The resulting mixture 
was allowed to warm up to room temperature and was further stirred for 12 h. The crude product was 
purified by column chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title compound 
144e as a yellow liquid (95 mg, 0.38 mmol, 76%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.33 (dd, J = 9.3, 6.7 Hz, 1H), 6.65–6.56 (m, 2H), 5.71 (s, 2H), 
3.60–3.56 (m, 2H), 3.47–3.43 (m, 2H), 3.30 (s, 3H), 2.33 (tt, J = 7.8, 4.5 Hz, 1H), 1.32–1.26 (m, 2H), 
1.10 (dq, J = 7.5, 3.5 Hz, 2H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 198.2, 162.6, 145.6, 138.2, 123.7, 108.4, 72.3, 71.4, 68.5, 
59.0, 20.7, 13.2. 
MS (EI, 70 eV): m/z (%) = 251 (2), 182 (20), 176 (51), 175 (63), 164 (25), 163 (55), 147 (24), 134 (17), 
122 (11), 94 (15), 89 (33), 59 (100), 41 (10).  
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HRMS (EI): m/z calc. for [C13H17NO4]: 251.1158; found: 251.1158 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3486, 2924, 2880, 1652, 1586, 1380, 1234, 1130, 1094, 1078, 
1042, 1000, 850, 804. 
6-(3,3-Dimethylbutanoyl)-1-((2-methoxyethoxy)methyl)pyridin-2(1H)-one (144f) 
 
According to TP3, the iodine-magnesium exchange of 2-pyridone 137a (155 mg, 0.50 mmol, 
1.00 equiv) was completed within 30 min using a solution of iPrMgCl·LiCl (36, 1.00 M in THF, 
0.60 mL, 0.60 mmol) at −40 °C. A solution of CuCN·2LiCl (1.00 M in THF, 0.60 mmol, 0.60 mL, 
1.20 equiv) was added and the reaction mixture was stirred for 30 min at −40 °C. tert-Butylacetyl 
chloride (0.08 mL, 0.60 mmol, 1.20 equiv) was added. The resulting mixture was allowed to warm to 
room temperature and was further stirred for 12 h. The crude product was purified by column 
chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title compound 144f as a brown liquid 
(101 mg, 0.36 mmol, 72%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.31–7.27 (m, 1H), 6.60–6.56 (m, 1H), 6.33 (dd, J = 6.7, 
1.0 Hz, 1H), 5.70 (s, 2H), 3.55 (dd, J = 5.4, 3.7 Hz, 2H), 3.42 (dd, J = 5.7, 3.1 Hz, 2H), 3.27 (s, 3H), 
2.74 (s, 2H), 1.06 (s, 9H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 197.8, 162.6, 146.0, 138.3, 123.4, 107.6, 72.1, 71.3, 68.5, 
58.8, 53.4, 31.1, 29.6. 
MS (EI, 70 eV): m/z (%) = 205 (59), 194 (12), 193 (62), 190 (14), 182 (21), 178 (14), 150 (92), 149 
(25), 148 (100), 138 (44), 137 (44), 127 (13), 122 (13), 121 (14), 120 (43), 112 (11), 109 (21), 95 (11), 
194 (13), 89 (42), 83 (12), 59 (59).  
HRMS (EI): m/z calc. for [C15H23NO4]: 281.1627; found: 281.0508 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 2954, 2874, 1656, 1590, 1466, 1360, 1238, 1082, 1044, 802. 
 
  
C. EXPERIMENTAL PART    93 
 
 
 
2.4.2 Reactions of Magnesiated 2,7-Naphthyridone with Electrophiles 
2-((2-Methoxyethoxy)methyl)-1-oxo-1,2-dihydro-2,7-naphthyridine-3-carbonitrile (145a) 
 
According to TP4, the iodine-magnesium exchange of 2,7-naphthyridone 141a (72 mg, 0.20 mmol, 
1.00 equiv) was completed within 20 min using a solution of iPrMgCl·LiCl (36, 1.30 M in THF, 
0.15 mL, 0.20 mmol, 1.00 equiv). The Grignard reagent was then added dropwise to a solution of p-
toluenesulfonyl cyanide (54 mg, 0.30 mmol) in dry THF (3 mL) at 0 °C via syringe. The resulting 
mixture was allowed to warm to room temperature and was further stirred for 12 h. The crude product 
was purified by column chromatography (EtOAc/MeOH = 9:1) to give the title compound 145a as a 
light brown solid (32 mg, 0.12 mmol, 60%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 9.64 (s, 1H), 8.89 (s, 1H), 7.44 (d, J = 5.2 Hz, 1H), 7.08 (s, 
1H), 5.69 (s, 2H), 3.86–3.78 (m, 2H), 3.58–3.50 (m, 2H), 3.30 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 160.7, 152.5, 151.8, 140.1, 122.0, 120.4, 119.7, 115.6, 112.6, 
75.5, 71.7, 69.8, 59.2. 
MS (EI, 70 eV): m/z (%) = 259 (1), 200 (14), 184 (33), 172 (14), 171 (159), 154 (25), 89 (55), 59 (100), 
58 (21), 45 (21). 
HRMS (EI): m/z calc. for [C13H13N3O3]: 259.0957; found: 259.0961 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 3064, 2925, 2854, 2236, 1665, 1616, 1126, 1071, 978, 791. 
M.p. (°C): 74. 
2-((2-Methoxyethoxy)methyl)-3-(phenylthio)-2,7-naphthyridin-1(2H)-one (145b) 
 
According to TP4, the iodine-magnesium exchange of 2,7-naphthyridone 141a (144 mg, 0.40 mmol, 
1.00 equiv) was finished within 20 min, using a solution of iPrMgCl·LiCl (36, 1.30 M in THF, 0.31 mL, 
0.40 mmol, 1.00 equiv). The Grignard reagent 143 was then added dropwise to a solution of S-phenyl 
benzenethiosulfonate (300 mg, 1.2 mmol) in dry THF (5 mL) at 0 °C via syringe. The resulting mixture 
was allowed to warm up to room temperature and was further stirred for 12 h. The reaction mixture was 
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quenched with sat. aq. NaHCO3 solution (10 mL), extracted with EtOAc (3 × 20 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated in vacuo. The crude product was purified 
by column chromatography (EtOAc/MeOH = 9.5:0.5) to give the title compound 145b as a brown-
yellow solid (98 mg, 0.29 mmol, 72%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 9.44 (s, 1H), 8.55 (d, J = 5.4 Hz, 1H), 7.54–7.49 (m, 2H), 
7.45–7.41 (m, 3H), 6.99 (d, J = 5.5 Hz, 1H), 5.96 (s, 1H), 5.82 (s, 2H), 3.81–3.77 (m, 2H), 3.51 (dd, 
J = 5.3, 3.8 Hz, 2H), 3.33 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 162.8, 151.5, 151.1, 148.4, 141.6, 134.2, 130.1, 130.1, 129.9, 
118.5, 118.1, 105.5, 74.0, 71.6, 69.0, 59.1. 
MS (EI, 70 eV): m/z (%) = 342 (31), 267 (29), 254 (81), 195 (11), 165 (11), 145 (10), 89 (31), 59 (100). 
HRMS (EI): m/z calc. for [C18H18N2O3S]: 342.1038; found: 342.1034 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 3070, 2924, 2883, 2815, 1660, 1596, 1523, 1102, 1080, 740. 
M.p. (°C): 68–70. 
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2.5 Direct Magnesiation of 6-Substituted 2-Pyridones 
3,6-Diiodo-1-((2-methoxyethoxy)methyl)pyridin-2(1H)-one (148a) 
 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 2-pyridone 
137a (155 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (1 mL) was cooled to −40 °C. 
TMPMgCl·LiCl (89, 1.06 M in THF, 0.57 mL, 0.60 mmol, 1.20 equiv) was added dropwise and the 
mixture was stirred at the same temperature for 2 h. Iodine (153 mg, 0.60 mmol, 1.20 equiv) dissolved 
in dry THF (1 mL) was then added dropwise at −40 °C. The resulting mixture was allowed to warm up 
to room temperature and was further stirred for 30 min. The reaction mixture was quenched with sat. 
aq. Na2S2O3 solution (5 mL), extracted with EtOAc (3 × 20 mL) and dried over anhydrous MgSO4. After 
filtration, the solvent was evaporated in vacuo. The crude product was purified by column 
chromatography (CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title compound 148a as a brown liquid 
(173 mg, 0.40 mmol, 80%). 
1H-NMR (600 MHz, CDCl3): 7.52 (d, J = 7.5 Hz, 1H), 6.53 (d, J = 7.5 Hz, 1H), 5.71 (s, 2H), 3.76–
3.70 (m, 2H), 3.51–3.46 (m, 2H), 3.31 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 160.4, 149.1, 121.2, 100.4, 92.5, 82.9, 71.4, 69.3, 59.0. 
MS (EI, 70 eV): m/z (%) = 326 (15), 310 (20), 298 (22), 297 (100), 155 (13), 154 (14), 115 (14), 89 
(16), 59 (63). 
HRMS (EI): m/z calc. for [C9H11I2NO3]: 385.0175; found: 385.0169 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 2810, 1630, 1574, 1490, 1442, 1312, 1192, 1062, 1000, 802, 752. 
3-(Hydroxy(phenyl)methyl)-6-iodo-1-((2-methoxyethoxy)methyl)pyridin-2(1H)-one (148b) 
 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 2-pyridone 
137a (155 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (1 mL) was cooled down to −40 °C. 
TMPMgCl·LiCl (89, 1.06 M in THF, 0.57 mL, 0.60 mmol, 1.20 equiv) was added dropwise and the 
mixture was stirred at the same temperature for 2 h. Benzaldehyde (0.06 mL, 0.60 mmol, 1.20 equiv) 
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was then added dropwise at −40 °C. The resulting mixture was allowed to warm up to room temperature 
and was further stirred for 30 min. The reaction mixture was quenched with sat. aq. NH4Cl solution 
(5 mL), extracted with EtOAc (3 × 20 mL) and dried over anhydrous MgSO4. After filtration, the solvent 
was evaporated in vacuo. The crude product was purified by column chromatography 
(CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title compound 148b as a yellow liquid (154 mg, 
0.37 mmol, 74%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.93 (d, J = 7.5 Hz, 1H), 7.41–7.30 (m, 5H), 6.05 (d, 
J = 3.8 Hz, 1H), 6.01–5.92 (m, 2H), 5.46 (d, J = 11.0 Hz, 1H), 4.05 (s, 1H), 3.78 (t, J = 4.4 Hz, 2H), 
3.59–3.44 (m, 2H), 3.34 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 161.1, 152.3, 149.1, 139.9, 128.9, 128.6, 126.7, 108.9, 91.6, 
73.9, 71.3, 71.3, 68.7, 59.0. 
MS (EI, 70 eV): m/z (%) = 338 (18), 328 (10), 327 (78), 326 (28), 311 (12), 310 (30), 309 (15), 250 
(18), 222 (18), 221 (13), 182 (22), 154 (32), 153 (17), 128 (17), 127 (100), 105 (40), 91 (30), 89 (11), 
77 (22), 59 (32). 
HRMS (EI): m/z calc. for [C16H18INO4]: 415.0281; found: 415.0267 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3348, 2924, 2880, 1638, 1582, 1452, 1196, 1082, 1060, 1024, 
844, 762, 734, 700. 
6-Iodo-1-((2-methoxyethoxy)methyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile (148c) 
 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 2-pyridone 
137a (155 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (1 mL) was cooled to −40 °C. 
TMPMgCl·LiCl (89, 1.06 M in THF, 0.57 mL, 0.60 mmol, 1.20 equiv) was added dropwise and the 
mixture was stirred at the same temperature for 2 h. p-Toluenesulfonyl cyanide (108 mg, 0.60 mmol, 
1.20 equiv) was then added dropwise at −40 °C. The resulting mixture was allowed to warm up to room 
temperature and was further stirred for 30 min. The reaction mixture was quenched with sat. aq. NH4Cl 
solution (5 mL), extracted with EtOAc (3 × 20 mL) and dried over anhydrous MgSO4. After filtration, 
the solvent was evaporated in vacuo. The crude product was purified by column chromatography 
(CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title compound 148c as a lightly brown solid (67 mg, 
0.20 mmol, 40%). 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 8.03 (d, J = 7.2 Hz, 1H), 6.48 (d, J = 7.3 Hz, 1H), 5.66 (s, 2H), 
3.83–3.80 (m, 2H), 3.55–3.52 (m, 2H), 3.34 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 159.1, 147.3, 121.2, 116.5, 112.3, 102.5, 77.7, 71.7, 70.2, 
59.2. 
MS (EI, 70 eV): m/z (%) = 334 (5), 276 (34), 259 (37), 247 (60), 246 (45), 132 (10), 104 (17), 89 (77), 
64 (16), 59 (100), 58 (12), 45 (25). 
HRMS (EI): m/z calc. for [C10H11IN2O3]: 333.9814; found: 333.9810 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3090, 2926, 2882, 2228, 1652, 1548, 1450, 1200, 1078, 846, 716. 
M.p. (°C): 108–110. 
3-Iodo-1-((2-methoxyethoxy)methyl)-6-phenylpyridin-2(1H)-one (149) 
 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 2-pyridone 
137b (130 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (1 mL) was cooled down to −40 °C. 
TMPMgCl·LiCl (89, 1.06 M in THF, 0.57 mL, 0.60 mmol, 1.20 equiv) was added dropwise and the 
mixture was stirred at the same temperature for 2 h. Iodine (154 mg, 0.60 mmol, 1.20 equiv) in dry THF 
(1 mL) was then added dropwise at −40 °C. The resulting mixture was allowed to warm to room 
temperature and was further stirred for 30 min. The reaction mixture was quenched with sat. aq. NH4Cl 
solution (5 mL), extracted with EtOAc (3 × 20 mL) and dried over anhydrous MgSO4. After filtration, 
the solvent was evaporated in vacuo. The crude product was purified by column chromatography 
(CH2Cl2/MeOH/Et3N = 9.7:0.3:0.05) to give the title compound 149 as a lightly brown liquid (90 mg, 
0.35 mmol, 70%). 
1H-NMR (600 MHz, CDCl3): 7.98 (d, J = 7.7 Hz, 1H), 7.54–7.38 (m, 5H), 5.88 (d, J = 7.3 Hz, 1H), 
5.31 (s, 2H), 3.86–3.82 (m, 2H), 3.55–3.48 (m, 2H), 3.33 (d, J = 0.6 , 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 161.0, 151.4, 148.7, 134.2, 129.7, 129.2, 128.5, 109.5, 91.4, 
76.4, 71.9, 69.7, 59.0. 
MS (EI, 70 eV): m/z (%) = 326 (15), 310 (20), 298 (22), 297 (100), 155 (13), 154 (14), 115 (14), 89 
(16), 59 (63). 
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HRMS (EI): m/z calc. for [C15H16INO3]: 385.0175; found: 385.0169 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3058, 2924, 2878, 1644, 1586, 1530, 1490, 1446, 1072, 844, 812, 
762, 698. 
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2.6 Cleavage of the MEM-Protecting Group and Chlorination 
3-(4-Chlorophenyl)-2,7-naphthyridin-1(2H)-one (150) 
 
In order to remove the MEM-protecting group, 2,7-naphthyridone 141d (680 mg, 2.0 mmol) was 
dissolved in EtOH (2 mL). Concentrated hydrochloric acid (1 mL) was added and the mixture was 
heated to 65 °C for 3 h. At the same temperature, the mixture was then evaporated to dryness under 
high vacuum. The crude product was purified by column chromatography (EtOAc/MeOH = 9.5:0.5) to 
give the title compound 150 as a colorless solid (430 mg, 1.7 mmol, 84%). 
1H-NMR (400 MHz, (CD3)2SO): δ / ppm = 9.32 (s, 1H), 8.71 (d, J = 5.5 Hz, 1H), 7.85–7.80 (m, 2H), 
7.63–7.58 (m, 3H), 6.94 (s, 1H). 
13C-NMR (100 MHz, (CD3)2SO): δ / ppm = 162.3, 151.0, 149.8, 144.1, 143.0, 134.9, 132.1, 129.0, 
128.9, 119.7, 119.7, 101.8. 
MS (ESI, 70 eV): m/z (%) = 257 (100), 235 (10). 
HRMS (ESI): m/z calc. for [C14H10ClN2O]: 257.0476; found: 257.0481 (M+ + H). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 2924, 2876, 1710, 1666, 1612, 1450, 1360, 1220, 1088, 826. 
M.p. (°C): 200. 
1-Chloro-3-(4-chlorophenyl)-2,7-naphthyridine (151) 
 
A pressure flask, equipped with a magnetic stirring bar, was charged with 150 (1.28 g, 5.0 mmol), 
followed by POCl3 (10 mL). The reaction mixture was heated at 180 °C for 24 h. Then, the reaction was 
poured on ice (150 g) and was made alkaline with potassium carbonate. The mixture was extracted 
several times with EtOAc extensively. The combined organic layers were dried over MgSO4, filtered 
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and concentrated in vacuo. The crude residue was purified by flash column chromatography 
(ihex/EtOAc = 9:1) to afford the desired product 151 as a yellow solid (1.12 g, 4.1 mmol, 82%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 9.73 (s, 1H), 8.79 (d, J = 5.6 Hz, 1H), 8.12–8.06 (m, 2H), 7.95 
(s, 1H), 7.70 (d, J = 5.7 Hz, 1H), 7.51–7.48 (m, 2H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 153.4, 152.2, 151.5, 147.9, 141.9, 136.5, 135.6, 129.4, 128.7, 
121.2, 119.5, 114.4. 
MS (EI, 70 eV): m/z (%) = 274 (100), 241 (15), 239 (48), 204 (17), 177 (11), 176 (13). 
HRMS (EI): m/z calc. for [C14H8Cl2N2]: 274.0065; found: 274.00581 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 2928, 2854, 1700, 1592, 1408, 1170, 1090, 1042, 1012, 836. 
M.p. (°C): 189. 
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2.7 Cobalt-Catalyzed Negishi Cross-Couplings 
3-(4-Chlorophenyl)-1-(4-methoxyphenyl)-2,7-naphthyridine (153a) 
 
According to TP5, the naphthyridine 151 (82 mg, 0.30 mmol, 1.00 equiv) was added to a solution of 
CoCl2 (10 mol %) and dry THF (1 mL) at room temperature. Appropriate zinc reagent 152a 
(0.45 mmol, 1.50 equiv) was added dropwise over 15 min via syringe at 0 °C. The reaction mixture was 
allowed to warm up to room temperature and stirred for 48 h. The crude product was purified by column 
chromatography (EtOAc/MeOH = 9.5:0.5) to give the title compound 153a as a lightly yellow solid 
(79 mg, 0.23 mmol, 77%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 9.53 (s, 1H), 8.67 (d, J = 5.5 Hz, 1H), 8.15 (d, J = 8.8 Hz, 
2H), 7.89 (s, 1H), 7.80 (d, J = 8.8 Hz, 2H), 7.65 (d, J = 5.5 Hz, 1H), 7.45 (d, J = 8.8 Hz, 2H), 7.10 (d, 
J = 8.8 Hz, 2H), 3.91 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 161.1, 160.9, 152.8, 152.5, 146.6, 140.8, 137.2, 135.6, 131.9, 
130.6, 129.1, 128.7, 120.9, 119.7, 114.2, 113.0, 55.6. 
MS (EI, 70 eV): m/z (%) = 346 (100), 345 (67), 331 (15), 317 (27), 316 (18), 315 (81), 304 (13), 303 
(25), 302 (25), 267 (13), 266 (12), 134 (14). 
HRMS (EI): m/z calc. for [C21H15ClN2O]: 346.0873; found: 346.0870 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3054, 2994, 2832, 1608, 1544, 1514, 1380, 1246, 1176, 1090, 
1012, 866, 828. 
M.p. (°C): 146. 
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4-(3-(4-Chlorophenyl)-2,7-naphthyridin-1-yl)-N,N-dimethylaniline (153b) 
 
According to TP5, the naphthyridine 151 (82 mg, 0.30 mmol, 1.00 equiv) was added to a solution of 
CoCl2 (10 mol %) and dry THF (1 mL) at room temperature. Appropriate zinc reagent 152b 
(0.45 mmol, 1.50 equiv) was added dropwise over 15 min via syringe at 0 °C. The reaction mixture was 
allowed to warm up to room temperature and stirred for 48 h. The crude product was purified by column 
chromatography (EtOAc/MeOH = 9.5:0.5) to give the title compound 153b as a lightly yellow solid 
(90 mg, 0.25 mmol, 83%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 9.61 (s, 1H), 8.64 (d, J = 5.7 Hz, 1H), 8.17 (d, J = 8.8 Hz, 2H), 
7.83 (s, 1H), 7.80 (d, J = 8.9 Hz, 2H), 7.63 (d, J = 5.7 Hz, 1H), 7.45 (d, J = 8.8 Hz, 2H), 6.88 (d, 
J = 8.8 Hz, 2H), 3.07 (s, 6H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 161.6, 153.1, 152.5, 151.5, 146.4, 141.1, 137.4, 135.4, 131.8, 
129.0, 128.7, 125.8, 120.8, 119.7, 112.2, 112.0, 40.4. 
MS (EI, 70 eV): m/z (%) = 359 (100), 358 (57), 344 (12), 342 (15), 317 (18), 316 (15), 315 (54), 179 
(12). 
HRMS (EI): m/z calc. for [C22H18ClN3]: 359.1189; found: 359.1183 (M+). 
IR (Diamond-ATR, neat): 𝜈 ̃ / cm-1 = 2918, 2812, 1608, 1528, 1382, 1196, 1088, 1010, 974, 864, 832. 
M.p. (°C): 163. 
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3-(4-Chlorophenyl)-1-(p-tolyl)-2,7-naphthyridine (153c) 
 
According to TP5, the naphthyridine 151 (82 mg, 0.30 mmol, 1.00 equiv) was added to a solution of 
CoCl2 (10 mol %) and dry THF (1 mL) at room temperature. Appropriate zinc reagent 152c 
(0.45 mmol, 1.50 equiv) was added dropwise over 15 min via syringe at 0 °C The reaction mixture was 
allowed to warm up to room temperature and stirred for 48 h. The crude product was purified by column 
chromatography (EtOAc / MeOH = 9.5:0.5) to give the title compound 153c as a lightly yellow solid 
(66 mg, 0.20 mmol, 67%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 9.54 (s, 1H), 8.69 (d, J = 5.7, 1H), 8.18 (d, J = 8.5 Hz, 2H), 
7.96 (s, 1H), 7.75 (d, J = 7.9 Hz, 2H), 7.70 (d, J = 5.7 Hz, 1H), 7.47 (d, J = 8.5 Hz, 2H), 7.41 (d, 
J = 7.7 Hz, 2H), 2.50 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 161.7, 153.0, 152.7, 146.7, 140.8, 139.8, 137.2, 135.7, 135.4, 
130.5, 129.5, 129.1, 128.8, 121.0, 119.7, 113.4, 21.6. 
MS (EI, 70 eV): m/z (%) = 330 (79), 329 (62), 317 (31), 316 (22), 315 (100), 146 (10). 
HRMS (EI): m/z calc. for [C21H15ClN2]: 330.0924; found: 330.0901 (M+). 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3054, 2922, 1610, 1546, 1494, 1412, 1380, 1330, 1186, 1094, 
1014, 976, 830, 788. 
M.p. (°C): 150. 
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3 Directed Zincation or Magnesiation of 2- and 4-Pyrones and their 
Derivatives 
3.1 Starting Materials 
2-Pyrone and 4-pyrone were purchased from TCI. Methyl coumalate was purchased from Alfa Aesar. 
3,5-Dibromo-2H-pyran-2-one was prepared using known procedures.97a 
3.2 Typical Procedures (TP) 
Typical procedure for the magnesation of 2-pyrone (154) using TMPMgCl·LiCl (89) (TP6): 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 2-pyrone 
(154, 1.00 equiv) was dissolved in dry THF (0.50 M solution). After the solution was cooled to –40 °C, 
TMPMgCl·LiCl (89, 1.20 equiv) was added and the mixture was stirred at the same temperature. The 
completion of the metalation was achieved after 15 min, stated by TLC-analysis of reaction aliquots 
quenched with a solution of I2 in dry THF. Subsequent reactions with electrophiles were carried out 
under the indicated conditions. After complete conversion, the mixture was quenched with sat.aq. NaCl 
(10 mL) and extracted with Et2O (3 × 20 mL) if not noted differently. The combined organic extracts 
were dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The crude product was purified 
by flash-column chromatography. 
Typical procedure for the zincation of methyl coumalate (156) using TMPZnCl·LiCl (92) (TP7): 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, methyl 
coumalate (156, 1.00 equiv) was dissolved in dry THF (0.50 M solution). After the solution was cooled 
to −78 °C, TMPZnCl·LiCl (92, 1.20 equiv) was added and the mixture was stirred at the same 
temperature. The completion of the metalation was achieved after 15 min, stated by TLC-analysis of 
reaction aliquots quenched with a solution of I2 in dry THF. After complete conversion, the mixture 
was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 20 mL) if not specifically 
indicated. The combined organic extracts were dried over anhydrous Na2SO4, filtered and concentrated 
in vacuo. The crude product was purified by flash-column chromatography. 
Typical procedure for the zincation of 3,5-dibromo-2H-pyran-2-one (157) using TMPZnCl·LiCl 
(92) (TP8): 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 3,5-
dibromo-2H-pyran-2-one (157, 1.00 equiv) was dissolved in dry THF (0.50 M solution). After the 
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solution was cooled to −10 °C, TMPZnCl·LiCl (92, 1.20 equiv) was added and the mixture was stirred 
at the same temperature. The completion of the metalation was achieved after 15 min, stated by TLC-
analysis of reaction aliquots quenched with a solution of I2 in dry THF. After complete conversion, the 
mixture was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 20 mL) if not 
specifically indicated. The combined organic extracts were dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo. The crude product was purified by flash-column chromatography. 
Typical procedure for the magnesiation of 6-substituted 2-pyrone (159) using TMPMgCl·LiCl 
(89) (TP9): 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 6-
substituted 2-pyrone (159, 1.00 equiv) was dissolved in dry THF (0.50 M solution). After the solution 
was cooled to −40 °C, TMPMgCl·LiCl (89, 1.20 equiv) was added and the mixture was stirred at the 
same temperature. The completion of the metalation was achieved after 1 h, stated by TLC-analysis of 
reaction aliquots quenched with a solution of I2 in dry THF. After complete conversion, the mixture 
was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 20 mL) if not specifically 
indicated. The combined organic extracts were dried over anhydrous Na2SO4, filtered and concentrated 
in vacuo. The crude product was purified by flash-column chromatography. 
Typical procedure for the zincation of 4-pyrone (155) using TMP2Zn·2MgCl2·2LiCl (93) (TP10): 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, 4-pyrone 
(155, 1.00 equiv) was dissolved in dry THF (0.50 M solution). After the solution was cooled to −35 °C, 
TMP2Zn·2MgCl2·2LiCl (93, 1.20 equiv) was added and the mixture was stirred at the same 
temperature. The completion of the metalation was achieved after 2 h, stated by TLC-analysis of 
reaction aliquots quenched with a solution of I2 in dry THF. After complete conversion, the mixture 
was quenched with sat. aq. NH4Cl (10 mL) and extracted with EtOAc (3 × 20 mL) if not specifically 
indicated. The combined organic extracts were dried over anhydrous Na2SO4, filtered and concentrated 
in vacuo. The crude product was purified by flash-column chromatography. 
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3.3 Reaction of Magnesiated 2-Pyrone with Electrophiles 
6-(Hydroxy(phenyl)methyl)-2H-pyran-2-one (159a) 
 
According to TP6, 2-pyrone (154, 0.50 M in THF, 1.00 mL, 0.50 mmol, 1.00 equiv) was completely 
metalated within 15 min at –40 °C, using TMPMgCl·LiCl (89, 1.10 M in THF, 0.54 mL, 0.60 mmol, 
1.20 equiv). Benzaldehyde (0.06 mL, 0.60 mmol, 1.20 equiv) was then added dropwise at –40 °C. The 
reaction mixture was warmed to 25 °C and was stirred until completion of the reaction. The crude 
product was purified by column chromatography (ihex/Et2O = 5:5) furnishing the compound 159a as a 
yellow solid (73 mg, 0.36 mmol, 72%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 7.53–7.46 (m, 3H), 7.40–7.29 (m, 3H), 6.50 (dt, J = 6.6, 
1.0 Hz, 1H), 6.13–6.09 (m, 1H), 5.52 (d, J = 3.8 Hz, 1H), 5.42 (d, J = 4.4 Hz, 1H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 167.7, 161.8, 144.9, 141.7, 129.2, 128.9, 127.8, 114.4, 
101.9, 73.1. 
MS (70 eV, EI) m/z (%): 202 (48), 198 (46), 186 (100), 173 (14), 128 (16), 107 (52), 95 (100). 
HRMS (EI): m/z calc. for [C12H10O3]: 202.0630; found 202.0622 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3072, 1716, 1535, 148, 1398, 1090, 1074, 845, 801. 
M.p. (°C): 107–108. 
6-((4-Chlorophenyl)(hydroxy)methyl)-2H-pyran-2-one (159b) 
 
According to TP6, 2-pyrone (154, 0.50 M in THF, 1.00 mL, 0.50 mmol, 1.00 equiv) was completely 
metalated within 15 min at –40 °C, using TMPMgCl·LiCl (89, 1.10 M in THF, 0.54 mL, 0.60 mmol, 
1.20 equiv). 4-Chlorobenzaldehyde (0.06 mL, 0.60 mmol, 1.20 equiv) was then added dropwise at –
40 °C. The reaction mixture was warmed to 25 °C and was stirred until completion of the reaction. The 
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crude product was purified by flash-column chromatography (ihex/Et2O = 4:6) furnishing the 
compound 159b as a yellow oil (71 mg, 0.30 mmol, 60%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 7.54–7.47 (m, 3H), 7.43–7.38 (m, 2H), 6.50 (dt, J = 6.6, 
0.9 Hz, 1H), 6.12 (dd, J = 9.4, 1.2 Hz, 1H), 5.53 (d, J = 12.5 Hz, 2H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 167.0, 161.6, 144.9, 140.7, 134.2, 129.5, 129.3, 114.7, 
102.1, 72.4. 
MS (70 eV, EI) m/z (%): 236 (20), 234 (10), 220 (11), 143 (34), 142 (10), 138 (100), 113 (25), 111 
(45), 97 (56), 96 (28), 77 (79), 75 (33), 51 (19), 50 (15). 
HRMS (EI): m/z calc. for [C12H9ClO3]: 236.0240; found 236.0243 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3072, 1716, 1535, 1488, 1398, 1090, 1074, 845, 801. 
6-(Methylthio)-2H-pyran-2-one (159c) 
 
According to TP6, 2-pyrone (154, 0.50 M in THF, 1.00 mL, 0.50 mmol, 1.00 equiv) was completely 
metalated within 15 min at –40 °C, using TMPMgCl·LiCl (89, 1.10 M in THF, 0.54 mL, 0.60 mmol, 
1.20 equiv). Methyl methanethiosulfonate (0.06 mL, 0.60 mmol, 1.20 equiv) was then added dropwise 
at –40 °C. The reaction mixture was warmed to 25 °C and was stirred until completion of the reaction. 
The crude product was purified by flash-column chromatography (ihex/Et2O = 4:6) furnishing the 
compound 159c as an orange oil (67 mg, 0.47 mmol, 95%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 7.42 (dd, J = 9.3, 7.0 Hz, 1H), 6.22 (dd, J = 7.0, 0.8 Hz, 
1H), 5.99 (dd, J = 9.3, 0.8 Hz, 1H), 2.54 (s, 3H). 
13C NMR (101 MHz, (CD3)2CO): δ/ppm = 165.7, 161.7, 145.0, 110.1, 102.4, 13.8. 
MS (70 eV, EI) m/z (%): 142 (42), 114 (12), 95 (100), 43 (13), 39 (37), 28 (22), 18 (20). 
HRMS (EI): m/z calc. for [C6H6O2S]: 142.0089; found 142.0076 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2928, 1724, 1606, 1513, 1435, 1173, 1080, 780. 
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6-(4-Chlorophenyl)-2H-pyran-2-one (159d) 
 
According to TP6, 2-pyrone (154, 0.50 M in THF, 1.00 mL, 0.50 mmol, 1.00 equiv) was completely 
metalated within 15 min at –40 °C, using TMPMgCl·LiCl (89, 1.10 M in THF, 0.54 mL, 0.60 mmol, 
1.20 equiv). The magnesium reagent was transmetalated to zinc in the presence of ZnCl2 (1.00 M 
solution in THF, 0.75 mL, 0.75 mmol, 1.50 equiv) and stirring for 30 min at −40 °C. The zinc reagent 
underwent a Negishi cross-coupling reaction in the presence of Pd(dba)2 (11 mg, 8 mol%), P(2-furyl)3 
(9.0 mg, 15 mol%) and 1-chloro-4-iodobenzene (143 mg, 0.60 mmol, 1.20 equiv) at 25 °C for 12 h. The 
crude product was purified by flash-column chromatography (ihex/Et2O = 5:5) furnishing the 
compound 159d as a yellowish solid (78 mg, 0.38 mmol, 75%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 7.87–7.83 (m, 2H), 7.58 (dd, J=9.3, 6.8, 1H), 7.53–7.48 
(m, 2H), 6.92 (dd, J = 6.8, 0.8 Hz, 1H), 6.25 (dd, J = 9.3, 0.8 Hz, 1H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 161.3, 160.2, 144.9, 137.0, 131.3, 130.0, 127.9, 115.0, 
102.4. 
MS (70 eV, EI) m/z (%): 206 (53), 180 (31), 179 (11), 178 (100), 149 (16), 139 (10), 115 (30), 111 
(14). 
HRMS (EI): m/z calc. for [C11H7ClO2]: 206.0135; found 206.0110 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3072, 1716, 1535, 1488, 1398, 1090, 1074, 845, 801. 
M.p. (°C): 100–101. 
6-(4-Methoxyphenyl)-2H-pyran-2-one (159e) 
 
According to TP6, 2-pyrone (154, 0.50 M in THF, 1.00 mL, 0.50 mmol, 1.00 equiv) was completely 
metalated within 15 min at –40 °C, using TMPMgCl·LiCl (89, 1.10 M in THF, 0.60 mmol, 0.54 mL, 
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1.20 equiv). The magnesium reagent was transmetalated to zinc in the presence of ZnCl2 (1.00 M 
solution in THF, 0.75 mmol, 1.50 equiv) and stirring for 30 min at −40 °C. The zinc reagent underwent 
a Negishi cross-coupling reaction in the presence of Pd(dba)2 (11 mg, 8 mol%), P(2-furyl)3 (9.0 mg, 
15 mol%) and 1-iodo-4-methoxybenzene (140 mg, 0.60 mmol, 1.20 equiv) at 25 °C for 12 h. The crude 
product was purified by flash-column chromatography (ihexane/Et2O = 6:4) furnishing the compound 
159e as a yellowish solid (91 mg, 0.45 mmol, 90%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 7.85–7.80 (m, 2H), 7.55 (dd, J = 9.3, 6.9 Hz, 1H), 7.08–
7.03 (m, 2H), 6.79 (dd, J = 6.9, 0.8 Hz, 1H), 6.16 (dd, J = 9.3, 0.8 Hz, 1H), 3.87 (s, 3H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 162.8, 161.8, 161.8, 145.3, 128.0, 125.0, 115.3, 113.2, 
100.5, 55.9. 
MS (70 eV, EI) m/z (%): 202 (44), 174 (100), 131 (40), 103 (16). 
HRMS (EI): m/z calc. for [C12H10O3]: 202.0630; found 202.0622 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3007, 1719, 1606, 1505, 1415, 1235, 1178, 1021, 835, 787. 
M.p. (°C): 137–139. 
6-(Pyridin-3-yl)-2H-pyran-2-one (159f) 
 
According to TP6, 2-pyrone (154, 0.50 M in THF, 1.00 mL, 0.50 mmol, 1.00 equiv) was completely 
metalated within 15 min at –40 °C, using TMPMgCl·LiCl (89, 1.10 M in THF, 0.54 mL, 0.60 mmol, 
1.20 equiv). The magnesium reagent was transmetalated to zinc in the presence of ZnCl2 (1.00 M 
solution in THF, 0.75 mmol, 1.50 equiv) and stirring for 30 min at −40 °C. The zinc reagent underwent 
a Negishi cross-coupling reaction in the presence of Pd(dba)2 (11 mg, 8 mol%), P(2-furyl)3 (9.0 mg, 
15 mol%) and 3-iodopyridine (60 mg, 0.60 mmol, 1.20 equiv) at 25 °C for 12 h. The crude product was 
purified by flash-column chromatography (ihexane/Et2O = 4:6) furnishing the compound 159f as a 
yellowish solid (83 mg, 0.48 mmol, 95%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 9.07 (d, J = 0.8 Hz, 1H), 8.68 (dd, J = 4.8, 1.6 Hz, 1H), 
8.22 (ddd, J = 8.1, 2.4, 1.6 Hz, 1H), 7.65 (dd, J = 9.4, 6.8 Hz, 1H), 7.55–7.50 (m, 1H), 7.05 (dd, J = 6.8, 
0.8 Hz, 1H), 6.32 (dd, J = 9.4, 0.8 Hz, 1H). 
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13C NMR (101 MHz, (CD3)2CO): δ / ppm = 161.3, 159.2, 152.2, 147.6, 144.9, 133.5, 128.6, 124.6, 
115.6, 103.1. 
MS (70 eV, EI) m/z (%): 173 (45), 145 (100), 117 (11), 95 (17), 78 (16), 57 (12), 55 (10), 50 (12), 43 
(13), 43 (16). 
HRMS (EI): m/z calc. for [C10H7NO2]: 173.0477; found 173.0472 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2917, 2849, 1726, 1628, 1540, 1476, 1266, 1108, 1069, 841, 793, 
695. 
M.p. (°C): 96–98. 
(E)-6-(But-2-en-2-yl)-2H-pyran-2-one (159g) 
 
According to TP6, 2-pyrone (154, 0.50 M in THF, 1.00 mL, 0.50 mmol, 1.00 equiv) was completely 
metalated within 15 min at –40 °C, using TMPMgCl·LiCl (89, 1.10 M in THF, 0.54 mL, 0.60 mmol, 
1.20 equiv). The magnesium reagent was transmetalated to zinc in the presence of ZnCl2 (1.00 M 
solution in THF, 0.75 mmol, 1.50 equiv) and stirring for 30 min at −40 °C. The zinc reagent underwent 
a Negishi cross-coupling reaction in the presence of PEPPSI-iPr (12 mg, 8 mol%) and (E)-2-bromobut-
2-ene (60 mg, 0.60 mmol, 1.20 equiv) at 25 °C for 12 h. The crude product was purified by flash-
column chromatography (ihexane/Et2O = 4:6) furnishing the compound 159g as a yellowish solid 
(72 mg, 0.48 mmol, 95%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 7.48 (dd, J = 9.3, 6.9 Hz, 1H), 6.56 (qd, J = 7.1, 1.2 Hz, 
1H), 6.32 (d, J = 6.9 Hz, 1H), 6.12 (d, J = 9.3 Hz, 1H), 1.88 (p, J = 1.0 Hz, 3H), 1.86–1.82 (m, 3H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 162.6, 161.6, 145.1, 129.4, 128.4, 114.0, 101.3, 14.2, 12.1. 
MS (70 eV, EI) m/z (%): 150 (94), 122 (100), 121 (13), 107 (71), 93 (18), 91 (13), 79 (49), 77 (21), 55 
(28), 53 (17), 43 (25), 41 (11). 
HRMS (EI): m/z calc. for [C9H10O2]: calc. 150.0681; found 150.0671 (M+). 
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IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3075, 2924, 1704, 1638, 1540, 1445, 1093, 1018, 832, 796, 784, 
705. 
M.p. (°C): 63–66. 
6-(Cyclohex-2-en-1-yl)-2H-pyran-2-one (159h) 
 
According to TP6, 2-pyrone (154, 0.50 м in THF, 1.00 mL, 0.50 mmol, 1.00 equiv) was completely 
metalated within 15 min at –40 °C, using TMPMgCl·LiCl (89, 1.10 M in THF, 0.54 mL, 0.60 mmol, 
1.20 equiv). The magnesium reagent was treated with CuCN·2LiCl (1.00 M solution in THF, 0.60 mL, 
0.60 mmol, 1.20 equiv) for 30 min at −40 °C. A subsequent allylation reaction was performed in the 
presence of 3-bromocyclohex-1-ene (193 mg, 0.60 mmol, 1.20 equiv) at −40 °C. The reaction mixture 
was stirred at 25 °C until completion of the reaction. The crude product was purified by flash-column 
chromatography (ihexane/Et2O = 4:6) furnishing the compound 159h as a yellow oil (44 mg, 
0.25 mmol, 50%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 7.44 (dd, J = 9.3, 6.7 Hz, 1H), 6.12–6.08 (m, 2H), 5.93 
(dtd, J = 9.9, 3.7, 2.3 Hz, 1H), 5.67 (dq, J = 10.1, 2.3 Hz, 1H), 3.27 (ddt, J = 9.2, 5.8, 2.7 Hz, 1H), 1.97 
(m, J = 13.4, 8.5, 5.8, 3.1 Hz, 2H), 1.82–1.55 (m, 4H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 169.3, 162.4, 144.9, 131.2, 125.8, 113.8, 102.9, 40.3, 27.9, 
25.4, 20.8. 
MS (70 eV, EI) m/z (%): 176 (100), 169 (11), 167 (11), 162 (31), 149 (12), 148 (40), 147 (17). 
HRMS (EI): m/z calc. for [C11H12O2]: 176.0837; found 176.0830 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2933, 1732, 1630, 1556, 1448, 1295, 1088, 801. 
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6-(Thiophene-2-carbonyl)-2H-pyran-2-one (159i) 
 
According to TP6, 2-pyrone (154, 0.50 м in THF, 1.00 mL, 0.50 mmol, 1.00 equiv) was completely 
metalated within 15 min at –40 °C, using TMPMgCl·LiCl (89, 1.10 M in THF, 0.54 mL, 0.60 mmol, 
1.20 equiv). The magnesium reagent was treated with CuCN·2LiCl (1.00 M solution in THF, 0.60 mL, 
0.60 mmol, 1.20 equiv) for 30 min at −40 °C. Acylation was achieved with thiophene-2-carbonyl 
chloride (0.06 mL, 0.60 mmol, 1.20 equiv) at −40 °C and warming to −15 °C. The reaction mixture was 
stirred at −15 °C until completion of the reaction. The crude product was purified by flash-column 
chromatography (ihex/Et2O 5:5) furnishing the compound 159i as a yellow solid (45 mg, 0.22 mmol 
44%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 8.33 (dd, J = 3.9, 1.1 Hz, 1H), 8.10 (dd, J = 5.0, 1.1 Hz, 
1H), 7.74 (dd, J = 9.4, 6.6 Hz, 1H), 7.35 (dd, J = 5.0, 3.9 Hz, 1H), 7.20 (dd, J = 6.6, 0.9 Hz, 1H), 6.63 
(dd, J = 9.4, 0.9 Hz, 1H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 176.9, 159.9, 156.6, 144.0, 141.5, 137.5, 137.0, 129.8, 
121.1, 109.8. 
MS (70 eV, EI) m/z (%): 206 (39), 111 (100), 95 (60), 39 (26), 28 (12), 18 (13). 
HRMS (EI): m/z calc. for [C10H6O3S]: 206.0038; found 206.0045 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3090, 1726, 1636, 1604, 1509, 1410, 1358, 1289, 1077, 858, 811, 
734. 
M.p. (°C): 143–146. 
  
C. EXPERIMENTAL PART    113 
 
 
 
6-(Cyclopropanecarbonyl)-2H-pyran-2-one (159j) 
 
According to TP6, 2-pyrone (154, 0.50 м in THF, 1.00 mL, 0.50 mmol, 1.00 equiv) was completely 
metalated within 15 min at –40 °C, using TMPMgCl·LiCl (89, 1.10 M in THF, 0.54 mL, 0.60 mmol, 
1.20 equiv). The magnesium reagent was treated with CuCN·2LiCl (1.00 M solution in THF, 0.60 mL, 
0.60 mmol, 1.20 equiv) for 30 min at −40 °C. Acylation was achieved with cyclopropanecarbonyl 
chloride (0.05 mL, 0.60 mmol, 1.20 equiv) at −40 °C and warming to −15 °C. The reaction mixture was 
stirred at −15 °C until completion of the reaction. The crude product was purified by flash-column 
chromatography (ihex/Et2O = 5:5) furnishing the compound 159j as a yellow solid (49 mg, 0.30 mmol, 
60%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 7.68 (dd, J = 9.4, 6.6 Hz, 1H), 7.09 (dd, J = 6.6, 1.0 Hz, 
1H), 6.59 (dd, J = 9.4, 0.9 Hz, 1H), 2.84–2.78 (m, 1H), 1.17–1.07 (m, 4H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 193.7, 160.2, 156.0, 143.8, 121.3, 107.6, 16.7, 12.9. 
MS (70 eV, EI) m/z (%): 164 (42), 149 (2), 129 (2), 126 (2), 125 (3), 123 (2), 111 (3), 109 (3), 97 (4), 
96 (8). 
HRMS (EI): m/z calc. for [C9H8O3]: calc. 164.0473; found 164.0472 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3058, 1718, 1672, 1406, 1244, 1060, 1018, 960, 816. 
M.p. (°C): 84–85. 
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3.4 Reaction of Zincated Methyl Coumalate with Electrophiles 
Methyl 6-(4-methoxyphenyl)-2-oxo-2H-pyran-5-carboxylate (160a) 
 
According to TP7, methyl coumalate (156, 72 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 15 min at –78 °C, using TMPZnCl·LiCl (92, 0.95 M in THF, 0.63 mL, 0.60 mmol, 1.20 equiv). 
The zinc reagent underwent a Negishi cross-coupling reaction in the presence of Pd(dba)2 (11 mg, 
8 mol%), P(2-furyl)3 (9.0 mg, 15 mol%) and 1-iodo-4-methoxybenzene (140 mg, 0.60 mmol, 
1.20 equiv) at 25 °C for 12 h. The crude product was purified by flash-column chromatography 
(ihex/EtOAc = 7:3) furnishing the compound 160a as an orange solid (59 mg, 0.23 mmol, 45%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.81 (d, J = 9.7 Hz, 1H), 7.57–7.50 (m, 2H), 6.97–6.91 (m, 
2H), 6.24 (d, J = 9.7 Hz, 1H), 3.86 (s, 3H), 3.72 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 167.2, 165.5, 162.3, 160.6, 144.6, 131.1, 124.3, 113.7, 112.4, 
108.6, 55.5, 52.4. 
MS (70 eV, EI) m/z (%): 260 (40), 232 (76), 201 (26), 135 (100), 77 (16). 
HRMS (EI): m/z calc. for [C14H12O5]: 260.0685; found 260.0681 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2954, 1723, 1606, 1505, 1436, 1331, 1256, 1178, 1071, 857, 781. 
M.p. (°C): 127–129. 
Methyl 6-(4-(ethoxycarbonyl)phenyl)-2-oxo-2H-pyran-5-carboxylate (160b) 
 
According to TP7, methyl coumalate (156, 72 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 15 min at –78 °C, using TMPZnCl·LiCl (92, 0.95 M in THF, 0.63 mL, 0.60 mmol, 1.20 equiv). 
The zinc reagent underwent a Negishi cross-coupling reaction in the presence of Pd(dba)2 (11 mg, 
8 mol%), P(2-furyl)3 (9.0 mg, 15 mol%) and ethyl 4-iodobenzoate (0.10 mL, 0.60 mmol, 1.20 equiv) at 
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25 °C for 12 h. The crude product was purified by flash-column chromatography (ihex/EtOAc = 7:3) 
furnishing the compound 160b as a yellowish liquid (87 mg, 0.29 mmol, 58%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 8.11 (d, J = 8.3 Hz, 2H), 7.84 (d, J = 9.7 Hz, 1H), 7.60 (d, 
J = 8.3 Hz, 2H), 6.35 (d, J = 9.7 Hz, 1H), 4.40 (q, J = 7.1 Hz, 2H), 3.68 (s, 3H), 1.40 (t, J = 7.1 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 166.1, 165.6, 164.5, 159.7, 143.9, 136.0, 132.7, 129.2, 129.0, 
114.0, 110.0, 61.4, 52.4, 14.3. 
MS (70 eV, EI) m/z (%): 302 (75), 274 (60), 257 (31), 246 (18), 243 (16), 229 (39), 197 (20), 178 (13), 
177 (100), 149 (26), 121 (11), 76 (12), 71 (11), 65 (11), 43 (57). 
HRMS (EI): m/z calc. for [C16H14O6]: 302.0790; found 302.0785 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2983, 1752, 1709, 1547, 1269, 1100, 1071, 997, 870, 769, 702. 
Methyl 6-(cyclohex-2-en-1-yl)-2-oxo-2H-pyran-5-carboxylate (160c) 
 
According to TP7, methyl coumalate (156, 72 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 15 min at –78 °C, using TMPZnCl·LiCl (92, 0.95 M in THF, 0.63 mL, 0.60 mmol, 1.20 equiv). 
The magnesium reagent was treated with CuCN·2LiCl (1.00 M solution in THF, 0.60 mL, 0.60 mmol, 
1.20 equiv) for 30 min at −78 °C. A subsequent allylation reaction was performed in the presence of 3-
bromocyclohex-1-ene (0.07 mL, 0.60 mmol, 1.20 equiv) at −78 °C. The reaction mixture was stirred at 
25 °C until completion of the reaction. The crude product was purified by flash-column chromatography 
(ihex/EtOAc = 7:3) furnishing the compound 160c as a white solid (82 mg, 0.35 mmol, 70%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.81 (d, J = 9.8 Hz, 1H), 6.17 (d, J = 9.8 Hz, 1H), 5.93 (ddt, 
J = 9.7, 4.6, 2.7 Hz, 1H), 5.56 (d, J = 12.4 Hz, 1H), 4.53 (ddt, J = 8.8, 5.9, 2.9 Hz, 1H), 3.87 (s, 3H), 
2.21–1.78 (m, 6H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 176.6, 164.5, 160.7, 144.1, 130.2, 124.8, 112.5, 108.4, 52.5, 
39.0, 27.4, 24.5, 21.5. 
MS (70 eV, EI) m/z (%): 234 (94), 230 (62), 225 (40), 217 (4), 215 (100), 209 (24), 202 (100), 174 
(72), 108 (52), 79 (76). 
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HRMS (ESI): m/z calc. for [C13H14O4]: 234.0892; found 234.0885 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2947, 1742, 1716, 1622, 1549, 1437, 1290, 1258, 1071, 909, 847, 
786. 
M.p. (°C): 90–92. 
Methyl 6-(cyclopropanecarbonyl)-2-oxo-2H-pyran-5-carboxylate (160d) 
 
According to TP7, methyl coumalate (156, 72 mg, 0.50 mmol) was completely metalated within 15 min 
at –78 °C, using TMPZnCl·LiCl (92, 0.95 M in THF, 0.63 mL, 0.60 mmol, 1.20 equiv). The zinc 
reagent was treated with CuCN·2LiCl (1.00 M solution in THF, 0.60 mL, 0.60 mmol, 1.20 equiv) for 
30 min at −78 °C. Acylation was achieved with cyclopropanecarbonyl chloride (0.05 mL, 0.60 mmol, 
1.20 equiv) at −78 °C and warming to −15 °C. The reaction mixture was stirred at 0 °C until completion 
of the reaction. The crude product was purified by flash-column chromatography (ihex/EtOAc = 7:3) 
furnishing the compound 160d as a yellow oil (44 mg, 0.20 mmol, 40%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.63 (d, J = 9.8 Hz, 1H), 6.43 (d, J = 9.7 Hz, 1H), 3.83 (s, 3H), 
2.45 (tt, J = 8.3, 4.5 Hz, 1H), 1.32 (p, J = 4.0 Hz, 2H), 1.19 (dq, J = 7.8, 3.8 Hz, 2H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 195.1, 164.0, 160.5, 158.5, 142.4, 117.2, 110.3, 53.1, 19.8, 
13.9. 
MS (70 eV, EI) m/z (%): 222 (2), 163 (6), 153 (100), 123 (10), 85 (68), 69 (98). 
HRMS (EI): m/z calc. for [C11H10O5]: 222.0528; found 222.0521 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2957, 1758, 1727, 1697, 1629, 1440, 1385, 1317, 1199, 1090, 
977, 770. 
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Methyl 6-(4-fluorobenzoyl)-2-oxo-2H-pyran-5-carboxylate (160e) 
 
According to TP7, methyl coumalate (156, 72 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 15 min at –78 °C, using TMPZnCl·LiCl (92, 0.95 M in THF, 0.63 mL, 0.60 mmol, 1.20 equiv). 
The zinc reagent was treated with CuCN·2LiCl (1.00 M solution in THF, 0.60 mL, 0.60 mmol, 
1.20 equiv) for 30 min at −78 °C. Acylation was achieved with 4-fluorobenzoyl chloride (54.0 mL, 
0.60 mmol, 1.20 equiv) at −78 °C and warming to −15 °C. The reaction mixture was stirred at 0 °C 
until completion of the reaction. The crude product was purified by flash-column chromatography 
(ihex/EtOAc = 7:3) furnishing the compound 160e as a yellow oil (77 mg, 0.28 mmol, 55%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.92–7.83 (m, 3H), 7.19 (t, J = 8.4 Hz, 2H), 6.42 (d, 
J = 10.2 Hz, 1H), 3.69–3.66 (m, 3H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 184.6, 166.8 (d, J = 258.3 Hz), 163.6, 162.8, 158.2, 142.3, 
132.3 (d, J = 9.8 Hz), 130.4, 116.6 (d, J = 22.4 Hz), 115.7, 109.5, 52.8. 
MS (70 eV, EI) m/z (%): 245 (20), 232 (34), 217 (100), 203 (16), 189 (16), 175 (24), 153 (16), 123 
(100), 85 (10). 
HRMS (EI): m/z [M + H+] calc. for [C14H10FO5]: 277.0507; found 277.0504 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2954, 1764, 1723, 1683, 1596, 1437, 1298, 1240, 1156, 1088, 
924, 833, 802, 783. 
Methyl 6-(3-chlorobenzoyl)-2-oxo-2H-pyran-5-carboxylate (160f) 
 
According to TP7, methyl coumalate (156, 72 mg, 0.50 mmol, 1.00 equiv) was completely metalated 
within 15 min at –78 °C, using TMPZnCl·LiCl (92, 0.95 M in THF, 0.63 mL, 0.60 mmol, 1.20 equiv). 
The zinc reagent was treated with CuCN·2LiCl (1.00 M solution in THF, 0.60 mL, 0.60 mmol, 
1.20 equiv) for 30 min at −78 °C. Acylation was achieved with 3-chlorobenzoyl chloride (0.08 mL, 
0.60 mmol, 1.20 equiv) at −78 °C and warming to −15 °C. The reaction mixture was stirred at 0 °C 
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until completion of the reaction. The crude product was purified by flash-column chromatography 
(ihex/EtOAc 7:3) furnishing the compound 160f as a yellow oil (93 mg, 0.32 mmol, 64%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.90 (dd, J = 7.8, 1.5 Hz, 1H), 7.81 (d, J = 9.8 Hz, 1H), 7.53 
(ddd, J = 8.1, 7.3, 1.7 Hz, 1H), 7.48–7.39 (m, 2H), 6.41 (d, J = 9.8 Hz, 1H), 3.69 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 184.6, 163.3, 163.1, 158.3, 142.7, 134.9, 134.3, 132.9, 132.4, 
131.5, 127.4, 115.8, 109.7, 52.9. 
MS (70 eV, EI) m/z (%): 292 (8), 250 (10), 203 (40), 153 (33), 140 (27), 139 (100), 111 (25), 85 (17), 
75 (17). 
HRMS (EI): m/z calc. for [C14H9ClO5]: 292.0139; found 292.0132 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2954, 1756, 1720, 1586, 1434, 1409, 1290, 1232, 1086, 1048, 
916, 832, 784, 768, 740. 
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3.5 Reaction of Zincated 3,5-Dibromo-2H-pyran-2-one with Electrophiles 
3,5-Dibromo-6-iodo-2H-pyran-2-one (163a) 
 
According to TP8, 3,5-dibromo-2H-pyran-2-one (157, 126 mg, 0.50 mmol, 1.00 equiv) was completely 
metalated within 1.5 h at −10 °C, using TMPZnCl·LiCl (92, 0.95 M in THF, 0.63 mL 0.60 mmol, 
1.20 equiv). Iodine (153 mg, 0.60 mmol, 1.20 equiv) was then added at −10°C. The reaction mixture 
was warmed to 25 °C and was stirred until completion of the reaction. The crude product was purified 
by flash-column chromatography (ihex/EtOAc = 9:1) furnishing the compound 163a as a yellow-brown 
(120 mg, 0.32 mmol, 64%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 8.03 (s, 1H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 157.1, 146.7, 118.1, 111.6, 111.1. 
MS (70 eV, EI) m/z (%): 379 (45), 338 (24), 255 (47), 253 (100), 251 (51), 227 (25), 224 (49), 223 
(26), 199 (26), 127 (12), 118 (20), 116 (21), 53 (6). 
HRMS (EI): m/z calc. for [C5HBr2IO2]: 377.7388; found 377.7382 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2921, 2853, 1715, 1574, 1486, 1207, 1055, 983, 902, 885, 733. 
M.p. (°C): 97–99. 
3,5-Dibromo-6-(2-chloropyridin-3-yl)-2H-pyran-2-one (163b) 
 
According to TP8, 3,5-dibromo-2H-pyran-2-one (157, 126 mg, 0.50 mmol, 1.00 equiv) was completely 
metalated within 1.5 h at −10 °C, using TMPZnCl·LiCl (92, 0.95 M in THF, 0.63 mL 0.60 mmol, 
1.20 equiv). The zinc reagent reacted in a Negishi cross-coupling reaction in the presence of Pd(dba)2 
(11 mg, 8 mol%), P(2-furyl)3 (9.0 mg, 15 mol%) and 2-chloro-3-iodopyridine (143 mg, 0.60 mmol, 
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1.20 equiv) at 25 °C for 12 h. The crude product was purified by flash-column chromatography 
(ihex/EtOAc = 7:3) furnishing the compound 163b as a yellow oil (107 mg, 0.30 mmol, 60%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 8.62 (dd, J = 4.8, 1.9 Hz, 1H), 8.26 (s, 1H), 8.16 (dd, 
J = 7.6, 1.9 Hz, 1H), 7.65 (dd, J = 7.6, 4.8 Hz, 1H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 157.2, 154.9, 153.0, 149.9, 148.4, 141.6, 128.7, 124.0, 
113.1, 101.6. 
MS (70 eV, EI) m/z (%): 365 (100), 363 (38), 339 (42), 337 (75), 335 (28), 286 (20), 232 (14), 229 
(78), 228 (58), 197 (13), 149 (14), 142 (17), 140 (60), 114 (17), 112 (40), 76 (21), 50 (11), 44 (18), 43 
(11). 
HRMS (EI): m/z calc. for [C10H4Br2ClNO2]: 362.8297; found 362.8296 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2922, 2853, 1737, 1716, 1602, 1492, 1409, 1248, 1177, 1055, 
1026, 913, 902, 845, 741, 733. 
3,5-Dibromo-6-(cyclohex-2-en-1-yl)-2H-pyran-2-one (163c) 
 
According to TP8, 3,5-dibromo-2H-pyran-2-one (157, 126 mg, 0.50 mmol, 1.00 equiv) was completely 
metalated within 1.5 h at −10 °C, using TMPZnCl·LiCl (92, 0.95 M in THF, 0.63 mL 0.60 mmol, 
1.20 equiv). The zinc reagent was treated with CuCN·2LiCl (1.00 M solution in THF, 0.60 mL, 
0.60 mmol, 1.20 equiv) for 30 min at −40 °C. A subsequent allylation reaction was performed in the 
presence of 3-bromocyclohex-1-ene (0.07 mL, 0.60 mmol, 1.20 equiv) at −40 °C. The reaction mixture 
was stirred at 25 °C until completion of the reaction. The crude product was purified by flash-column 
chromatography (ihex/EtOAc = 7:3) furnishing the compound 163c as a yellow oil (100 mg, 0.30 mmol, 
60%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 8.02 (s, 1H), 6.00–5.86 (m, 1H), 5.65–5.56 (m, 1H), 3.78 
(ddp, J = 8.5, 5.7, 2.6 Hz, 1H), 2.09 (ddd, J = 11.4, 5.7, 2.8 Hz, 2H), 1.99 (dtd, J = 11.3, 5.7, 2.7 Hz, 
1H), 1.90 (dtt, J = 12.1, 5.5, 2.2 Hz, 1H), 1.82–1.72 (m, 1H), 1.71–1.58 (m, 1H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 164.8, 157.9, 148.8, 131.0, 125.0, 109.9, 97.9, 40.5, 26.8, 
25.0, 21.8. 
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MS (70 eV, EI) m/z (%): 334 (38), 332 (20), 305 (12), 280 (16), 255 (11), 254 (57), 253 (57), 251 (12), 
224 (13), 197 (14), 146 (25), 117 (10), 81 (100), 80 (15), 79 (33), 77 (17), 53 (22), 51 (10), 41 (21). 
HRMS (EI): m/z calc. for [C11H10Br2O2]: 331.9048; found 331.9033 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2927, 2834, 1719, 1608, 1532, 1287, 1134, 1033, 986, 959, 902, 
867, 740, 716. 
3,5-Dibromo-6-(thiophene-2-carbonyl)-2H-pyran-2-one (163d) 
 
According to TP8, 3,5-dibromo-2H-pyran-2-one (157, 126 mg, 0.50 mmol, 1.00 equiv) was completely 
metalated within 1.5 h at −10 °C, using TMPZnCl·LiCl (92, 0.95 M in THF, 0.63 mL 0.60 mmol, 
1.20 equiv). The zinc reagent was treated with CuCN·2LiCl (1 M solution in THF, 0.60 mL, 0.60 mmol, 
1.20 equiv) for 30 min at −40 °C. Acylation was achieved with thiophene-2-carbonyl chloride 
(0.06 mL, 0.60 mmol, 1.20 equiv) at −40 °C and warming to −10 °C. The reaction mixture was stirred 
at −15 °C until completion of the reaction. The crude product was purified by flash-column 
chromatography (ihex/EtOAc = 7:3) furnishing the compound 163d as a yellow oil (100 mg, 
0.28 mmol, 55%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 8.25 (d, J = 1.0 Hz, 1H), 8.20–8.15 (m, 2H), 7.34 (ddd, 
J = 4.9, 3.9, 1.0 Hz, 1H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 177.6, 155.8, 152.2, 148.9, 141.5, 138.7, 138.3, 130.0, 
116.0, 100.7. 
MS (70 eV, EI) m/z (%): 364 (12), 285 (5), 283 (4), 112 (6), 111 (100), 83 (5). 
HRMS (EI): m/z calc. for [C9H8O3]: 361.8248; found 361.8240 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2922, 2858, 1731, 1638, 1510, 1409, 1354, 1289, 1240, 1062, 
1028, 933, 902, 823, 735. 
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6-Benzoyl-3,5-dibromo-2H-pyran-2-one (163e) 
 
According to TP8, 3,5-dibromo-2H-pyran-2-one (157, 126 mg, 0.50 mmol, 1.00 equiv) was completely 
metalated within 15 min at −10 °C, using TMPZnCl·LiCl (92, 0.95 M in THF, 0.63 mL 0.60 mmol, 
1.20 equiv). The zinc reagent was treated with CuCN·2LiCl (1.00 M solution in THF, 0.60 mL, 
0.60 mmol, 1.20 equiv) for 30 min at −40 °C. Acylation was achieved with benzoyl chloride (0.07 mL, 
0.60 mmol, 1.20 equiv) at −40 °C and warming to −10 °C. The reaction mixture was stirred at −10 °C 
until completion of the reaction. The crude product was purified by flash-column chromatography 
(ihex/EtOAc 7:3) furnishing the compound 163e as a yellow oil (94 mg, 0.26 mmol, 53%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 8.23 (s, 1H), 8.10–8.04 (m, 2H), 7.80–7.74 (m, 1H), 7.65–
7.59 (m, 2H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 186.5, 156.0, 153.0, 148.4, 135.8, 135.0, 130.9, 130.0, 
115.5, 100.1. 
MS (70 eV, EI) m/z (%): 359 (9), 355 (5), 106 (6), 105 (100), 77 (28), 50 (2). 
HRMS (EI): m/z calc. for [C12H6Br2O3]: 355.8684; found 355.8678 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2923, 1741, 1668, 1594, 1448, 1272, 1226, 1040, 949, 798, 725, 
681. 
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3.6 Further Functionalization of the 6-Substituted 2-Pyrones  
5-Iodo-6-(methylthio)-2H-pyran-2-one (165) 
 
According to TP9, 6-(methylthio)-2H-pyran-2-one (159c, 0.50 M in THF, 1.00 mL, 0.50 mmol, 
1.00 equiv) was completely metalated within 1 h at –40 °C, using TMPMgCl·LiCl (89, 1.10 M in THF, 
0.54 mL, 0.60 mmol, 1.20 equiv). Iodine (152 mg, 0.60 mmol, 1.20 equiv) was then added at –40 °C. 
The reaction mixture was warmed to 25 °C and was stirred until completion of the reaction. The crude 
product was purified by column chromatography (ihex/Et2O = 4:6) furnishing the compound 165 as a 
yellow oil (58 mg, 0.22 mmol, 43%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 8.01 (d, J = 7.4 Hz, 1H), 6.11 (d, J = 7.4 Hz, 1H), 2.56 (s, 
3H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 166.7, 158.9, 153.6, 104.3, 77.5, 14.0. 
MS (70 eV, EI) m/z (%): 267 (64), 39 (13), 220 (100), 192 (17), 85 (13), 55 (10), 44 (11), 43 (10). 
HRMS (EI): m/z calc. for [C6H5IO2S]: 267.9055; found 267.9063 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2927, 2868, 1708, 1590, 1492, 1325, 1237, 1107, 967, 744. 
3-Iodo-6-(4-methoxyphenyl)-2H-pyran-2-one (167a) 
 
According to TP9, 2-pyrone (159e, 0.50 M in THF, 1.00 mL, 0.50 mmol) was completely metalated 
within 1 h at –40 °C, using TMPMgCl·LiCl (89, 1.10 M in THF, 0.54 mL, 0.60 mmol, 1.20 equiv). 
Iodide (152 mg, 0.60 mmol, 1.20 equiv) was then added at –40 °C. The reaction mixture was warmed 
to 25 °C and was stirred until completion of the reaction. The crude product was purified by column 
chromatography (ihex/Et2O = 4:6) furnishing the compound 167a as a yellow-orange oil (157 mg, 
0.48 mmol, 95%). 
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1H NMR (400 MHz, (CD3)2CO): δ / ppm = 8.19 (d, J = 7.4 Hz, 1H), 7.89–7.84 (m, 2H), 7.10–7.05 
(m, 2H), 6.68 (d, J = 7.4 Hz, 1H), 3.89 (s, 3H).  
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 163.2, 162.4, 159.0, 154.3, 128.2, 124.3, 115.4, 102.2, 
81.4, 55.9. 
MS (70 eV, EI) m/z (%):327 (61), 299 (21), 201 (10), 146 (11), 145 (100), 135 (19), 130 (10), 102 (23), 
92 (10), 77 (11), 76 (8), 63 (9). 
HRMS (EI): m/z calc. for [C12H9IO3]: 327.9600; found 327.9585 (M+). 
IR (Diamond-ATR, neat): ν ̃ / cm-1 = 2924, 1708, 1598, 1504, 1458, 1257, 1176, 1107, 1024, 837. 
3-(Hydroxy(phenyl)methyl)-6-(4-methoxyphenyl)-2H-pyran-2-one (167b) 
 
According to TP9, 2-pyrone (159e, 0.25 M in THF, 1.00 mL, 0.25 mmol) was completely metalated 
within 1 h at –40 °C, using TMPMgCl·LiCl (89, 1.10 M in THF, 0.27 mL, 0.30 mmol, 1.20 equiv). 
Benzaldehyde (0.03 mL, 0.30 mmol, 1.20 equiv) was then added at –40 °C. The reaction mixture was 
warmed to 25 °C and was stirred until completion of the reaction. The crude product was purified by 
column chromatography (ihex/EtOAc = 8:2) furnishing the compound 167b as a yellow oil (34 mg, 
0.11 mmol, 45%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.71–7.64 (m, 2H), 7.39 (d, J = 7.3 Hz, 2H), 7.34–7.29 (m, 
2H), 7.25 (dd, J = 8.3, 6.1 Hz, 1H), 7.20–7.14 (m, 1H), 6.88 (d, J = 9.0 Hz, 2H), 6.47 (d, J = 7.1 Hz, 
1H), 5.74 (s, 1H), 3.79 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ / ppm = δ = 162.6, 161.9, 160.1, 140.8, 140.0, 128.7, 128.2, 127.4, 
127.4, 126.8, 123.7, 114.5, 100.0, 72.1, 55.6. 
MS (70 eV, EI) m/z (%): 308 (100), 292 (15), 291 (11), 279 (18), 264 (15), 263 (39), 262 (24), 231 
(30), 204 (10), 203 (71), 202 (11), 145 (13), 135 (66), 107 (10), 105 (30), 79 (14). 
HRMS (EI): m/z calc. for [C19H16O4]: 308.1049; found 308.1043 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2838, 1697, 1694, 1605, 1554, 1510, 1257, 1175, 1026, 806, 700. 
C. EXPERIMENTAL PART    125 
 
 
 
3.7 Reaction of Zincated 4-Pyrone with Electrophiles 
2-(4-Chlorophenyl)-4H-pyran-4-one (169a) 
 
According to TP10, 4H-pyran-4-one (155, 0.50 M in THF, 1.00 mL, 0.50 mmol, 1.00 equiv) was 
completely metalated within 2 h at −35 °C, using TMP2Zn·2MgCl2·2LiCl (93, 0.55 M in THF, 0.55 mL, 
0.30 mmol, 0.60 equiv). The zinc reagent reacted in a Negishi cross-coupling reaction in the presence 
of Pd(dba)2 (11 mg, 8 mol%), P(2-furyl)3 (9.0 mg, 15 mol%) and 1-chloro-4-iodobenzene (114 mg, 
0.60 mmol, 1.20 equiv) at 25 °C for 12 h. The crude product was purified by flash-column 
chromatography (ihex/EtOAc = 7:3) furnishing the compound 169a as a yellow solid (52 mg, 
0.25 mmol, 50%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = δ = 8.11 (d, J = 6.1 Hz, 1H), 7.96–7.88 (m, 2H), 7.61–7.54 
(m, 2H), 6.81 (d, J = 2.4 Hz, 1H), 6.29 (dd, J = 5.9, 2.4 Hz, 1H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 178.4, 163.0, 156.4, 137.6, 131.2, 130.1, 128.3, 117.5, 
113.1. 
MS (70 eV, EI) m/z (%):206 (97), 205 (68), 138 (33), 101 (14), 89 (8). 
HRMS (EI): m/z calc. for [C11H7ClO2]: 206.0135; found 206.0123 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2914, 1649, 1539, 1424, 1363, 1201, 1092, 1055, 1029, 836, 798, 
720. 
M.p. (°C): 124–126. 
2-(Pyridin-3-yl)-4H-pyran-4-one (169b) 
 
According to TP10, 4H-pyran-4-one (155, 0.50 M in THF, 1.00 mL 0.50 mmol, 1.00 equiv) was 
completely metalated within 2 h at −35 °C, using TMP2Zn·2MgCl2·2LiCl (93, 0.55 M in THF, 0.55 mL, 
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0.30 mmol, 0.60 equiv). The zinc reagent underwent a Negishi cross-coupling reaction in the presence 
of Pd(dba)2 (11 mg, 8 mol%), P(2-furyl)3 (9.0 mg, 15 mol%) and 3-iodopyridine (60 mg, 0.60 mmol, 
1.20 equiv) at 25 °C for 12 h. The crude product was purified by flash-column chromatography 
(ihex/EtOAc = 7:3) furnishing the compound 169b as a brown solid (74 mg, 0.43 mmol, 86%). 
1H NMR (400 MHz, (CD3)2CO): δ / ppm = 9.09 (dd, J = 2.4, 0.9 Hz, 1H), 8.74 (dd, J = 4.8, 1.6 Hz, 
1H), 8.26 (ddd, J = 8.1, 2.4, 1.6 Hz, 1H), 8.15 (dd, J = 5.9, 0.3 Hz, 1H), 7.56 (ddd, J = 8.1, 4.8, 0.9 Hz, 
1H), 6.89 (d, J = 2.5 Hz, 1H), 6.32 (dd, J = 5.9, 2.4 Hz, 1H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 178.3, 162.2, 156.6, 152.8, 147.9, 134.0, 128.4, 124.6, 
117.7, 113.8. 
MS (70 eV, EI) m/z (%):173 (100), 174 (12), 145 (59), 116 (10), 106 (14), 103 (35), 78 (11), 76 (15), 
51 (7), 50 (11). 
HRMS (EI): m/z calc. for [C10H7NO2]: 173.0477; found 173.0476 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2924, 1647, 1425, 1368, 1251, 1200, 1125, 1058, 1012, 932, 831, 
703. 
M.p. (°C): 115–116. 
2-(Thiophene-2-carbonyl)-4H-pyran-4-one (169c) 
 
According to TP10, 4H-pyran-4-one (155, 0.50 M in THF, 1.00 mL, 0.50 mmol, 1.00 equiv) was 
completely metalated within 2 h at −35 °C, using TMP2Zn·2MgCl2·2LiCl (93, 0.55 M in THF, 0.55 mL, 
0.30 mmol, 0.60 equiv). The zinc reagent was treated with CuCN·2LiCl (1.00 M solution in THF, 
0.60 mL, 0.60 mmol, 1.20 equiv) for 30 min at −35 °C. Acylation was achieved with thiophene-2-
carbonyl chloride (0.06 mL, 0.60 mmol, 1.20 equiv) at −35 °C and warming to −5 °C. The reaction 
mixture was stirred at −5 °C until completion of the reaction. The crude product was purified by flash-
column chromatography. The crude product was purified by flash-column chromatography 
(ihex/EtOAc = 7:3) furnishing the compound 169c as a yellow-orange solid (73 mg, 0.35 mmol, 71%). 
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1H NMR (400 MHz, (CD3)2CO): δ / ppm = 8.28 (dd, J = 3.9, 1.1 Hz, 1H), 8.24 (dd, J = 5.9, 0.3 Hz, 
1H), 8.14 (dd, J = 5.0, 1.1 Hz, 1H), 7.34 (dd, J = 5.0, 3.9 Hz, 1H), 6.89 (dd, J = 2.6, 0.3 Hz, 1H), 6.46 
(dd, J = 5.9, 2.6 Hz, 1H). 
13C NMR (101 MHz, (CD3)2CO): δ / ppm = 178.2, 178.2, 159.7, 156.5, 141.2, 138.1, 137.4, 129.9, 
119.0, 118.7. 
MS (70 eV, EI) m/z (%): 206 (31), 178 (22), 110 (100), 82 (7). 
HRMS (EI): m/z calc. for [C10H6O3S]: 206.0038; found 206.0037 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3077, 1634, 1409, 1376, 1352, 1279, 1201, 1109, 1057, 940, 833, 
798, 720. 
M.p. (°C): 128–131. 
2-(Cyclopropanecarbonyl)-4H-pyran-4-one (169d) 
 
According to TP10, 4H-pyran-4-one (155, 0.50 M in THF, 1.00 mL, 0.50 mmol, 1.00 equiv) was 
completely metalated within 2 h at −35 °C, using TMP2Zn·2MgCl2·2LiCl (93, 0.55 M in THF, 0.54 mL, 
0.30 mmol, 0.60 equiv). The zinc reagent was treated with CuCN·2LiCl (1.00 M solution in THF, 
0.60 mL, 0.60 mmol, 1.20 equiv) for 30 min at −35 °C. Acylation was achieved with 
cyclopropanecarbonyl chloride (0.05 µL, 0.60 mmol, 1.20 equiv) at −35 °C and warming to −5 °C. The 
reaction mixture was stirred at −5 °C until completion of the reaction. The crude product was purified 
by flash-column chromatography. The crude product was purified by flash-column chromatography 
(ihex/EtOAc = 7:3) furnishing the title compound 169d as a yellow-brown solid (41 mg, 0.25 mmol, 
50%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.84 (d, J = 5.8 Hz, 1H), 6.98 (d, J = 2.6 Hz, 1H), 6.44 (dd, 
J = 5.8, 2.6 Hz, 1H), 2.66 (ddd, J = 12.4, 7.8, 4.5 Hz, 1H), 1.32–1.26 (m, 2H), 1.16 (dq, J = 7.6, 4.2, 
3.7 Hz, 2H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 194.1, 179.0, 157.9, 154.9, 118.8, 116.8, 17.0, 13.8. 
MS (70 eV, EI) m/z (%): 164 (53), 123 (8), 69 (100), 41 (27). 
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HRMS (EI): m/z calc. for [C9H8O3]: 164.0473; found 164.0465 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3078, 1648, 1410, 1367, 1244, 1197, 1178, 1103, 1056, 997, 834, 
720. 
M.p. (°C): 75–77. 
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4 Aryl and Heteroaryl Magnesium Reagents in Toluene by Br/Mg- or 
Cl/Mg-Exchange 
4.1 Screening of Magnesium Exchange Reagent 
Table 15: Variation of the Alkoxide Residue.  
 
Entry R1 Yield (%)[a] 
1 CH(Bu)2 0 
2 C(CH3)(Et)(iPr) 83 
3 CH(Me)Hex 99 
4 CH2CH(Et)Bu 99[b] 
[a] Yield of 174a determined by GC-analysis of water quenched reaction aliquots. [b] 2-Ethylhexanol was used 
instead of 2-octanol because it is commercially available. 
 
Table 16: Variation of the Alkyl Residue. 
 
Entry R1 Yield (%)[a] 
1 nBu 35 
2 sBu 99 
3 tBu 49 
[a] Yield of 174a determined by GC-analysis of water quenched reaction aliquots. 
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Table 17: Bromine-magnesium exchange for 4-bromoanisole (174a) using various magnesium-exchange 
reagents. 
 
Entry Mg-exchange reagent Equiv Solvent Yield(%)[a] 
1 iPrMgCl·LiCl (36) 1.20 THF 1 [0][b] 
2 sBu2Mg·2LiCl (81) 0.60 THF 13 [0][b] 
3 nBu3MgLi 0.40 THF 99 [0][b],[d] 
4 sBuMgOR·LiOR (170a) 1.20 toluene 85 
5 sBuMgOR·LiOR (170a) 1.20 toluene 99[c],[e] 
6 sBuMgOR·LiOR (170a) 1.20 THF 14[c] 
[a] Yield of 174a determined by GC-analysis of water quenched reaction aliquots. [b] Yield obtained in toluene. 
[c] Yield obtained in the presence of TMEDA (1.20 equiv). [d] Decomposition was observed by reaction with 
various electrophiles. [e] The reactions were also performed in hexane, cyclohexane or cyclopentyl methyl ether 
(CPME) with the same yield. 
Table 18: Chlorine-magnesium exchange on aryl chloride 179a using various magnesium-exchange 
reagents. 
 
Entry Mg-exchange reagent Equiv Additive Yield (%)[a] 
1 iPrMgCl·LiCl (36) 1.20 PMDTA 0 [0][b] 
2 sBu2Mg·2LiCl (81) 0.60 PMDTA 0 [0][b] 
3 nBu3MgLi 0.40 PMDTA decomposition 
4 sBuMgOR·LiOR (170a) 1.20 PMDTA 0 [0][b] 
5 sBu2Mg·2LiOR (170b) 0.60 - 48 
6 sBu2Mg·2LiOR (170b) 0.60 TMEDA 59 
7 sBu2Mg·2LiOR(170b) 0.60 PMDTA 73 [20][c] 
[a] Yield of 180a determined by GC-analysis of water quenched reaction aliquots. [b] Yield obtained in the 
presence of TMEDA. [c] Yield obtained in THF. 
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Lithium tributylmagnesiate is not suitable for a chlorine-magnesium exchange (entry 3). 
sBu2Mg·2LiOR (170b) is certainly the most powerful exchange reagent to date for performing bromine-
magnesium exchanges and is also able to trigger a chlorine-magnesium exchange. sBuMgOR·LiOR 
(170a) gave no exchange with aryl chlorides. It was possible to replace sBuMgOR·LiOR (170a) by 
sBu2Mg·2LiOR (170b) in the case of 4-bromoanisole. However, the reaction conditions were not 
improved. In case of halogenated heterocycles, we observed more decomposition by using 
sBu2Mg·2LiOR (170b) instead of sBuMgOR·LiOR (170a), due to the too high reactivity of the reagent. 
Thus, the use of sBuMgOR·LiOR (170a) compared to sBu2Mg 2LiOR (170b) is beneficial in the 
performance of bromine-magnesium exchanges, since the aryl- and heteroarylmagnesium alkoxides are 
more stable in toluene. Furthermore, the storage of sBuMgOR·LiOR (170a) over several weeks is 
possible. 
4.2 Preparation of sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a): 
Method A: 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with nBu2Mg (0.66 M in hexane, 15.0 mL, 9.9 mmol) and the reaction mixture was cooled to 0 °C. 
Then, 2-ethylhexanol (3.10 mL, 20 mmol) was added dropwise. After 24 h a gelatinous compound was 
obtained.111 To the reaction mixture sBuLi (1.21 M in hexane, 8.18 mL, 9.9 mmol) was added dropwise. 
After the addition was complete, the reaction mixture was allowed to warm to room temperature for 
2 h. The solvents were removed under vaccum affording a lightly yellow foam. Freshly distilled toluene 
(9 mL) was added under vigourous stirring at 0 °C. The freshly prepared 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu was titrated prior to use at 0 °C by iodometric titration. The 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu concentration of the resulting clear solution was 1.00–
1.50 M. 
 
Method B: 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with Mg[OCH2CH(Et)Bu]2112 (0.85 M in heptane, 15.0 mL, 13 mmol) and was cooled to 0 °C. Then, 
sBuLi (1.21 M in hexane, 10.6 mL, 13 mmol) was added dropwise. After the addition was complete, the 
reaction mixture was allowed to warm to room temperature for 2 h. The solvents were removed under 
vaccum affording a lightly yellow foam. Freshly distilled toluene (9 mL) was added under vigourous 
stirring at 0 °C. The prepared sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu was titrated prior to use at 
0 °C by iodometric titration. The sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu concentration of the 
resulting clear solution was 1.00–1.50 M. 
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4.3 Preparation of sBu2Mg·2LiOCH2CH(Et)Bu (170b): 
Method A: 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with nBu2Mg (0.66 M in hexane, 15.0 mL, 9.9 mmol) and the reaction mixture was cooled to 0 °C. 
Then, 2-ethylhexanol (3.10 mL, 20 mmol) was added dropwise. After 24 h a gelatinous compound was 
obtained. To the reaction mixture sBuLi (1.21 M in hexane, 16.4 mL, 20 mmol) was added dropwise. 
After the addition was complete, the reaction mixture was allowed to warm to room temperature for 
2 h. The solvents were removed under vaccum affording a lightly yellow foam. Freshly distilled toluene 
(9 mL) was added under vigourous stirring at 0 °C. The prepared sBu2Mg·2LiOCH2CH(Et)Bu was 
titrated prior to use at 0 °C by iodometric titration. The sBu2Mg·2LiOCH2CH(Et)Bu concentration of 
the resulting clear solution was 0.60–0.85 M. 
 
Method B: 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with Mg[OCH2CH(Et)Bu]2 (0.85 M in heptane, 15.0 mL, 13 mmol) and was cooled to 0 °C. Then, 
sBuLi (1.21 M in hexane, 21.2 mL, 26 mmol) was added dropwise. After the addition was complete, the 
reaction mixture was allowed to warm to room temperature for 2 h. The solvents were removed under 
vaccum affording a lightly yellow foam. Freshly distilled toluene (9 mL) was added under vigourous 
stirring at 0 °C. The freshly prepared sBu2Mg·2LiOCH2CH(Et)Bu was titrated prior to use at 0 °C by 
iodometric titration. The sBu2Mg·2LiOCH2CH(Et)Bu concentration of the resulting clear solution was 
0.60–0.85 M. 
 
4.4 Titration Using Iodine128 
A dry flask was charged with accurately weighed I2 (0.25 mmol), fitted with a rubber septum, and 
flushed with argon. THF (3–5 mL) was added and stirring was started. After the iodine was completely 
dissolved, the resulting brown solution was cooled to 0 °C in an ice bath and the organomagnesium 
reagent was added dropwise via a 1.00 mL syringe (0.01 mL graduations) until the brown color 
disappeared. The amount consumed contains 1.00 equiv of the organometallic reagent relative to iodine 
in the case of monoorganometallic reagents and 0.50 equiv for diorganometallic reagents. 
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4.5 Typical Procedures 
Typical Procedure for the Preparation of Arylmagnesium Alkoxides via a Bromine-Magnesium 
Exchange using 170a (TP11): 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with the corresponding aryl bromide (1.00 equiv) in dry toluene (0.50–1.0 M solution) and TMEDA 
(1.20 equiv) was added. The resulting solution was stirred at indicated temperature and 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.20 equiv) was added dropwise. The completion of 
the bromine-magnesium exchange was checked by GC-analysis of reaction aliquots quenched with 
water, using tetradecane as internal standard. Subsequent reactions with electrophiles were carried out 
under the indicated conditions. After complete conversion, the mixture was quenched with sat. aq. 
NH4Cl solution or aq. NaHCO3 and extracted with EtOAc (3 × 20 mL). The combined organic extracts 
were dried over Na2SO4, filtered and concentrated. 
Typical Procedure for the Preparation of Arylmagnesium Alkoxides via a Chlorine-Magnesium 
Exchange using 170b (TP12): 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with the corresponding aryl chloride (1.00 equiv) in dry toluene (0.50–1.0 M solution) and TMEDA 
(1.20 equiv) was added. The resulting solution was stirred at 25 °C and sBuMg2·LiOCH2CH(Et)Bu 
(170b, 1.20 equiv) was added dropwise. The completion of the chlorine-magnesium- exchange was 
checked by GC-analysis of reaction aliquots quenched with water, using tetradecane as internal 
standard. Subsequent reactions with electrophiles were carried out under the indicated conditions. After 
complete conversion, the mixture was quenched with sat. aq. NH4Cl solution or aq. NaHCO3 and 
extracted with EtOAc (3 × 20 mL). The combined organic extracts were dried over Na2SO4, filtered 
and concentrated.  
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4.6 Aryl Magnesium Reagents in Toluene by Br/Mg-Exchange 
4-Iodoanisole (175a) 
 
According to TP11, to a mixture of 4-bromoanisole (173a, 0.06 mL, 0.50 mmol, 1.00 equiv), TMEDA 
(0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at 25 °C. After 15 min, iodine (152 mg, 0.60 mmol, 1.20 equiv, in 1.00 mL THF) was added and the 
reaction mixture was stirred for 1 h at 25 °C. Purification of the crude product by flash column 
chromatography (ihex/EtOAc = 9:1) afforded title compound 175a as a white solid (81 mg, 0.35 mmol, 
70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.63–7.49 (d, 2H), 6.76–6.61 (d, 2H), 3.78 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 159.6, 138.3, 116.5, 82.8, 55.5. 
MS (EI, 70 eV): m/z (%) = 234 (100), 191 (15), 154 (11), 126 (10), 92 (64), 77 (41), 76 (11), 74 (14), 
64 (23), 62 (23), 61 (10), 48 (19). 
HRMS (EI): m/z calc. for [C7H7IO]: 233.9542; found: 233.9540 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2966, 2837, 1586, 1486, 1287, 1248, 1175, 1028, 833, 813. 
M.p. (°C): 52–55. 
3-(4-Methoxyphenyl)pentan-3-ol (175b) 
 
According to TP11, to a mixture of 4-bromoanisole (173a, 0.06 mL, 0.50 mmol, 1.00 equiv), TMEDA 
(0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at 25 °C. After 15 min, 3-pentanone (0.06 mL, 0.60 mmol, 1.20 equiv) was added and the reaction 
mixture was stirred for 2 h at 25 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 175b as a light yellow oil (78 mg, 0.40 mmol, 80%). 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 7.32–7.24 (d, 2H), 6.87 (d, J = 8.7 Hz, 2H), 3.81 (s, 3H), 
1.92–1.72 (m, 4H), 0.76 (t, J = 7.4 Hz, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.2, 138.0, 127.3, 126.8, 113.4, 55.3, 35.0, 8.0. 
MS (EI, 70 eV): m/z (%) = 194 (2), 176 (11), 165 (100), 57 (19). 
HRMS (EI): m/z calc. for [C12H18O2]: 194.1307; found: 194.1282 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2972, 2837, 1677, 1601, 1510, 1462, 1245, 1174, 1031, 828. 
(4-Chlorophenyl)(cyclopropyl)(4-methoxyphenyl)methanol (175c) 
 
According to TP11, to a mixture of 4-bromoanisole (173a, 0.06 mL, 0.50 mmol, 1.00 equiv), TMEDA 
(0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at 25 °C. After 15 min, (4-chlorophenyl)(cyclopropyl) methanone (0.12 mL, 0.60 mmol, 1.20 equiv) 
was added and the reaction mixture was stirred for 2 h at 25 °C. Purification of the crude product by 
flash column chromatography (ihex/EtOAc = 9:1) afforded the title compound 175c as a light yellow 
oil (124 mg, 0.43 mmol, 86%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.37–7.31 (m, 4H), 7.28–7.23 (m, 2H), 6.86–6.80 (m, 2H), 
3.78 (s, 3H), 1.82 (s, OH), 1.54 (m, J = 8.3, 5.5, 1H), 0.62 (m, J = 8.0, 5.0, 3.0, 1H), 0.55–0.39 (m, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.9, 146.2, 139.2, 132.8, 128.3, 128.1, 113.5, 76.6, 55.4, 
21.8, 2.3, 1.6. 
MS (EI, 70 eV): m/z (%) = 281 (38), 225 (98), 209 (32), 207 (100), 149 (32), 128 (22), 117 (20), 115 
(24), 104 (19), 91 (68), 81 (18), 79 (23), 78 (87), 77 (29), 43 (35). 
HRMS (EI): m/z calc. for [C17H17ClO2]: 288.0917; found: 288.0909 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 1608, 1508, 1246, 1174, 1090, 1034, 1014, 984, 880, 818. 
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(3-Methoxyphenyl)(phenyl)methanol (175d) 
 
According to TP11, to a mixture of 3-bromoanisole (173b, 0.06 mL, 0.50 mmol, 1.00 equiv), TMEDA 
(0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at 25 °C. After 15 min, benzaldehyde (0.06 mL, 0.60 mmol, 1.20 equiv) was added and the reaction 
mixture was stirred for 1 h at 25 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 175d as a light yellow oil (104 mg, 0.48 mmol, 95%). 
1H-NMR (599 MHz, CDCl3): δ / ppm = 7.37–7.30 (m, 4H), 7.27–7.21 (m, 2H), 6.97–6.88 (m, 2H), 
6.80 (dd, J = 8.2, 2.6 Hz, 1H), 5.71 (s, 1H), 3.74 (s, 3H), 2.82 (s, OH). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 159.7, 145.6, 143.8, 129.5, 128.5, 127.5, 126.6, 119.0, 112.9, 
112.1, 76.0, 55.2. 
MS (EI, 70 eV): m/z (%) = 214 (81), 152 (12), 135 (47), 107 (19), 105 (90), 94 (13), 92 (12), 79 (31), 
78 (20), 77 (100), 65 (15), 51 (18). 
HRMS (EI): m/z calc. for [C14H14O2]: 214.0994; found: 214.0987 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2835, 1598, 1488, 1453, 1435, 1258, 1149, 1036, 784, 702.  
1-(3,5-Dimethoxyphenyl)ethan-1-on (175e) 
 
According to TP11, to a mixture of 1-bromo-3,5-dimethoxybenzene (173c, 109 mg, 0.50 mmol, 
1.00 equiv), TMEDA (0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at 25 °C. After 15 min, N-methoxy-N-methylacetamide (0.06 mL, 0.60 mmol, 1.20 equiv) was added 
and the reaction mixture was stirred for 1 h at 25 °C. Purification of the crude product by flash column 
chromatography (ihex/EtOAc = 9:1) afforded the title compound 175e as a light yellow oil (80 mg, 
0.44 mmol, 89%). 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 7.07 (s, 2H), 6.64 (s, 1H), 3.82 (s, 6H), 2.56 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 197.8, 161.0, 139.2, 106.3, 105.4, 55.7, 26.8. 
MS (EI, 70 eV): m/z (%) = 180 (74), 165 (100), 137 (25), 122 (31), 77 (12), 63 (10), 24 (24). 
HRMS (EI): m/z calc. for [C10H12O2]: 180.0786; found: 180.0780 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2938, 1680, 1590, 1356, 1297, 1203, 1152, 1065, 1043, 842, 681. 
N,N-Dimethyl-2-(methylthio)aniline (175f) 
 
According to TP11, to a mixture of 2-bromo-N,N-dimethylaniline (173d, 109 mg, 0.50 mmol, 
1.00 equiv), TMEDA (0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at 25 °C. After 15 min, S-methyl methanesulfonothioate (0.05 mL, 0.60 mmol, 1.20 equiv) was added 
and the reaction mixture was stirred for 1 h at 25 °C. Purification of the crude product by flash column 
chromatography (ihex/EtOAc = 9:1) afforded the title compound 175f as a light orange oil (70 mg, 
0.42 mmol, 84%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.21–7.15 (m, 1H), 6.69–6.64 (m, 2H), 6.58–6.54 (m, 1H), 
2.96 (s, 6H), 2.50 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 150.9, 139.1, 129.5, 114.9, 111.0, 109.9, 40.6, 16.1. 
MS (EI, 70 eV): m/z (%) = 167 (100), 166 (71), 152 (10), 151 (18), 134 (13), 43 (73). 
HRMS (EI): m/z calc. for [C9H13NS]: 167.0769; found: 167.0759 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2917, 2799, 1584, 1561, 1490, 1346, 1104, 988, 955, 759, 685. 
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(4-(Dimethylamino)phenyl)(phenyl)methanone (175g) 
 
According to TP11, to a mixture of 2-bromo-N,N-dimethylaniline (173e, 109 mg, 0.50 mmol, 
1.00 equiv), TMEDA (0.06 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol 1.20 equiv) 
at 25 °C. After 4 h, N-methoxy-N-methylacetamide (0.06 mL, 0.60 mmol, 1.20 equiv) was added and 
the reaction mixture was stirred for 2 h at 25 °C. Purification of the crude product by flash column 
chromatography (ihex/EtOAc = 9:1) afforded the title compound 175g as a light orange oil (74 mg, 
0.33 mmol, 65%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.43 (m, J = 7.7, 1.5, 0.8 Hz, 2H), 7.37–7.22 (m, 5H), 7.13 
(m, J = 8.3, 6.7, 1.8 Hz, 1H), 7.07 (m, J = 7.7, 1.5, 0.8 Hz, 1H), 2.60 (s, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 195.2, 153.4, 139.4, 132.8, 131.2, 129.5, 128.1, 124.9, 110.7, 
40.2. 
MS (EI, 70 eV): m/z (%) = 225 (65), 224 (13), 148 (199), 134 (21), 105 (15), 77 (37). 
HRMS (EI): m/z calc. for [C15H15NO]: 225.1154; found: 225.1131 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2945, 2830, 1595, 1485, 1453, 1149, 1033, 1016, 934, 771, 761, 
699. 
Dicyclopropyl(3-(dimethylamino)phenyl)methanol (175h) 
 
According to TP11, to a mixture of 3-bromo-N,N-dimethylaniline (173f, 365 mg, 1.0 mmol, 
1.00 equiv), TMEDA (0.18 mL, 1.2 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 1.20 mL, 1.2 mmol 1.20 equiv) at 
25 °C. After 1.5 h, dicyclopropyl ketone (0.14 mL, 1.2 mmol, 1.20 equiv) was added and the reaction 
mixture was stirred for 2 h at 25 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 175h as a colorless oil (185 mg, 0.80 mmol, 80%). 
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1H-NMR (400 MHz, C6D6): δ / ppm = 7.25 (t, J = 7.9 Hz, 1H), 7.17 (s, 1H), 7.07 (dt, J = 7.7, 1.2 Hz, 
1H), 6.57 (ddd, J = 8.2, 2.6, 0.8 Hz, 1H), 2.63 (s, 6H), 1.10 (tt, J = 8.4, 5.5 Hz, 2H), 0.63 (m, J = 9.5, 
5.5, 4.0 Hz, 2H), 0.50 (m, J = 9.5, 5.6, 4.0 Hz, 2H), 0.40–0.32 (m, 2H), 0.24–0.17 (m, 2H). 
13C-NMR (101 MHz, C6D6): δ / ppm = 150.8, 148.9, 128.7, 115.1, 111.6, 111.0, 73.5, 40.6, 21.5, 2.3, 
0.6. 
MS (EI, 70 eV): m/z (%) = 231 (48), 213 (32), 184 (32), 182 (28), 170 (34), 168 (34), 167 (49), 165 
(62), 154 (26), 153 (52), 152 (57), 144 (30), 128 (74), 115 (100), 91 (29), 69 (34). 
HRMS (EI): m/z calc. for [C15H21NO]: 231.1623; found: 231.1617 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3004, 2800, 1601, 1578, 1495, 1432, 1347, 1154, 994, 774, 699. 
N-(Phenyl(4-(trimethylsilyl)phenyl)methyl)aniline (175i) 
 
According to TP11, to a mixture of (4-bromophenyl)trimethylsilane (173g, 0.09 mL, 1.0 mmol, 
1.00 equiv), TMEDA (0.18 mL, 1.2 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 1.20 mL, 1.2 mmol, 1.20 equiv) 
at 25 °C. After 15 min, N-benzylideneaniline (217 mg, 1.2 mmol, 1.20 equiv) was added and the 
reaction mixture was stirred for 2 h at 25 °C. Purification of the crude product by flash column 
chromatography (ihex/EtOAc/Et3N = 10:0.05:0.05) afforded the title compound 175i as a colorless oil 
(285 mg, 0.86 mmol, 86%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.39 (d, J = 8.0 Hz, 2H), 7.26 (dt, J = 15.9, 7.6 Hz, 6H), 7.19–
7.15 (m, 1H), 7.06–7.01 (m, 2H), 6.64–6.58 (m, 1H), 6.49–6.43 (m, 2H), 5.40 (s, 1H), 0.16 (s, 9H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 147.5, 143.6, 143.0, 139.6, 133.9, 129.3, 128.9, 127.5, 127.5, 
126.9, 117.8, 113.6, 63.2, −1.0. 
MS (EI, 70 eV): m/z (%) = 331 (4), 240 (15), 239 (100), 211 (10), 165 (27), 135 (11), 73 (15). 
HRMS (EI): m/z calc. for [C22H25NSi]: 331.1756; found: 331.1752 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3410, 2953, 1599, 1500, 1425, 1312, 1246, 1107, 832, 746, 689, 
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1-(3-(Trimethylsilyl)phenyl)cyclohexan-1-ol (175j) 
 
According to TP11, to a mixture of (3-bromophenyl)trimethylsilane (173h, 0.09 mL, 1.0 mmol, 
1.00 equiv), TMEDA (0.18 mL, 1.2 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 1.20 mL, 1.2 mmol, 1.20 equiv) 
at 25 °C. After 15 min, cyclohexanone (0.12 mL, 1.2 mmol, 1.20 equiv) was added and the reaction 
mixture was stirred for 2 h at 25 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 175j as a colorless oil (186 mg, 0.75 mmol, 75%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.71 (s, 1H), 7.51 (dt, J = 7.7, 1.6 Hz, 1H), 7.44 (d, J = 7.2 Hz, 
1H), 7.36 (t, J = 7.5 Hz, 1H), 1.92–1.75 (m, 7H), 1.70–1.64 (m, 3H), 0.30 (s, 9H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 148.6, 140.4, 131.9, 129.3, 127.7, 125.3, 73.4, 39.0, 25.6, 
22.3, −0.9. 
MS (EI, 70 eV): m/z (%) = 230 (50), 216 (13), 215 (100), 157 (29), 156 (27), 129 (10), 128 (14), 75 
(32), 73 (17). 
HRMS (EI): m/z calc. for [C15H24OSi]: 248.1596; found: 248.1590 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2936, 2856, 2247, 1448, 1248, 1121, 969, 906, 836, 729. 
1-(3,4-Dichlorophenyl)-2-methyl-1-phenylpropan-1-ol (175k) 
 
According to TP11, to a mixture of 4-bromo-1,2-dichlorobenzene (173i, 0.06 mL, 0.50 mmol, 
1.00 equiv), TMEDA (0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at 25 °C. After 15 min, 2-methyl-1-phenylpropan-1-one (0.09 mL, 0.60 mmol, 1.20 equiv) was added 
and the reaction mixture was stirred for 2 h at 25 °C. Purification of the crude product by flash column 
chromatography (ihex/EtOAc = 9:1) afforded the title compound 175k as a white solid (106 mg, 
0.36 mmol, 72%). 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 7.63 (d, J = 2.1 Hz, 1H), 7.47 (dt, J = 8.4, 1.8 Hz, 2H), 7.31 
(m, J = 8.4, 3.4 Hz, 4H), 7.23–7.18 (m, 1H), 2.84 (hept, J = 6.7 Hz, 1H), 2.05 (s, OH), 0.89 (dd, 
J = 14.5, 6.7 Hz, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 147.3, 145.9, 132.4, 130.4, 130.1, 128.6, 128.0, 127.1, 125.7, 
125.4, 80.1, 35.1, 17.1. 
MS (EI, 70 eV): m/z (%) = 251 (100), 175 (52), 173 (83), 105 (27), 77 (12). 
HRMS (EI): m/z calc. for [C13H9Cl2O]: 251.0030; found: 251.0023 (M − iPr). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2972, 2876, 1468, 1378, 1168, 1028, 976, 818, 748, 708. 
M.p. (°C): 85–90. 
4.7 Aryl Magnesium Reagents in Toluene by Br/Mg-Exchange and Subsequent Copper-
Catalyzed Reactions 
(3-Chlorophenyl)(4-methoxyphenyl)methanone (175l) 
 
According to TP11, to a mixture of 4-bromoanisole (173a, 0.06 mL, 0.50 mmol, 1.00 equiv), TMEDA 
(0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at 25 °C. After 15 min, CuI (9.0 mg, 10 mol%) was added and stirring was continued for 1 h at 0 °C. 3-
Chloro-benzoyl chloride (0.08 mL, 0.60 mmol, 1.20 equiv) was added and the reaction mixture was 
stirred for 1 h at 0 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 175l as a white solid (118 mg, 0.48 mmol, 95%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.81 (d, J = 9.0 Hz, 2H), 7.73 (s, 1H), 7.66–7.60 (m, 1H), 7.54 
(d, J = 9.0 Hz, 1H), 7.41 (t, J = 7.8 Hz, 1H), 6.98 (d, J = 8.9 Hz, 2H), 3.90 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 194.1, 163.7, 140.2, 134.6, 132.7, 132.0, 129.8, 129.7, 129.7, 
127.9, 113.9, 55.7. 
MS (EI, 70 eV): m/z (%) = 246 (28), 136 (9), 135 (100), 77 (7). 
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HRMS (EI): m/z calc. for [C14H11ClO2]: 246.0448; found: 246.0441 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2928, 1728, 1644, 1602, 1506, 1418, 1254, 1028, 838, 768, 756. 
M.p. (°C): 67–68. 
Cyclopropyl(4-methoxyphenyl)methanone (175m) 
 
According to TP11, to a mixture of 4-bromoanisole (173a, 0.06 mL, 0.50 mmol, 1.00 equiv), TMEDA 
(0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at 25 °C. After 15 min, CuI (9.0 mg, 10 mol%) was added and stirring was continued for 1 h at 0 °C. 
Cyclopropanecarbonyl chloride (0.05 mL, 0.60 mmol, 1.20 equiv) was added and the reaction mixture 
was stirred for 1 h at 0 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 175m as a colorless oil (53 mg, 0.30 mmol, 60%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.05–7.98 (m, 2H), 7.00–6.93 (m, 2H), 3.88 (s, 3H), 2.64 (m, 
J = 7.9, 4.6 Hz, 1H), 1.25–1.17 (m, 2H), 1.00 (dq, J = 7.1, 3.5 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 199.2, 163.4, 131.2, 130.4, 113.8, 55.6, 16.8, 11.3. 
MS (EI, 70 eV): m/z (%) = 176 (22), 175 (8), 135 (100), 77 (8). 
HRMS (EI): m/z calc. for [C11H12O2]: 176.0837; found: 176.0830 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 1656, 1594, 1384, 1224, 1166, 1022, 990, 834, 756, 692. 
(3-(1,3-Dioxolan-2-yl)phenyl)(phenyl)methanone (175n) 
 
According to TP11, to a mixture of 2-(3-bromophenyl)-1,3-dioxolane (173j, 0.15 mL, 1.0 mmol, 
1.00 equiv), TMEDA (0.18 mL, 1.2 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 1.20 mL, 1.2 mmol, 1.20 equiv) 
at 25 °C. After 15 min, CuI (9.0 mg, 10 mol%) was added and stirring was continued for 1 h at 0 °C. 
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Benzoyl chloride (0.14 mL, 1.2 mmol, 1.20 equiv) was added and the reaction mixture was stirred for 
1 h at 0 °C. Purification of the crude product by flash column chromatography (ihex/EtOAc = 9:1) 
afforded the title compound 175n as a colorless oil (178 mg, 0.70 mmol, 70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.93 (t, J = 1.7 Hz, 1H), 7.82–7.77 (m, 3H), 7.72 (dt, J = 7.7, 
1.3 Hz, 1H), 7.62–7.56 (m, 1H), 7.53–7.45 (m, 3H), 5.86 (s, 1H), 4.16–4.02 (m, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 196.5, 138.5, 137.8, 137.6, 132.6, 131.0, 130.6, 130.2, 128.5, 
128.4, 128.3, 103.3, 65.5. 
MS (EI, 70 eV): m/z (%) = 254 (15), 253 (95), 209 (18), 209 (69), 195 (21), 192 (13), 183 (13), 182 
(89), 181 (90), 177 (12), 166 (37), 165 (45), 153 (8), 152 (17), 149 (19), 105 (100), 77 (53), 76 (10), 73 
(43). 
HRMS (EI): m/z calc. for [C16H14O3]: 254.0943; found: 254.0889 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2888, 1657, 1597, 1447, 1275, 1075, 940, 786, 712, 697, 641. 
(4-Fluorophenyl)(4-propylphenyl)methanone (175o) 
 
According to TP11, to a mixture of 1-bromo-4-propylbenzene (173k, 0.06 mL, 0.50 mmol, 1.00 equiv), 
TMEDA (0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at 25 °C. After 15 min, CuI (9.0 mg, 10 mol%) was added and stirring was continued for 1 h at 0 °C. 4-
Fluorobenzoyl chloride (0.07 mL, 0.60 mmol, 1.20 equiv) was added and the reaction mixture was 
stirred for 1 h at 0 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 175o as a colorless oil (76 mg, 0.32 mmol, 64%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.83 (ddd, J = 8.2, 5.2, 2.4 Hz, 2H), 7.71 (d, J = 8.2 Hz, 2H), 
7.29 (d, J = 8.1 Hz, 2H), 7.19–7.12 (m, 2H), 2.71–2.65 (m, 2H), 1.69 (h, J = 7.4 Hz, 2H), 0.97 (t, 
J = 7.3 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 195.2, 165.4 (d, J = 253.7 Hz), 148.2, 135.2, 134.3, 132.7 (d, 
J = 9.1 Hz), 130.3, 128.6, 115.5 (d, J = 21.8 Hz), 38.2, 24.4, 13.9.  
MS (EI, 70 eV): m/z (%) = 242 (41), 213 (11), 199 (49), 148 (10), 147 (100), 123 (31), 91 (11). 
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HRMS (EI): m/z calc. for [C16H15FO]: 242.1107; found: 242.1101 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 1646, 1594, 1500, 1298, 1218, 1154, 930, 852, 758, 684. 
2-Allyl-1,1'-biphenyl (175p) 
 
According to TP11, to a mixture of 2-bromo-1,1'-biphenyl (173l, 0.06 mL, 0.50 mmol, 1.00 equiv), 
TMEDA (0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol 1.20 equiv) 
at 25 °C. After 15 min, CuI (9.0 mg, 10 mol%) was added and stirring was continued for 1 h at 0 °C. 
Allyl bromide (0.05 mL, 0.60 mmol, 1.20 equiv) was added and the reaction mixture was stirred for 1 h 
at 0 °C. Purification of the crude product by flash column chromatography (ihex/EtOAc = 9:1) afforded 
the title compound 175p as a light yellow oil (89 mg, 0.46 mmol, 92%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.45–7.27 (m, 9H), 5.92 (ddt, J = 16.6, 10.1, 6.4 Hz, 1H), 5.04 
(dq, J = 10.1, 1.4 Hz, 1H), 4.95 (dq, J = 17.0, 1.6 Hz, 1H), 3.37 (dt, J = 6.3, 1.4 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 142.1, 141.8, 137.9, 137.3, 130.2, 129.8, 129.4, 128.1, 127.5, 
127.0, 126.2, 115.9, 37.6. 
MS (EI, 70 eV): m/z (%) = 194 (13), 180 (15), 179 (100), 178 (50), 165 (28), 152 (11). 
HRMS (EI): m/z calc. for [C15H14]: 194.1096; found: 194.1089 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2984, 1736, 1448, 1372, 1234, 1110, 1044, 938, 846, 786. 
3',5'-Dimethyl-1,2,3,4-tetrahydro-1,1'-biphenyl (175q) 
 
According to TP11, to a mixture of 1-bromo-3,5-dimethylbenzene (173m, 0.07 mL, 0.50 mmol, 
1.00 equiv), TMEDA (0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
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at 25 °C. After 15 min, CuI (9.0 mg, 10 mol%) was added and stirring was continued for 1 h at 0 °C. 3-
Bromocyclohexene (0.07 mL, 0.60 mmol, 1.20 equiv) was added and the reaction mixture was stirred 
for 1 h at 0 °C. Purification of the crude product by flash column chromatography (ihex) afforded the 
title compound 175q as a colorless oil (84 mg, 0.45 mmol, 90%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.90 (s, 3H), 5.93 (m, J = 9.8, 3.4 Hz, 1H), 5.76 (dd, J = 10.1, 
2.1 Hz, 1H), 3.39 (m, J = 7.8, 5.1, 2.6 Hz, 1H), 2.36 (s, 6H), 2.15 (m, J = 7.9, 2.6 Hz, 2H), 2.10–2.01 
(m, 1H), 1.81 (m, J = 14.5, 4.4 Hz, 1H), 1.74–1.54 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 146.8, 137.9, 130.7, 128.2, 127.8, 125.7, 42.0, 32.8, 25.2, 
21.5, 21.5. 
MS (EI, 70 eV): m/z (%) = 186 (91), 182 (35), 171 (59), 167 (23), 165 (24), 157 (26), 143 (86), 141 
(27), 128 (43), 115 (26), 91 (20), 79 (31), 44 (100). 
HRMS (EI): m/z calc. for [C14H18]: 186.1409; found: 186.1402 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2984, 1737, 1446, 1372, 1235, 1044, 938, 847, 608. 
3'-Chloro-4'-methyl-1,2,3,4-tetrahydro-1,1'-biphenyl (175r) 
 
According to TP11, to a mixture of 4-bromo-2-chlorotoluene (173n, 0.13 mL, 1.0 mmol, 1.00 equiv), 
TMEDA (0.18 mL, 1.0 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 1.20 mL, 1.2 mmol 1.20 equiv) at 
25 °C. After 15 min, CuI (18 mg, 10 mol%) was added and stirring was continued for 1 h at 0 °C. 3-
Bromocyclohexene (0.14 mL, 1.2 mmol, 1.20 equiv) was added and the reaction mixture was stirred 
for 1 h at 0 °C. Purification of the crude product by flash column chromatography (ihex) afforded the 
title compound 175r as a colorless oil (183 mg, 0.89 mmol, 89%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.23 (s, 1H), 7.16 (d, J = 7.8 Hz, 1H), 7.03 (d, J = 7.8 Hz, 1H), 
5.98–5.87 (m, 1H), 5.69 (dd, J = 10.1, 2.0 Hz, 1H), 3.37 (ddt, J = 7.7, 5.1, 2.5 Hz, 1H), 2.37 (s, 3H), 
2.11 (m, J = 5.4, 3.6, 2.2 Hz, 2H), 2.05–1.98 (m, 1H), 1.79–1.71 (m, 1H), 1.69–1.50 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 146.1, 134.3, 133.5, 130.9, 129.7, 128.9, 128.4, 126.2, 41.3, 
32.6, 25.1, 21.1, 19.7. 
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MS (EI, 70 eV): m/z (%) = 206 (100), 291 (30), 171 (73), 156 (17), 143 (100), 141 (18), 129 (15), 128 
(47), 115 (19). 
HRMS (EI): m/z calc. for [C13H15Cl]: 206.0862; found: 206.0855 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2926, 1574, 1564, 1494, 1445, 1248, 1049, 994, 875, 815, 707, 
698. 
1-(4-Methoxyphenyl)propan-2-ol (175s) 
 
According to TP11, to a mixture of 4-bromoanisole (173a, 0.06 mL, 0.50 mmol, 1.00 equiv), TMEDA 
(0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at 25 °C. After 15 min, CuI (9.0 mg, 10 mol%) was added and stirring was continued for 1 h at 0 °C. 
Propylene oxide (0.04 mL, 0.60 mmol, 1.20 equiv) was added and the reaction mixture was stirred for 
4 h at 0 °C. Purification of the crude product by flash column chromatography (ihex/EtOAc = 9:1) 
afforded the title compound 175s as a colorless oil (89 mg, 0.46 mmol, 92%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.13 (d, J = 8.4 Hz, 2H), 6.86 (d, J = 8.5 Hz, 2H), 3.97 (dt, 
J = 12.8, 6.1 Hz, 1H), 3.79 (s, 3H), 2.73 (dd, J = 13.6, 4.8 Hz, 1H), 2.62 (dd, J = 13.6, 7.9 Hz, 1H), 1.66 
(s, OH), 1.23 (d, J = 6.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.4, 130.6, 130.4, 114.1, 69.1, 55.4, 45.0, 22.8. 
MS (EI, 70 eV): m/z (%) = 166 (12), 122 (68), 121 (100), 107 (15), 91 (13), 77 (8). 
HRMS (EI): m/z calc. for [C10H14O2]: 166.0994; found: 166.0988 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2937, 1512, 1448, 1320, 1247, 1159, 1093, 983, 815, 661. 
N-(1,3-Diphenylpropan-2-yl)-4-methylbenzenesulfonamide (175t) 
 
According to TP11, to a mixture of 4-bromoanisole (173a, 0.06 mL, 0.50 mmol, 1.00 equiv), TMEDA 
(0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
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sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol 1.20 equiv) 
at 25 °C. After 15 min, CuI (9.0 mg, 10 mol%) was added and stirring was continued for 1 h at 0 °C. 2-
Methyl-1-tosylaziridine (127 mg, 0.60 mmol, 1.20 equiv) was added and the reaction mixture was 
stirred for 10 h at 0 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 175t as a light yellow oil (118 mg, 0.37 mmol, 73%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.61 (d, J = 8.3, 2H), 7.22 (d, J = 8.0 Hz, 2H), 6.94–6.89 (m, 
2H), 6.76–6.72 (m, 2H), 4.25 (d, J = 7.2 Hz, NH), 3.78 (s, 3H), 3.47 (hept, J = 6.7 Hz, 1H), 2.66–2.56 
(m, 2H), 2.41 (s, 3H), 1.09 (d, J = 6.5 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.6, 143.2, 137.8, 130.4, 129.7, 129.1, 127.1, 114.1, 55.4, 
51.1, 42.6, 21.7, 21.5. 
MS (EI, 70 eV): m/z (%) = 319 (1), 198 (94), 155 (100), 122 (31), 121 (30), 91 (58). 
HRMS (EI): m/z calc. for [C17H21NO3S]: 319.1242; found: 319.1240 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3268, 1454, 1290, 1146, 1088, 980, 816, 758, 704, 656. 
N-(1,3-Diphenylpropan-2-yl)-4-methylbenzenesulfonamide (175u) 
 
According to TP11, to a mixture of brombenzene (173o, 0.06 mL, 0.50 mmol, 1.00 equiv), TMEDA 
(0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at 25 °C. After 15 min, CuI (9.0 mg, 10 mol%) was added and stirring was continued for 1 h at 0 °C. 2-
Benzyl-1-tosylaziridine (172 mg, 0.60 mmol, 1.20 equiv) was added and the reaction mixture was 
stirred for 10 h at 0 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 175u as a white solid (175 mg, 0.48 mmol, 95%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.42–7.37 (m, 2H), 7.20 (dt, J = 4.5, 2.2, 6H), 7.09 (d, 
J = 8.0 Hz, 2H), 7.06–7.00 (m, 4H), 4.26 (d, J = 6.8, NH), 3.61 (h, J = 6.6, 1H), 2.81 (dd, J = 13.8, 6.3, 
2H), 2.72 (dd, J = 13.8, 6.7, 2H), 2.38 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 143.0, 137.2, 136.9, 129.6, 129.6, 128.7, 127.0, 126.8, 56.3, 
40.9, 21.6. 
MS (EI, 70 eV): m/z (%) = 366 (1), 156 (15), 119 (16), 118 (20), 92 (27), 65 (18). 
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HRMS (EI): m/z calc. for [C22H24NO2S]: 366.1522; found: 366.1518 (M+ + H). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3268, 1454, 1290, 1146, 1088, 980, 816, 758, 704, 656. 
M.p. (°C): 99–101. 
4-Methyl-N-(4-methyl-1-phenylpentan-2-yl)benzenesulfonamide (175v) 
 
According to TP11, to a mixture of brombenzene (173o, 0.06 mL, 0.50 mmol, 1.00 equiv), TMEDA 
(0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at 25 °C. After 15 min, CuI (9.0 mg, 10 mol%) was added and stirring was continued for 1 h at 0 °C. 2-
Isobutyl-1-tosylaziridine (152 mg, 0.60 mmol, 1.20 equiv) was added and the reaction mixture was 
stirred for 10 h at 0 °C. Purification of the crude product by flash column chromatography (ihex/EtOAc 
9:1) afforded the title compound 175v as a light yellow oil (89 mg, 0.46 mmol, 92%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.69 (d, J = 8.3 Hz, 2H), 7.26–7.17 (m, 5H), 7.03–6.99 (m, 
2H), 4.18 (s, NH), 3.51 (dq, J = 14.2, 6.4 Hz, 1H), 2.74–2.63 (m, 2H), 2.41 (s, 3H), 1.56 (m, J = 6.4, 
6.0 Hz, 1H), 1.24–1.18 (m, 2H), 0.80 (d, J = 6.7 Hz, 3H), 0.66 (d, J = 6.5, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 143.3, 138.1, 137.1, 129.8, 129.7, 128.6, 127.2, 126.7, 53.0, 
44.0, 41.7, 24.5, 23.0, 21.9, 21.7. 
MS (EI, 70 eV): m/z (%) = 166 (12), 122 (68), 121 (100), 107 (15), 91 (13), 77 (8). 
HRMS (EI): m/z calc. for [C10H14O2]: 166.0994; found: 166.0988 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3278, 2954, 1320, 1156, 1088, 1032, 814, 746, 700, 662. 
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4.8 Aryl Magnesium Reagents in Toluene by Br/Mg-Exchange and Subsequent Palladium-
Catalyzed Cross-Couplings 
4-Methoxy-4'-(trifluoromethyl)-1,1'-biphenyl (175w) 
 
According to TP11, to a mixture of 4-bromoanisole (173a, 0.07 mL, 0.60 mmol, 1.20 equiv), TMEDA 
(0.10 mL, 0.72 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.78 mL, 0.72 mmol 1.20 equiv) 
at 25 °C. After 15 min, using a syringe-pump, the magnesium-species was then added dropwise to a 
solution of Pd(OAc)2 (3.4 mg, 3 mol%), SPhos (8.2 mg, 4 mol%) and 1-chloro-4-
(trifluoromethyl)benzene (0.06 mL, 0.50 mmol, 1.00 equiv) in toluene (1 mL) over 1 h at room 
temperature. The resulting mixture was further stirred for 1 h. The reaction mixture was quenched with 
sat. aq. NH4Cl solution (10 mL), extracted with EtOAc (3 × 20 mL) and dried over anhydrous Na2SO4. 
After filtration, the solvent was evaporated in vacuo. Purification of the crude product by flash column 
chromatography (ihex/EtOAc = 9:1) afforded the title compound 175w as a light brown solid (89 mg, 
0.36 mmol, 70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.71–7.64 (m, 4H), 7.58–7.53 (m, 2H), 7.05–7.00 (m, 2H), 
3.88 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 160.0, 144.4 (q, J = 1.3 Hz), 132.3, 128.8 (d, J = 32.4 Hz, 
2C), 128.5, 127.0, 125.8 (q, J = 3.8 Hz, 2C), 124.5 (d, J = 271.8 Hz), 114.6, 55.5.  
MS (EI, 70 eV): m/z (%) = 252 (100), 237 (43), 209 (63), 188 (10), 183 (14), 139 (10). 
HRMS (EI): m/z calc. for [C14H11F3O]: 252.0762; found: 252.0757 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2966, 1602, 1568, 1532, 1460, 1444, 1402, 1326, 1296, 1276, 
1202, 1182, 1076, 1036, 960, 828, 746. 
M.p. (°C): 115–117. 
C. EXPERIMENTAL PART    150 
 
 
 
4'-Methoxy-[1,1'-biphenyl]-4-carbonitrile (175x) 
 
According to TP11, to a mixture of 4-bromoanisole (173a, 0.07 mL, 0.60 mmol, 1.00 equiv), TMEDA 
(0.10 mL, 0.72 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.78 mL, 0.72 mmol 1.20 equiv) 
at 25 °C. After 15 min, Zn(OPiv) (160 mg, 0.60 mmol, 1.20 equiv) was added and the reaction mixture 
was stirred for 30 min. PEPPSI-iPr (14 mg, 4 mol%) and 4-bromobenzonitrile (109 mg, 0.60 mmol, 
1.00 equiv) was added at 25 °C and the resulting mixture was further stirred overnight. The reaction 
mixture was quenched with sat. aq. NH4Cl solution (10 mL), extracted with EtOAc(3 × 20 mL) and 
dried over anhydrous Na2SO4. After filtration, the solvent was evaporated in vacuo. Purification of the 
crude product by flash column chromatography (ihex/EtOAc = 9:1) afforded the title compound 175x 
as a light brown solid (76 mg, 0.36 mmol, 72%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.73–7.61 (m, 4H), 7.54 (d, J = 8.7 Hz, 2H), 7.01 (d, 
J = 8.7 Hz, 2H), 3.87 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 160.3, 145.4, 132.7, 131.7, 128.5, 127.3, 119.3, 114.7, 110.2, 
55.6. 
MS (EI, 70 eV): m/z (%) = 209 (100), 194 (50), 166 (55), 140 (30), 139 (10). 
HRMS (EI): m/z calc. for [C14H11ON]: 209.0841; found: 209.0834 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2961, 2221, 1603, 1492, 1445, 1294, 1239, 1176, 1036, 1000, 
822. 
M.p. (°C): 101–103. 
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4.9 Heteroaryl Magnesium Reagents in Toluene by Br/Mg-Exchange 
Benzofuran-5-yl(phenyl)methanone (178a) 
 
According to TP11, to a mixture of 5-bromobenzofuran (176a, 0.08 mL, 0.20 mmol, 1.00 equiv), 
TMEDA (0.09 mL, 0.60mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol 1.20 equiv) 
at 25 °C. After 15 min, CuI (9.0 mg, 10 mol%) was added and stirring was continued for 1 h at 0 °C. 
Benzoyl chloride (0.07 mL, 0.60 mmol, 1.20 equiv) was added and the reaction mixture was stirred for 
1 h at 0 °C. Purification of the crude product by flash column chromatography (ihex/EtOAc = 9:1) 
afforded the title compound 178a as yellow oil (78 mg, 0.35 mmol, 70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.09 (d, J = 1.5 Hz, 1H), 7.83 (m, J = 12.2, 8.5, 1.6 Hz, 3H), 
7.72 (d, J = 2.2 Hz, 1H), 7.63–7.57 (m, 2H), 7.50 (t, J = 7.5 Hz, 2H), 6.86 (dd, J = 2.2, 0.9 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 196.7, 157.4, 146.5, 138.4, 133.0, 132.3, 130.1, 128.4, 127.4, 
127.0, 124.6, 111.5, 107.4. 
MS (EI, 70 eV): m/z (%) = 222 (54), 221 (15), 145 (13), 145 (100), 89 (11). 
HRMS (EI): m/z calc. for [C15H10O2]: 222.0681; found: 222.0674 (M+). 
Benzofuran-5-yl(4-fluorophenyl)methanol (178b) 
 
According to TP11, to a mixture of 3-bromobenzothiophen (176b, 108 mg, 0.50 mmol, 1.00 equiv), 
TMEDA (0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol 1.20 equiv) 
at −10 °C. After 15 min, N-methoxy-N-methylacetamide (0.06 mL, 0.60 mmol, 1.20 equiv) was added 
and the reaction mixture was stirred for 1 h at 25 °C. Purification of the crude product by flash column 
chromatography (ihex/EtOAc = 9:1) afforded the title compound 178b as a yellow oil (79 mg, 
0.33 mmol, 65%). 
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1H-NMR (599 MHz, CDCl3): δ / ppm = (s, 1H), 7.98 (d, J = 8.4 Hz, 1H), 7.85–7.81 (m, 3H), 7.63–
7.59 (m, 1H), 7.54 (d, J = 5.4 Hz, 1H), 7.51 (t, J = 7.6 Hz, 2H), 7.42 (d, J = 5.4 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 196.9, 144.0, 139.2, 138.2, 134.1, 132.4, 130.2, 128.5, 128.0, 
126.4, 125.5, 124.7, 122.6. 
MS (EI, 70 eV): m/z (%) = 238 (61), 237 (17), 161 (15), 161 (100), 133 (12), 89 (12). 
HRMS (EI): m/z calc. for [C15H10OS]: 238.0452; found: 238.0447 (M+). 
Benzofuran-2-yl(1-methyl-1H-indol-5-yl)methanol (178c) 
 
According to TP11, to a mixture of 5-bromo-1-methyl-1H-indole (176c, 104 mg, 0.50 mmol, 
1.00 equiv), TMEDA (0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol 1.20 equiv) 
at 25 °C. After 15 min, benzofuran-2-carbaldehyde (0.07 mL, 0.60 mmol, 1.20 equiv) was added and 
the reaction mixture was stirred for 1 h at 25 °C. Purification of the crude product by flash column 
chromatography (ihex/EtOAc = 9:1) afforded the title compound 178c as an orange oil (86 mg, 
0.31 mmol, 62%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.75 (s, 1H), 7.55–7.51 (m, 1H), 7.48–7.44 (m, 1H), 7.39–
7.31 (m, 2H), 7.29–7.19 (m, 2H), 7.09 (d, J = 3.1 Hz, 1H), 6.57 (s, 1H), 6.51 (d, J = 3.1 Hz, 1H), 6.05 
(s, 1H), 3.79 (s, 3H), 2.64 (s, OH). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 159.6, 155.2, 136.8, 131.7, 129.7, 128.5, 128.3, 124.1, 122.8, 
121.1, 120.8, 119.7, 111.4, 109.5, 103.8, 101.4, 71.6, 33.0. 
MS (EI, 70 eV): m/z (%) = 277 (100), 261 (22), 260 (96), 158 (48), 144 (19), 132 (23), 130 (20). 
HRMS (EI): m/z calc. for [C18H15NO2]: 277.1103; found: 277.1106 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3033, 1581, 1488, 1452, 1376, 1252, 1146, 1007, 957, 800, 739, 
720. 
M.p. (°C): 180 
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Benzofuran-2-yl(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methanol (178d) 
 
According to TP11, to a mixture of 3-bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine (176d, 105 mg, 
0.50 mmol, 1.00 equiv), TMEDA (0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol 1.20 equiv) 
at 25 °C. After 15 min, benzofuran-2-carbaldehyde (0.07 mL, 0.60 mmol, 1.20 equiv) was added and 
the reaction mixture was stirred for 1 h at 25 °C. Purification of the crude product by flash column 
chromatography (ihex/EtOAc = 9:1) afforded the title compound 178d as an orange oil (97 mg, 
0.35 mmol, 70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.37 (dd, J = 4.7, 1.5 Hz, 1H), 8.01 (dd, J = 7.9, 1.5 Hz, 1H), 
7.60–7.56 (m, 1H), 7.50 (d, J = 7.6 Hz, 1H), 7.34–7.23 (m, 3H), 7.08 (dd, J = 7.9, 4.7 Hz, 1H), 6.71 (s, 
1H), 6.26 (s, 1H), 3.89 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.4, 155.1, 148.2, 143.6, 128.3, 128.2, 127.7, 124.4, 123.0, 
121.3, 118.7, 115.9, 113.1, 111.5, 103.8, 64.9, 31.4. 
MS (EI, 70 eV): m/z (%) = 276 (41), 275 (13), 225 (24), 207 (39), 160 (10), 159 (100), 131 (18), 43 
(24). 
HRMS (EI): m/z calc. for [C17H12N2O2]: 276.0895; found: 276.0895(M+ − 2H). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2928, 1690, 1600, 1556, 1454, 1409, 1300, 1255, 1126, 948, 774, 
751. 
(6-Methoxypyridin-2-yl)(phenyl)methanol (178e) 
 
According to TP11, to a mixture of 2-bromo-6-methoxypyridine (176e, 0.06 mL, 0.50 mmol, 
1.00 equiv), TMEDA (0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol, 1.20 equiv) 
at −30 °C. After 15 min, benzaldehyde (0.06 mL, 0.60 mmol, 1.20 equiv) was added and the reaction 
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mixture was stirred for 1 h at 0 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 178e as colorless oil (77 mg, 0.36 mmol, 72%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.50 (t, J = 7.8 Hz, 1H), 7.43–7.39 (m, 2H), 7.35 (t, J = 7.4 Hz, 
2H), 7.28 (t, J = 7.2 Hz, 1H), 6.67 (dd, J = 7.8 Hz, 2H), 5.69 (d, J = 4.5 Hz, 1H), 4.94 (d, J = 4.6 Hz, 
OH), 4.00 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 163.3, 158.9, 143.3, 139.6, 128.5, 127.8, 127.0, 113.8, 109.3, 
77.2, 76.8, 74.8, 53.5. 
MS (EI, 70 eV): m/z (%) = 215 (66), 214 (19), 154 (17), 138 (100), 124 (12), 110 (54), 109 (69), 108 
(31), 105 (13), 104 (11), 94 (15), 93 (12), 91 (18), 80 (23), 79 (20), 78 (13), 77 (35). 
HRMS (EI): m/z calc. for [C13H13NO2]: 215.0946; found: 215.0939 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3410, 2952, 1600, 1508, 1468, 1416, 1292, 1186, 1098, 1028, 
990, 882, 810, 736, 654. 
(5-Bromo-2,6-dimethoxypyridin-3-yl)(4-fluorophenyl)methanol (178f) 
 
According to TP11, to a mixture of 3,5-dibromo-2,6-dimethoxypyridine (176f, 148 mg, 0.50 mmol, 
1.00 equiv), TMEDA (0.09 mL, 0.60 mmol, 1.20 equiv) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 0.60 mL, 0.60 mmol 1.20 equiv) 
at −30 °C. After 15 min, 4-fluorobenzaldehyde (0.06 mL, 0.60 mmol, 1.20 equiv) was added and the 
reaction mixture was stirred for 1 h at 0 °C. Purification of the crude product by flash column 
chromatography (ihex/EtOAc = 9:1) afforded the title compound 178f as colorless oil (115 mg, 
0.34 mmol, 68%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.62 (s, 1H), 7.32 (dd, J = 8.5, 5.4 Hz, 2H), 7.01 (t, J = 8.7 Hz, 
2H), 5.88 (d, J = 4.0 Hz, 1H), 3.98 (s, 3H), 3.93 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 162.3 (d, J = 245.8 Hz), 158.3, 157.8, 141.5, 138.3 (d, 
J = 3.1 Hz), 128.2 (d, J = 8.1 Hz, 2C), 119.0, 115.4 (d, J = 21.4 Hz, 2C), 95.7, 69.8, 54.5, 53.9. 
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MS (EI, 70 eV): m/z (%) = 341 (99), 340 (11), 325 (31), 324 (30), 248 (55), 247 (12), 246 (70), 244 
(16), 220 (11), 218 (15), 125 (23), 123 (48), 95 (11). 
HRMS (EI): m/z calc. for [C14H13BrFNO3]: 341.0063; found: 341.0051 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3328, 2952, 1592, 1578, 1472, 1420, 1400, 1384, 1306, 1268, 
1192, 1058, 1016, 830, 788, 726. 
2,5-Diallyl-3,4-dichlorothiophene (178g) 
 
According to TP11, to a mixture of tetrachlorothiophene (176g, 111 mg, 0.50 mmol, 1.00 equiv), 
TMEDA (0.19 mL, 1.30 mmol) and toluene (1 mL) was added 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (170a, 1.00 M in toluene, 2.60 mL, 2.60 mmol, 2.60 equiv) 
at 25 °C. After 4 h, CuI (18 mg, 20 mol%) was added and stirring was continued for 1 h at 0 °C. Allyl 
bromide (0.11 mL, 1.3 mmol, 2.60 equiv) was added and the reaction mixture was stirred for 1 h at 
0 °C. Purification of the crude product by flash column chromatography (ihex/EtOAc = 9:1) afforded 
the title compound 178g as a colorless oil (70 mg, 0.30 mmol, 60%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 5.89 (ddt, J = 16.6, 10.0, 6.6 Hz, 2H), 5.27–5.09 (m, 4H), 3.51 
(dt, J = 6.5, 1.3 Hz, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 134.1, 132.9, 120.9, 117.6, 32.8. 
MS (EI, 70 eV): m/z (%) = 232 (65), 206 (18), 205 (27), 199 (32), 197 (93), 196 (10), 171 (18), 169 
(54), 163 (10), 162 (100), 161 (51), 156 (22), 155 (12), 147 (16), 135 (26), 134 (64, 130 (20, 129 (26), 
128 (43), 121 (23), 115 (13). 
HRMS (EI): m/z calc. for [C4H2Cl2S]: 231.9880; found: 231.9874 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3082, 2982, 1670, 1540, 1486, 1426, 1296, 1228, 1164, 1088, 
1058, 988, 918, 772, 732, 686. 
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4.10 Aryl Magnesium Reagents in Toluene by Cl/Mg-Exchange 
 (2,5-Dimethoxyphenyl)(phenyl)methanol (181a) 
 
According to TP12, to a mixture of 2-chloro-1,4-dimethoxybenzene (179a, 0.14 mL, 1.0 mmol, 
1.00 equiv), PMDTA (0.12 mL, 0.60 mmol, 0.60 equiv) and toluene (1 mL) was added 
sBu2Mg·2LiOCH2CH(Et)Bu (170b, 0.70 M in toluene, 0.86 mL, 0.60 mmol, 0.60 equiv) at 25 °C. After 
1 h, benzaldehyde (0.15 mL, 1.5 mmol, 1.50 equiv) was added and the reaction mixture was stirred for 
1 h at 25 °C. Purification of the crude product by flash column chromatography (ihex/EtOAc = 9:1) 
afforded the title compound 181a as a light yellow oil (149 mg, 0.61 mmol, 61%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.45–7.41 (m, 2H), 7.38–7.33 (m, 2H), 7.31–7.27 (m, 1H), 
6.89 (d, J = 2.9, 1H), 6.86–6.78 (m, 2H), 6.05 (d, J = 4.1 Hz, 1H), 3.77 (d, J = 3.6 Hz, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 153.9, 151.0, 143.2, 133.2, 128.3, 127.3, 126.6, 114.2, 112.9, 
112.0, 72.3, 56.1, 55.8. 
MS (EI, 70 eV): m/z (%) = 244 (100), 226 (11), 167 (13), 165 (15), 139 (45), 105 (30), 91 
(14), 79 (12), 77 (28), 43 (37). 
HRMS (EI): m/z calc. for [C15H16O3]: 244.1099; found: 244.1095 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2938, 2834, 1591, 1492, 1452, 1276, 1212, 1177, 1037, 
831. 
(5-(Dimethylamino)-2-methoxyphenyl)(1-methyl-1H-indol-2-yl)methanol (181b) 
 
According to TP12, to a mixture of 1,3-dichloro-2-methoxybenzene (179b, 185 mg, 1.0 mmol, 
1.00 equiv), PMDTA (0.12 mL, 0.60 mmol, 0.60 equiv) and toluene (1 mL) was added 
sBu2Mg·2LiOCH2CH(Et)Bu (170b, 0.70 M in toluene, 0.86 mL, 0.60 mmol 0.60 equiv) at 25 °C. After 
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1 h, 1-methyl-1H-indole-2-carbaldehyde (239 mg, 1.5 mmol, 1.50 equiv) was added and the reaction 
mixture was stirred for 1 h at 25 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 181b as a light yellow solid (217 mg, 0.70 mmol, 
70%). 
1H-NMR (400 MHz, C6D6): δ / ppm = 8.04 (dd, J = 6.8, 1.5, 1H), 7.25–7.17 (m, 3H), 6.99 (d, J = 7.2, 
1H), 6.71–6.58 (m, 4H), 3.30 (s, 3H), 2.83 (s, 3H), 2.57 (s, 6H). 
13C-NMR (101 MHz, C6D6): δ / ppm = 149.8, 146.2, 137.9, 133.8, 127.4, 121.9, 120.9, 119.6, 119.0, 
114.5, 112.9, 112.1, 109.4, 67.0, 55.6, 41.4, 31.8. 
MS (EI, 70 eV): m/z (%) = 294 (100), 280 (10), 279 (55), 263 (13), 234 (15), 144 (36), 139 (18), 131 
(11). 
HRMS (EI): m/z calc. for [C19H22N2O2]: 310.1681; found: 310.1672 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2827, 1505, 1448, 1421, 1317, 1240, 1234, 1034, 997, 782, 739, 
684. 
M.p. (°C): 109–110. 
(5-Chloro-2-methoxyphenyl)(4-chlorophenyl)methanol (181c) 
 
According to TP12, to a mixture of 2,4-dichloro-1-methoxybenzene (179c, 0.14 mL, 1.0 mmol, 
1.00 equiv), PMDTA (0.12 mL, 0.60 mmol, 0.60 equiv) and toluene (1 mL) was added 
sBu2Mg·2LiOCH2CH(Et)Bu (170b, 0.70 M in toluene, 0.86 mL, 0.60 mmol, 0.60 equiv) at 25 °C. After 
1 h, 4-chlorobenzaldehyde (211 mg, 1.5 mmol, 1.50 equiv) was added and the reaction mixture was 
stirred for 1 h at 25 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 181c as a light yellow oil (141 mg, 0.50 mmol, 50 %). 
1H-NMR (400 MHz, C6D6): δ / ppm = 7.51 (d, J = 2.6 Hz, 1H), 7.09–7.03 (m, 4H), 7.01 (dd, J = 8.7, 
2.7 Hz, 1H), 6.13 (d, J = 8.7 Hz, 1H), 5.75 (d, J = 4.2 Hz, 1H), 3.03 (s, 3H), 2.72 (d, J = 4.5 Hz, OH). 
13C-NMR (101 MHz, C6D6): δ / ppm = 155.0, 142.2, 134.3, 133.3, 128.6, 128.4, 127.8, 127.4, 126.3, 
112.1, 70.3, 55.1. 
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MS (EI, 70 eV): m/z (%) = 282 (78), 266 (38), 264 (61), 247 (34), 229 (44), 201 (30), 194 (39), 171 
(31), 169 (100), 165 (24), 154 (32), 143 (30), 141 (33), 138 (56), 125 (25). 
HRMS (EI): m/z calc. for [C14H12Cl2O2]: 282.0214; found: 282.0206 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2945, 2839, 1596, 1485, 1408, 1246, 1180, 1127, 1090, 1031, 
1013, 902, 809. 
Benzofuran-2-yl(3-chloro-2-methoxyphenyl)methanol (181d) 
 
According to TP12, to a mixture of 1,3-dichloro-2-methoxybenzene (179d, 0.14 mL, 1.0 mmol, 
1.00 equiv), PMDTA (0.12 mL, 0.60 mmol, 0.60 equiv) and toluene (1 mL) was added 
sBu2Mg·2LiOCH2CH(Et)Bu (170b, 0.70 M in toluene, 0.86 mL, 0.60 mmol, 0.60 equiv) at 25 °C. After 
1 h, benzofuran-2-carbaldehyde (0.18 mL, 1.5 mmol, 1.50 equiv) was added and the reaction mixture 
was stirred for 1 h at 25 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 181d as a light yellow oil (202 mg, 0.70 mmol, 70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.53 (dd, J = 7.1, 1.4 Hz, 1H), 7.46–7.42 (m, 2H), 7.37 (dd, 
J = 8.0, 1.6 Hz, 1H), 7.30–7.20 (m, 2H), 7.09 (t, J = 7.9 Hz, 1H), 6.57 (s, 1H), 6.24 (d, J = 4.1 Hz, 1H), 
3.81 (s, 3H), 3.60 (s, OH). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.3, 155.0, 153.6, 135.7, 130.6, 128.1, 127.7, 127.0, 125.2, 
124.4, 122.9, 121.2, 111.4, 104.0, 65.9, 61.5. 
MS (EI, 70 eV): m/z (%) = 288 (100), 271 (20), 171 (24), 169 (71), 165 (21), 155 (44), 147 (42), 145 
(20), 131(41), 119 (20), 118 (33), 91 (33), 89 (22). 
HRMS (EI): m/z calc. for [C16H13ClO3]: 288.0553; found: 288.0546 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2945, 1465, 1454, 1425, 1254, 1234, 1134, 999, 791, 751. 
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(2-Methoxynaphthalen-1-yl)(methyl)sulfane (181e) 
 
According to TP12, to a mixture of 1-chloro-2-methoxynaphthalene (179e, 96 mg, 0.50 mmol, 
1.00 equiv), PMDTA (0.06 mL, 0.30 mmol, 0.60 equiv) and toluene (1 mL) was added 
sBu2Mg·2LiOCH2CH(Et)Bu (170b, 0.70 M in toluene, 0.43 mL, 0.30 mmol 0.60 equiv) at 25 °C. After 
1 h, S-methyl methanesulfonothioate (0.08 mL, 0.75 mmol, 1.50 equiv) was added and the reaction 
mixture was stirred for 1 h at 25 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc = 9:1) afforded the title compound 181e as a light yellow oil (63 mg, 0.31 mmol, 62%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.62 (d, J = 8.6 Hz, 1H), 7.85 (d, J = 9.0 Hz, 1H), 7.79 (d, 
J = 8.7 Hz, 1H), 7.56 (m, J = 8.5, 6.8, 1.3 Hz, 1H), 7.38 (m, J = 8.0, 6.8, 1.1 Hz, 1H), 7.30 (d, 
J = 9.0 Hz, 1H), 4.06 (s, 3H), 2.39 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.3, 135.8, 130.5, 129.5, 128.4, 127.3, 125.6, 124.0, 118.1, 
113.3, 56.9, 18.6. 
MS (EI, 70 eV): m/z (%) = 204 (100), 189 (35), 171 (23), 161 (15), 128 (19), 115 (25). 
HRMS (EI): m/z calc. for [C12H12OS]: 204.0609; found: 204.0603 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2921, 2839, 1590, 1504, 1462, 1326, 1264, 1244, 1068, 969, 806, 
748, 654. 
(2-Methoxynaphthalen-1-yl)(methyl)sulfane (181f) 
 
According to TP12, to a mixture of 1-chloro-2-methoxynaphthalene (179e, 96 mg, 0.50 mmol, 
1.00 equiv), PMDTA (0.06 mL, 0.30 mmol, 0.60 equiv) and toluene (1 mL) was added 
sBu2Mg·2LiOCH2CH(Et)Bu (170b, 0.70 M in toluene, 0.43 µL, 0.30 mmol 0.60 equiv) at 25 °C. After 
1 h, CuI (9.0 mg, 10 mol%) was added and stirring was continued for 1 h at 0 °C. Allyl bromide 
(0.06 mL, 1.5 mmol, 1.50 equiv) was added and the reaction mixture was stirred for 1 h at 0 °C. 
Purification of the crude product by flash column chromatography (ihex/EtOAc = 9:1) afforded the title 
compound 181f as a light yellow oil (75 mg, 0.38 mmol, 75%). 
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1H-NMR (599 MHz, CDCl3): δ / ppm = 7.94 (d, J = 8.6 Hz, 1H), 7.79 (d, J = 7.8 Hz, 1H), 7.76 (d, 
J = 9.0 Hz, 1H), 7.47 (m, J = 8.4, 6.8, 1.3 Hz, 1H), 7.34 (m, J = 8.0, 6.8, 1.0 Hz, 1H), 7.30 (d, 
J = 9.0 Hz, 1H), 6.09–6.01 (m, 1H), 5.02–4.96 (m, 2H), 3.96 (s, 3H), 3.87 (dt, J = 5.8, 1.6 Hz, 2H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 154.6, 136.9, 133.3, 129.4, 128.6, 128.2, 126.4, 123.7, 123.4, 
121.1, 115.1, 113.8, 56.9, 29.2. 
MS (EI, 70 eV): m/z (%) = 198 (100), 197 (15), 183 (45), 167 (61), 166 (11), 165 (73), 155 (13), 153 
(32), 152 (29), 141 (21), 139 (12), 128 (19), 115 (21). 
HRMS (EI): m/z calc. for [C14H14O]: 198.1045; found: 198.1037 (M+). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3074, 2933, 2837, 1625, 1595, 1513, 1262, 1251, 1080, 910, 805, 
745. 
(2,4-Dimethylphenyl)(2-(methoxymethoxy)naphthalen-1-yl)methanol (181g) 
 
According to TP12, to a mixture of 1-chloro-2-(methoxymethoxy)naphthalene (179f, 222 mg, 
1.0 mmol, 1.00 equiv), PMDTA (0.12 µL, 0.60 mmol, 0.60 equiv) and toluene (1 mL) was added 
sBu2Mg·2LiOCH2CH(Et)Bu (170b, 0.70 M in toluene, 0.86 mL, 0.60 mmol 0.60 equiv) at 25 °C. After 
15 min, 2,4-dimethylbenzaldehyde (0.21 mL, 1.5 mmol, 1.50 equiv) was added and the reaction 
mixture was stirred for 1 h at 25 °C. Purification of the crude product by flash column chromatography 
(ihex/EtOAc/ Et3N = 9:0.05:0.05) afforded the title compound 181g as a light yellow oil (255 mg, 
0.79 mmol, 79%). 
1H-NMR (400 MHz, C6D6): δ / ppm = 8.19 (d, J = 8.0 Hz, 1H), 7.57 (dd, J = 11.3, 8.5 Hz, 2H), 7.34 
(dd, J = 12.1, 8.5 Hz, 2H), 7.13–7.09 (m, 1H), 6.99 (d, J = 7.7 Hz, 1H), 6.89 (s, 1H), 6.77 (d, J = 7.8 Hz, 
1H), 4.71 (s, 2H), 3.73 (d, J = 7.7 Hz, 1H), 3.00 (s, 3H), 2.47 (s, 3H), 2.09 (s, 3H). 
13C-NMR (101 MHz, C6D6): δ / ppm = 153.1, 138.5, 136.8, 136.5, 132.6, 131.7, 130.3, 129.7, 128.4, 
127.2, 126.4, 126.1, 124.6, 124.5, 124.0, 116.2, 94.8, 69.0, 55.6, 20.6, 19.6. 
MS (EI, 70 eV): m/z (%) = 322 (3), 260 (8), 259 (12), 246 (34), 215 (6), 115 (6), 45 (15). 
HRMS (EI): m/z calc. for [C21H22O3]: 322.1569; found: 322.1563 (M+). 
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IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2920, 1709, 1596, 1510, 1465, 1235, 1149, 1012, 923, 811. 
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5 Crystallographic Data  
Single Crystal X-Ray Diffraction Studies 
Single crystals of compound 141a, 159a and 163a, suitable for X-ray diffraction, were obtained by 
slow evaporation of a DCM solutions. The crystals were introduced into perfluorinated oil and a 
suitable single crystal was carefully mounted on the top of a thin glass wire. Data collection was 
performed with an Oxford Xcalibur 3 diffractometer equipped with a Spellman generator (50  kV, 
40 mA) and a Kappa CCD detector, operating with Mo-Kα radiation (λ = 0.71071 Ǻ).  
Data collection was performed with the CrysAlis CCD software;  132 CrysAlis RED software133 was 
used for data reduction. Absorption correction using the SCALE3 ABSPACK multiscan method 134 
was applied. The structures were solved with SHELXS-97, 135 refined with SHELXL-97136 and 
finally checked using PLATON. 137  
  
                                                     
132 CrysAlis CCD, Oxford Diffraction Ltd., Version 1.171.27p5 beta (release 01-04-2005 CrysAlis171.NET) 
(compiled Apr 1 2005, 17:53:34). 
133 CrysAlis RED, Oxford Diffraction Ltd., Version 1.171.27p5 beta (release 01-04-2005 CrysAlis171.NET) 
(compiled Apr 1 2005, 17:53:34). 
134 SCALE3 ABSPACK – An Oxford Diffraction Program (1.0.4, gui:1.0.3) (C), Oxford Diffraction, Ltd., 2005. 
135 Sheldrick, G. M. (1997) SHELXS-97: Program for Crystal Structure Solution, University of 
Göttingen,Germany. 
136 Sheldrick, G. M. (1997) SHELXL-97: Program for the Refinement of Crystal Structures, University of 
Göttingen, Germany. 
137 Spek, A. L. (1999) PLATON: A Multipurpose Crystallographic Tool, Utrecht University, Utrecht, The 
Netherlands. 
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3-Iodo-2-((2-methoxyethoxy)methyl)-2,7-naphthyridin-1(2H)-one (141a) 
CCDC-1565047 contains supplementary crystallographic data for this compound. These data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
 
Figure 5: Molecular structure of compound 141a in the crystal, DIAMOND representation; thermal ellipsoids 
are drawn at 50% probability level. 
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Table 19: Details for X-ray data collection and structure refinement for compound 141a. 
 141a 
Empirical formula C12H13IN2O3 
Formula mass 360.14 
T[K] 173(2) 
Crystal size [mm] 0.42 × 0.17 × 0.11 
Crystal description colorless block 
Crystal system triclinic 
Space group P-1 
a [Å] 8.5985(2) 
b [Å] 8.9813(2) 
c [Å] 10.1508(2) 
α [°] 113.998(2) 
β [°] 91.780(2) 
γ [°] 111.582(2) 
V [Å 3] 650.70(3) 
Z 2 
ρcalc. [g cm-3] 1.838 
μ [mm-1] 2.463 
F(000) 352 
Θ range [°] 4.15–25.24 
Index ranges −12 ≤ h ≤ 12 
 −12 ≤ k ≤ 12 
 −14 ≤ l ≤ 14 
Reflns. collected 12980 
Reflns. obsd. 3629 
Reflns. unique 3946 
(Rint = 0.0320) 
R1, wR2 (2σ data) 0.0214, 0.0480 
R1, wR2 (all data) 0.0253, 0.0499 
GOOF on F2 1.041 
Peak/hole [e Å -3] 0.526 / −0.759 
 
Table 20: Selected bond lengths (Å) of compound 141a. 
I1–C1 2.114(2) N2–C5 1.356(3) 
C1–C2 1.339(2) C11–C10 1.501(3) 
C1–N1 1.394(2) C4–C5 1.370(3) 
O2–C9 1.402(2) C7–C3 1.403(2) 
O2–C10 1.435(2) C7–C8 1.460(3) 
N1–C8 1.405(2) C3–C4 1.403(3) 
N1–C9 1.468(2) C3–C2 1.426(2) 
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O3–C12 1.411(3) O1–C8 1.228(2) 
O3–C11 1.413(3) N2–C6 1.324(3) 
C7–C6 1.402(3)   
Table 21: Selected bond angles (°) of compound 141a. 
C2–C1–N1 122.6(2) C5–C4–C3 119.3(2) 
C2–C1–I1 117.0(1) O1–C8–N1 120.7(2) 
N1–C1–I1 120.4(1) O1–C8–C7 123.6(2) 
C9–O2–C10 114.1(2) N1–C8–C7 115.7(2) 
C1–N1–C8 121.5(2) O2–C9–N1 113.6(2) 
C1–N1–C9 121.5(2) N2–C5–C4 123.9(2) 
C8–N1–C9 116.9(2) O2–C10–C11 109.0(2) 
C12–O3–C11 113.1(2) C4–C3–C2 124.0(2) 
C6–C7–C3 118.8(2) C6–N2–C5 117.0(2) 
C6–C7–C8 119.8(2) O3–C11–C10 109.6(2) 
C3–C7–C8 121.4(2) N2–C6–C7 123.7(2) 
C7–C3–C4 117.2(2) C1–C2–C3 119.9(2) 
C7–C3–C2 118.8(2)   
Table 22: Selected torsion angles (°) of compound 141a. 
C2–C1–N1–C8 −0.5(3) C2–C3–C4–C5 −179.5(2) 
I1–C1–N1–C8 −178.4(1) C1–N1–C8–O1 178.9(2) 
C2–C1–N1–C9 −177.3(2) C9–N1–C8–O1 −4.2(3) 
I1–C1–N1–C9 4.9(2) C1–N1–C8–C7 −0.7(2) 
C6–C7–C3–C4 −3.0(3) C9–N1–C8–C7 176.2(2) 
C8–C7–C3–C4 176.1(2) C6–C7–C8–O1 1.8(3) 
C6–C7–C3–C2 178.2(2) C3–C7–C8–O1 −177.3(2) 
C8–C7–C3–C2 −2.7(3) C6–C7–C8–N1 −178.6(2) 
C12–O3–C11–C10 −171.8(2) C3–C7–C8–N1 2.4(3) 
C5–N2–C6–C7 0.6(3) C10–O2–C9–N1 −76.2(2) 
C3–C7–C6–N2 1.8(3) C1–N1–C9–O2 −83.2(2) 
C8–C7–C6–N2 −177.2(2) C8–N1–C9–O2 99.9(2) 
N1–C1–C2–C3 0.2(3) C6–N2–C5–C4 −1.9(3) 
I1–C1–C2–C3 178.1(1) C3–C4–C5–N2 0.6(3) 
C7–C3–C2–C1 1.4(3) C9–O2–C10–C11 −167.4(2) 
C4–C3–C2–C1 −177.3(2) O3–C11–C10–O2 −69.2(2) 
C7–C3–C4–C5 1.8(3)   
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6-(Hydroxy(phenyl)methyl)-2H-pyran-2-one (159a) 
CCDC-1847973 contains supplementary crystallographic data for this compound. These data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
Figure 6: Molecular structure of compound 159a in the crystal, DIAMOND representation; thermal ellipsoids 
are drawn at 50% probability level. Symmetry code: i: x, 0.5−y, −0.5+z. 
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Table 23: Details for X-ray data collection and structure refinement for compound 159a. 
 159a 
Empirical formula C12H10O3 
Formula mass 202.20 
T[K] 173(2) 
Crystal size [mm] 0.34 × 0.21 × 0.04 
Crystal description colorless platelet 
Crystal system monoclinic 
Space group Ia 
a [Å] 6.7309(4) 
b [Å] 13.6616(8) 
c [Å] 10.5298(6) 
α [°] 90 
β [°] 98.991(5) 
γ [°] 90 
V [Å 3] 956.37(10) 
Z 4 
ρcalc. [g cm−3] 1.404 
μ [mm-1] 0.101 
F(000) 424 
Θ range [°] 4.50–25.24 
Index ranges −6 ≤ h ≤ 8 
 −17 ≤ k ≤ 18 
 −14 ≤ l ≤ 10 
Reflns. collected 2910 
Reflns. obsd. 1390 
Reflns. unique 1546  
(Rint = 0.0286) 
R1, wR2 (2σ data) 0.0336, 0.0668 
R1, wR2 (all data) 0.0395, 0.0699 
GOOF on F2 1.039 
Peak/hole [e Å −3] 0.166 / −0.157 
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Table 24: Selected bond lengths (Å) of compound 159a. 
O1–C1 1.218(3) C6–C7 1.522(3) 
O2–C1 1.373(3) C7–C8 1.384(3) 
O2–C5 1.378(3) C7–C12 1.389(3) 
O3–C6 1.428(3) C8–C9 1.390(3) 
C1–C2 1.431(3) C9–C10 1.377(4) 
C2–C3 1.343(3) C10–C11 1.378(4) 
C3–C4 1.431(3) C11–C12 1.391(3) 
C4–C5 1.332(3) C5–C6 1.502(3) 
 
Table 25: Selected bond angles (°) of compound 159a. 
C1–O2–C5 122.2(2) C8–C7–C12 119.4(2) 
O1–C1–O2 116.6(2) C8–C7–C6 121.5(2) 
O1–C1–C2 126.7(2) C12–C7–C6 119.1(2) 
O2–C1–C2 116.7(2) C7–C8–C9 120.4(2) 
C3–C2–C1 121.1(2) C10–C9–C8 119.8(2) 
C2–C3–C4 119.7(2) C9–C10–C11 120.4(2) 
C5–C4–C3 119.4(2) C10–C11–C12 119.9(2) 
C4–C5–O2 120.8(2) C7–C12–C11 120.1(2) 
C4–C5–C6 128.8(2) O3–C6–C7 112.7(2) 
O2–C5–C6 110.4(2) C5–C6–C7 112.0(2) 
O3–C6–C5 106.0(2)   
Table 26: Selected torsion angles (°) of compound 159a. 
C5–O2–C1–O1 177.6(2) O2–C5–C6–C7 159.3(2) 
C5–O2–C1–C2 −2.6(3) O3–C6–C7–C8 −37.9(3) 
O1–C1–C2–C3 −177.3(2) C5–C6–C7–C8 81.6(3) 
O2–C1–C2–C3 2.9(3) O3–C6–C7–C12 143.4(2) 
C1–C2–C3–C4 −1.1(3) C5–C6–C7–C12 −97.2(2) 
C2–C3–C4–C5 −1.1(3) C12–C7–C8–C9 0.8(3) 
C3–C4–C5–O2 1.4(3) C6–C7–C8–C9 −177.9(2) 
C3–C4–C5–C6 −176.1(2) C7–C8–C9–C10 −0.8(4) 
C1–O2–C5–C4 0.5(3) C8–C9–C10–C11 0.2(4) 
C1–O2–C5–C6 178.4(2) C9–C10–C11–C12 0.3(4) 
C4–C5–C6–O3 100.3(3) C8–C7–C12–C11 −0.3(3) 
O2–C5–C6–O3 −77.4(2) C6–C7–C12–C11 178.5(2) 
C4–C5–C6–C7 −23.0(3) C10–C11–C12–C7 −0.3(3) 
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Table 27: Hydrogen bond data of compound 159a; angles in (°), distances in (Å). 
D–H ··· A  D–H H ··· A D ··· A D–H ··· A 
O3i–H3i ··· O1 0.997(10) 1.783(10) 2.773(2) 171.6(12) 
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3,5-Dibromo-6-iodo-2H-pyran-2-one (163a) 
CCDC-1851127 contains supplementary crystallographic data for this compound. These data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
Figure 7: Molecular structure of compound 163a in the crystal, DIAMOND representation; thermal ellipsoids 
are drawn at 50% probability level. 
 
Figure 8: Halogen bonding in the crystal structure of compound 163a, DIAMOND representation; thermal 
ellipsoids are drawn at 50% probability level. Symmetry codes: upper unlabeled molecule: 0.5-x, −0.5+y, 1.5−z; 
lower unlabeled molecule: x, −1+y, z; isolated bromine atom: 0.5−x, 0.5+y, 1.5−z. Sum of the van der Waals 
radii: Br/O: 337 pm, I/O: 350 pm. 
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Table 28: Details for X-ray data collection and structure refinement for compound 163a. 
 163a 
Empirical formula C5HBr2IO2 
Formula mass 379.78 
T[K] 143(2) 
Crystal size [mm] 0.30 × 0.10 × 0.05 
Crystal description dark yellow block 
Crystal system monoclinic 
Space group P21/n 
a [Å] 8.0015(3) 
b [Å] 8.9288(3) 
c [Å] 11.3513(5) 
α [°] 90 
β [°] 92.236(4) 
γ [°] 90 
V [Å 3] 810.36(5) 
Z 4 
ρcalc. [g cm-3] 3.113 
μ [mm-1] 13.748 
F(000) 680 
Θ range [°] 4.26–25.24 
Index ranges −11 ≤ h ≤ 11 
 −12 ≤ k ≤ 12 
 −16 ≤ l ≤ 16 
Reflns. collected 16311 
Reflns. obsd. 2068 
Reflns. unique 2469 
(Rint = 0.0457) 
R1, wR2 (2σ data) 0.0269, 0.0557 
R1, wR2 (all data) 0.0367, 0.0597 
GOOF on F2 1.024 
Peak/hole [e Ǻ-3] 1.206 / −1.036 
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Table 29: Selected bond lengths (Å) of compound 163a. 
I1–C5 2.066(3) O2–C1 1.379(4) 
Br2–C4 1.875(3) O1–C1 1.218(4) 
Br1–C2 1.873(3) C1–C2 1.445(5) 
C4–C5 1.342(5) C3–C2 1.350(4) 
C4–C3 1.436(4) O2–C5 1.366(4) 
Table 30: Selected bond angles (°) of compound 163a. 
C5–C4–C3 118.8(3) C3–C2–C1 120.9(3) 
C5–C4–Br2 122.9(3) C3–C2–Br1 121.8(3) 
C3–C4–Br2 118.2(2) C1–C2–Br1 117.3(2) 
C5–O2–C1 123.9(3) C4–C5–O2 120.5(3) 
O1–C1–O2 116.8(3) C4–C5–I1 127.8(2) 
O1–C1–C2 127.8(3) O2–C5–I1 111.6(2) 
O2–C1–C2 115.4(3) C2–C3–C4 120.3(3) 
Table 31: Selected torsion angles (°) of compound 163a. 
C5–O2–C1–O1 −179.2(3) O1–C1–C2–Br1 3.1(5) 
C5–O2–C1–C2 3.8(5) O2–C1–C2–Br1 179.8(2) 
C5–C4–C3–C2 0.7(5) C3–C4–C5–O2 2.7(5) 
Br2–C4–C3–C2 −177.7(3) Br2–C4–C5–O2 −179.0(2) 
C4–C3–C2–C1 −1.9(5) C3–C4–C5–I1 −177.1(2) 
C4–C3–C2–Br1 178.1(2) Br2–C4–C5–I1 1.2(5) 
O1–C1–C2–C3 −176.9(4) C1–O2–C5–C4 −5.1(5) 
O2–C1–C2–C3 −0.3(5) C1–O2–C5vI1 174.7(2) 
 
